User login
Analysis of Predictors and Outcomes of Allogeneic Blood Transfusion After Shoulder Arthroplasty
In shoulder arthroplasty, it is not uncommon for patients to receive postoperative blood transfusions; rates range from 7% to 43%.1-6 Allogeneic blood transfusions (ABTs) are costly and not entirely free of risks.7 The risk for infection has decreased because of improved screening and risk reduction strategies, but there are still significant risks associated with ABTs, such as clerical errors, acute and delayed hemolytic reactions, graft-versus-host reactions, transfusion-related acute lung injury, and anaphylaxis.8-10 As use of shoulder arthroplasty continues to increase, the importance of minimizing unnecessary transfusions is growing as well.7
Predictive factors for ABT have been explored in other orthopedic settings, yet little has been done in shoulder arthroplasty.1-6,11-15 Previous shoulder arthroplasty studies have shown that low preoperative hemoglobin (Hb) levels are independent risk factors for postoperative blood transfusion. However, there is debate over the significance of other variables, such as procedure type, age, sex, and medical comorbidities. Further, prior studies were limited by relatively small samples from single institutions; the largest series included fewer than 600 patients.1-6
We conducted a study to determine predictors of ABT in a large cohort of patients admitted to US hospitals for shoulder arthroplasty. We also wanted to evaluate the effect of ABT on postoperative outcomes, including inpatient mortality, adverse events, prolonged hospital stay, and nonroutine discharge. According to the null hypothesis, in shoulder arthroplasty there will be no difference in risk factors between patients who require ABT and those who did not, after accounting for confounding variables.
Materials and Methods
This study was exempt from institutional review board approval, as all data were appropriately deidentified before use in this project. We used the Nationwide Inpatient Sample (NIS) to retrospectively study the period 2002–2011, from which all demographic, clinical, and resource use data were derived.16 NIS, an annual survey conducted by the Agency for Healthcare Research and Quality (AHRQ) since 1988, has generated a huge amount of data, forming the largest all-payer inpatient care database in the United States. Yearly samples contain discharge data from about 8 million hospital stays at more than 1000 hospitals across 46 states, approximating a 20% random sample of all hospital discharges at participating institutions.17 These data are then weighted to generate statistically valid national estimates.
The NIS database uses International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes to identify 15 medical diagnoses up to the year 2008 and a maximum of 25 medical diagnoses and 15 procedures thereafter. In addition, the database includes information on patient and hospital characteristics as well as inpatient outcomes such as length of stay, total hospitalization charges, and discharge disposition.18,19 Given its large sample size and data volume, NIS is a powerful tool in the analysis of data associated with a multitude of medical diagnoses and procedures.20
We used the NIS database to study a population of 422,371 patients (age, >18 years) who underwent total shoulder arthroplasty (TSA) or hemiarthroplasty (HSA) between 2002 and 2011. ICD-9-CM procedure codes for TSA (81.80, 81.88) and HSA (81.81) were used to identify this population. We also analyzed data for reverse TSA for the year 2011. Then we divided our target population into 2 different cohorts: patients who did not receive any blood transfusion products and patients who received a transfusion of allogeneic packed cells (ICD-9-CM code 99.04 was used to identify the latter cohort).
In this study, normal distribution of the dataset was assumed, given the large sample size. The 2 cohorts were evaluated through bivariate analysis using the Pearson χ2 test for categorical data and the independent-samples t test for continuous data. The extent to which diagnosis, age, race, sex, and medical comorbidities were predictive of blood transfusion after TSA or HSA was evaluated through multivariate binary logistic regression analysis. Statistical significance was set at P < .05. All statistical analyses and data modeling were performed with SPSS Version 22.0.
Results
Using the NIS database, we stratified an estimated 422,371 patients who presented for shoulder arthroplasty between January 1, 2002, and December 31, 2011, into a TSA cohort (59.3%) and an HSA cohort (40.7%). Eight percent (33,889) of all patients received an ABT; the proportion of patients who received ABT was higher (P < .001) for the HSA cohort (55.6%) than the TSA cohort (39.4%). Further, the rate of ABT after shoulder arthroplasty showed an upward inclination (Figure).
Demographically, patients who received ABT tended (P < .001) to be older (74±11 years vs 68±11 years) and of a minority race (black or Hispanic) and to fall in either the lowest range of median household income (21.5% vs 20.7%; ≤$38,999) or the highest (27.3% vs 25.4%; ≥$63,000). Shoulder arthroplasty with ABT occurred more often (P < .001) at hospitals that were urban (13.3% vs 11.3%), medium in size (27.3% vs 23.4%), and nonteaching (56.2% vs 54.3%). In addition, ABT was used more often (P < .001) in patients with a primary diagnosis of fracture (43.1% vs 14.3%) or fracture nonunion (4.4% vs 2.1%). These groups also had a longer (P < .001) hospital stay (5.0±4.3 days vs 2.5±2.2 days). Table 1 summarizes these findings.
The 2 cohorts were then analyzed for presence of medical comorbidities (Table 2). Patients who required ABT during shoulder arthroplasty had a significantly (P < .001) higher prevalence of congestive heart failure, chronic lung disease, hypertension, uncomplicated and complicated diabetes mellitus, liver disease, renal failure, fluid and electrolyte disorders, pulmonary circulatory disease, weight loss, coagulopathy, and deficiency anemia.
In multivariate regression modeling (Table 3), demographic predictors of ABT (P < .001) included increasing age (odds ratio [OR], 1.03 per year; 95% confidence interval [95% CI], 1.03-1.03), female sex (OR, 1.55; 95% CI, 1.51-1.60), and minority race (black or Hispanic). Odds of requiring ABT were higher for patients with Medicare (OR, 1.25; 95% CI, 1.20-1.30) and patients with Medicaid (OR, 1.63; 95% CI, 1.51-1.77) than for patients with private insurance.
ABT was more likely to be required (P < .001) in patients with a primary diagnosis of fracture (OR, 4.49; 95% CI, 4.34-4.65), avascular necrosis (OR, 2.06; 95% CI, 1.91-2.22), rheumatoid arthritis (OR, 1.91; 95% CI, 1.72-2.12), fracture nonunion (OR, 3.55; 95% CI, 3.33-3.79), or rotator cuff arthropathy (OR, 1.47; 95% CI, 1.41-1.54) than for patients with osteoarthritis. Moreover, compared with patients having HSA, patients having TSA were more likely to require ABT (OR, 1.20; 95% CI, 1.17-1.24). According to the analysis restricted to the year 2011, compared with patients having anatomical TSAs, patients having reverse TSAs were 1.6 times more likely (P < .001) to require ABT (OR, 1.63; 95% CI, 1.50-1.79).
With the exception of obesity, all comorbidities were significant (P < .001) independent predictors of ABT after shoulder arthroplasty: deficiency anemia (OR, 3.42; 95% CI, 3.32-3.52), coagulopathy (OR, 2.54; 95% CI, 2.36-2.73), fluid and electrolyte disorders (OR, 1.91; 95% CI, 1.84-1.97), and weight loss (OR, 1.78; 95% CI, 1.58-2.00).
Patients who received ABT were more likely to experience adverse events (OR, 1.74; 95% CI, 1.68-1.81), prolonged hospital stay (OR, 3.21; 95% CI, 3.12-3.30), and nonroutine discharge (OR, 1.77; 95% CI, 1.72-1.82) (Table 4). There was no difference in mortality between the 2 cohorts.
Discussion
There is an abundance of literature on blood transfusions in hip and knee arthroplasty, but there are few articles on ABT in shoulder arthroplasty, and they all report data from single institutions with relatively low caseloads.1,2,11-13,15,21 In the present study, we investigated ABT in shoulder arthroplasty from the perspective of a multi-institutional database with a caseload of more than 400,000. Given the rapidly increasing rates of shoulder arthroplasty, it is important to further examine this issue to minimize unnecessary blood transfusion and its associated risks and costs.7
We found that 8% of patients who had shoulder arthroplasty received ABT, which is consistent with previously reported transfusion rates (range, 7%-43%).1-6 Rates of ABT after shoulder arthroplasty have continued to rise. The exception, a decrease during the year 2010, can be explained by increased efforts to more rigidly follow transfusion indication guidelines to reduce the number of potentially unnecessary ABTs.21-24 Our study also identified numerous significant independent predictors of ABT in shoulder arthroplasty: age, sex, race, insurance status, procedure type, primary diagnoses, and multiple medical comorbidities.
Demographics
According to our analysis, more than 80% of patients who received ABT were over age 65 years, which aligns with what several other studies have demonstrated: Increasing age is a predictor of ABT, despite higher rates of comorbidities and lower preoperative Hb levels in this population.1,2,4,5,25-27 Consistent with previous work, female sex was predictive of ABT.2,5 It has been suggested that females are more likely predisposed to ABT because of lower preoperative Hb and smaller blood mass.2,5,28 Interestingly, our study showed a higher likelihood of ABT in both black and Hispanic populations. Further, patients with Medicare or Medicaid were more likely to receive ABT.
Primary Diagnosis
Although patients with a primary diagnosis of osteoarthritis constitute the majority of patients who undergo shoulder arthroplasty, our analysis showed that patients with a diagnosis of proximal humerus fracture were more likely to receive ABT. This finding is reasonable given studies showing the high prevalence of proximal humerus fractures in elderly women.29,30 Similarly, patients with a humerus fracture nonunion were more likely to receive a blood transfusion, which is unsurprising given the increased complexity associated with arthroplasty in this predominately elderly population.31 Interestingly, compared with patients with osteoarthritis, patients with any one of the other primary diagnoses were more likely to require a transfusion—proximal humerus fracture being the most significant, followed by humerus fracture nonunion, avascular necrosis, rheumatoid arthritis, and rotator cuff arthropathy.
Type of Arthroplasty
Bivariate analysis revealed that 55.6% of the patients who received ABT underwent HSA; the other 44.4% underwent TSA. The effect of primary diagnosis on procedure choice likely played a role in this finding. HSA indications include humerus fracture, which has been associated with increased ABT, whereas patients with osteoarthritis requiring TSA are significantly less likely to require ABT, as reflected in this analysis.7,32-34 Previous studies have failed to show a difference in blood transfusion rates between TSA and HSA.2,4-6,35 Conversely, with confounding factors controlled for, multivariate logistic regression analysis showed that TSA was 1.2 times more likely than HSA to require ABT, which could be explained by the increased operative time, case complexity, and blood loss that may be associated with the glenoid exposure.36,37 With analysis restricted to the year 2011, patients with reverse TSAs were 1.6 times more likely than patients with anatomical TSAs to receive a blood transfusion (OR, 1.63; 95% CI, 1.50-1.79). Although this finding differs from what was previously reported, it fits given that patients having reverse TSAs are often older and may present with a more significant comorbidity profile.3 In addition, there are the increased technical surgical aspects associated with “salvage surgery” for challenging indications such as cuff arthropathy and failed previous arthroplasty.38-41
Medical Comorbidities
Patients who received ABT were more likely to present with numerous medical comorbidities. Previous studies have indicated that the presence of multiple medical comorbidities significantly increased blood transfusion rates, possibly by working synergistically.42 All studies of blood transfusion in shoulder arthroplasty concluded that lower preoperative Hb was an independent predictor.1-6 Schumer and colleagues4 reported a 4-fold increase in likelihood of blood transfusion in patients with a preoperative Hb level less than 12.5 g/dL. In addition, Millett and colleagues6 showed a 20-fold increase in likelihood of transfusion in patients with a preoperative Hb level less than 11.0 g/dL compared with patients with a level higher than 13.0 g/dL. Patients with a Hb level between 11.0 and 13.0 g/dL showed a 5-fold increase in likelihood of transfusion.6 We should note that correction of preoperative anemia through various pharmacologic methods (eg, erythropoietin, intravenous iron supplementation) has been shown to decrease postoperative transfusion rates.43,44 Although we could not include preoperative Hb levels in the present study, given inherent limitations in using NIS, our multivariate analysis showed that preoperative deficiency anemia and coagulopathy were the most significant predictors of ABT.
In addition, the multivariate logistic regression model showed that both cardiac disease and diabetes were independent predictors of ABT, confirming data reported by Ahmadi and colleagues.1 Although not as well characterized in other studies, in the current analysis multiple other medical comorbidities, including fluid and electrolyte abnormalities, weight loss, liver disease, renal failure, and chronic lung disease, had significant predictive value. Contrarily, obesity significantly decreased the odds of ABT, likely because of higher baseline blood volume in obese patients.
Patient Outcomes
Patients who undergo shoulder arthroplasty with ABT are more likely to experience adverse events or a prolonged hospital stay and are more often discharged to a nursing home or an extended-care facility. In this population, however, deaths did not occur at a significantly higher rate—similar to what was found for patients who underwent hip or knee arthroplasty with blood transfusions.45
Little has been done to investigate the effect of pharmacologic agents on the need for perioperative ABT for orthopedic shoulder procedures. Aprotinin, tranexamic acid, epoetin-α, and aminocaproic acid have all been effective in limiting ABT during the perioperative period in various orthopedic hip, knee, and spine procedures.9,46-53 Given the increased morbidity associated with ABT, it may be beneficial to use similar methods to limit blood loss in high-risk patients undergoing shoulder arthroplasty.
Study Limitations
NIS has intrinsic limitations. Given its massive volume, it is subject to errors in both data entry and clinical coding. Moreover, the database lacks data that would have been useful in our study: preoperative Hb levels, intraoperative course, number of units transfused, total blood loss, use of blood conservation techniques, transfusion protocols, and severity of comorbidities. Reverse TSA was given a unique ICD-9-CM code in October 2010, so 2011 was the only year we were able to examine the relationship between reverse TSA and transfusions. Further, our analysis was unable to identify any medications, including chronic anticoagulants or postoperative prophylaxis, that have been shown to significantly affect blood transfusion rates.54 Yet, there are obvious advantages to using the NIS database, as previously outlined across the medical landscape.
Conclusion
Our results confirmed previous findings and identified new predictors of ABT in shoulder arthroplasty in a large cohort. We examined demographics and perioperative complications while identifying predictors of ABT use. Patients who received ABT were older, female, and nonwhite and were covered by Medicare or Medicaid insurance, and many had a primary diagnosis of proximal humerus fracture. The ABT cohort had numerous medical comorbidities, including deficiency anemia and coagulopathy. Identifying this patient population is a prerequisite to educating patients while minimizing unnecessary risks and costs.
Using NIS data on a population of 422,371 patients who underwent shoulder arthroplasty, we identified the 5 likeliest predictors of ABT: fracture, fracture nonunion, deficiency anemia, coagulopathy, and avascular necrosis. Of the identified variables associated with ABT, deficiency anemia may be the most amenable to treatment; therefore, there may be benefit in delaying elective shoulder arthroplasty in this cohort. Given these findings, it is important to identify at-risk patients before surgery, with the intent to provide education and minimize risk.
1. Ahmadi S, Lawrence TM, Sahota S, et al. The incidence and risk factors for blood transfusion in revision shoulder arthroplasty: our institution’s experience and review of the literature. J Shoulder Elbow Surg. 2014;23(1):43-48.
2. Sperling JW, Duncan SF, Cofield RH, Schleck CD, Harmsen WS. Incidence and risk factors for blood transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2005;14(6):599-601.
3. Hardy JC, Hung M, Snow BJ, et al. Blood transfusion associated with shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(2):233-239.
4. Schumer RA, Chae JS, Markert RJ, Sprott D, Crosby LA. Predicting transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2010;19(1):91-96.
5. Gruson KI, Accousti KJ, Parsons BO, Pillai G, Flatow EL. Transfusion after shoulder arthroplasty: an analysis of rates and risk factors. J Shoulder Elbow Surg. 2009;18(2):225-230.
6. Millett PJ, Porramatikul M, Chen N, Zurakowski D, Warner JJ. Analysis of transfusion predictors in shoulder arthroplasty. J Bone Joint Surg Am. 2006;88(6):1223-1230.
7. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011;93(24):2249-2254.
8. Ceccherini-Nelli L, Filipponi F, Mosca F, Campa M. The risk of contracting an infectious disease from blood transfusion. Transplantation Proc. 2004;36(3):680-682.
9. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014;96(4):272-278.
10. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000;82(1):89-100.
11. Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013;95(19):1777-1783.
12. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br. 2004;86(7):970-973.
13. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28(8 suppl):34-37.
14. Yoshihara H, Yoneoka D. Predictors of allogeneic blood transfusion in spinal fusion in the United States, 2004–2009. Spine. 2014;39(4):304-310.
15. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty. 2012;27(6):961-967.
16. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Obstructive sleep apnea as a risk factor after shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(12):e6-e9.
17. Maynard C, Sales AE. Changes in the use of coronary artery revascularization procedures in the Department of Veterans Affairs, the National Hospital Discharge Survey, and the Nationwide Inpatient Sample, 1991–1999. BMC Health Serv Res. 2003;3(1):12.
18. Pereira BM, Chan PH, Weinstein PR, Fishman RA. Cerebral protection during reperfusion with superoxide dismutase in focal cerebral ischemia. Adv Neurol. 1990;52:97-103.
19. Hambright D, Henderson RA, Cook C, Worrell T, Moorman CT, Bolognesi MP. A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. J Shoulder Elbow Surg. 2011;20(1):77-85.
20. Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(5):671-678.
21. Pierson JL, Hannon TJ, Earles DR. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am. 2004;86(7):1512-1518.
22. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth. 2007;99(6):794-800.
23. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br. 2003;85(4):484-489.
24. Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg Br. 2012;94(11 suppl A):8-10.
25. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263-2268.
26. Rogers MA, Blumberg N, Heal JM, Langa KM. Utilization of blood transfusion among older adults in the United States. Transfusion. 2011;51(4):710-718.
27. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfusion Med. 2007;17(1):1-15.
28. Fosco M, Di Fiore M. Factors predicting blood transfusion in different surgical procedures for degenerative spine disease. Eur Rev Med Pharmacol Sci. 2012;16(13):1853-1858.
29. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2012;12:CD000434.
30. Neuhaus V, Swellengrebel CH, Bossen JK, Ring D. What are the factors influencing outcome among patients admitted to a hospital with a proximal humeral fracture? Clin Orthop Relat Res. 2013;471(5):1698-1706.
31. Volgas DA, Stannard JP, Alonso JE. Nonunions of the humerus. Clin Orthop Relat Res. 2004;(419):46-50.
32. Chambers L, Dines JS, Lorich DG, Dines DM. Hemiarthroplasty for proximal humerus fractures. Curr Rev Musculoskeletal Med. 2013;6(1):57-62.
33. Jain NB, Hocker S, Pietrobon R, Guller U, Bathia N, Higgins LD. Total arthroplasty versus hemiarthroplasty for glenohumeral osteoarthritis: role of provider volume. J Shoulder Elbow Surg. 2005;14(4):361-367.
34. Izquierdo R, Voloshin I, Edwards S, et al. Treatment of glenohumeral osteoarthritis. J Am Acad Orthop Surg. 2010;18(6):375-382.
35. Shields E, Iannuzzi JC, Thorsness R, Noyes K, Voloshin I. Perioperative complications after hemiarthroplasty and total shoulder arthroplasty are equivalent. J Shoulder Elbow Surg. 2014;23(10):1449-1453.
36. Gartsman GM, Roddey TS, Hammerman SM. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis. J Bone Joint Surg Am. 2000;82(1):26-34.
37. Singh A, Yian EH, Dillon MT, Takayanagi M, Burke MF, Navarro RA. The effect of surgeon and hospital volume on shoulder arthroplasty perioperative quality metrics. J Shoulder Elbow Surg. 2014;23(8):1187-1194.
38. Groh GI, Groh GM. Complications rates, reoperation rates, and the learning curve in reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(3):388-394.
39. Boileau P, Gonzalez JF, Chuinard C, Bicknell R, Walch G. Reverse total shoulder arthroplasty after failed rotator cuff surgery. J Shoulder Elbow Surg. 2009;18(4):600-606.
40. Boileau P, Watkinson D, Hatzidakis AM, Hovorka I. Neer Award 2005: the Grammont reverse shoulder prosthesis: results in cuff tear arthritis, fracture sequelae, and revision arthroplasty. J Shoulder Elbow Surg. 2006;15(5):527-540.
41. Boileau P, Watkinson DJ, Hatzidakis AM, Balg F. Grammont reverse prosthesis: design, rationale, and biomechanics. J Shoulder Elbow Surg. 2005;14(1 suppl S):147S-161S.
42. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2004;86(1):57-61.
43. Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Med Rev. 2013;27(4):221-234.
44. Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289-299.
45. Danninger T, Rasul R, Poeran J, et al. Blood transfusions in total hip and knee arthroplasty: an analysis of outcomes. ScientificWorldJournal. 2014;2014:623460.
46. Baldus CR, Bridwell KH, Lenke LG, Okubadejo GO. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls. Spine. 2010;35(2):235-239.
47. Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res. 2014;472(5):1552-1557.
48. Delasotta LA, Orozco F, Jafari SM, Blair JL, Ong A. Should we use preoperative epoetin-alpha in the mildly anemic patient undergoing simultaneous total knee arthroplasty? Open Orthop J. 2013;7:47-50.
49. Delasotta LA, Rangavajjula A, Frank ML, Blair J, Orozco F, Ong A. The use of preoperative epoetin-alpha in revision hip arthroplasty. Open Orthop J. 2012;6:179-183.
50. Kelley TC, Tucker KK, Adams MJ, Dalury DF. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion. 2014;54(1):26-30.
51. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty. 2014;29(5):889-894.
52. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev. 2008(3):CD006883.
53. Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1742-1752.
54. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty. 2004;19(3):281-287.
In shoulder arthroplasty, it is not uncommon for patients to receive postoperative blood transfusions; rates range from 7% to 43%.1-6 Allogeneic blood transfusions (ABTs) are costly and not entirely free of risks.7 The risk for infection has decreased because of improved screening and risk reduction strategies, but there are still significant risks associated with ABTs, such as clerical errors, acute and delayed hemolytic reactions, graft-versus-host reactions, transfusion-related acute lung injury, and anaphylaxis.8-10 As use of shoulder arthroplasty continues to increase, the importance of minimizing unnecessary transfusions is growing as well.7
Predictive factors for ABT have been explored in other orthopedic settings, yet little has been done in shoulder arthroplasty.1-6,11-15 Previous shoulder arthroplasty studies have shown that low preoperative hemoglobin (Hb) levels are independent risk factors for postoperative blood transfusion. However, there is debate over the significance of other variables, such as procedure type, age, sex, and medical comorbidities. Further, prior studies were limited by relatively small samples from single institutions; the largest series included fewer than 600 patients.1-6
We conducted a study to determine predictors of ABT in a large cohort of patients admitted to US hospitals for shoulder arthroplasty. We also wanted to evaluate the effect of ABT on postoperative outcomes, including inpatient mortality, adverse events, prolonged hospital stay, and nonroutine discharge. According to the null hypothesis, in shoulder arthroplasty there will be no difference in risk factors between patients who require ABT and those who did not, after accounting for confounding variables.
Materials and Methods
This study was exempt from institutional review board approval, as all data were appropriately deidentified before use in this project. We used the Nationwide Inpatient Sample (NIS) to retrospectively study the period 2002–2011, from which all demographic, clinical, and resource use data were derived.16 NIS, an annual survey conducted by the Agency for Healthcare Research and Quality (AHRQ) since 1988, has generated a huge amount of data, forming the largest all-payer inpatient care database in the United States. Yearly samples contain discharge data from about 8 million hospital stays at more than 1000 hospitals across 46 states, approximating a 20% random sample of all hospital discharges at participating institutions.17 These data are then weighted to generate statistically valid national estimates.
The NIS database uses International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes to identify 15 medical diagnoses up to the year 2008 and a maximum of 25 medical diagnoses and 15 procedures thereafter. In addition, the database includes information on patient and hospital characteristics as well as inpatient outcomes such as length of stay, total hospitalization charges, and discharge disposition.18,19 Given its large sample size and data volume, NIS is a powerful tool in the analysis of data associated with a multitude of medical diagnoses and procedures.20
We used the NIS database to study a population of 422,371 patients (age, >18 years) who underwent total shoulder arthroplasty (TSA) or hemiarthroplasty (HSA) between 2002 and 2011. ICD-9-CM procedure codes for TSA (81.80, 81.88) and HSA (81.81) were used to identify this population. We also analyzed data for reverse TSA for the year 2011. Then we divided our target population into 2 different cohorts: patients who did not receive any blood transfusion products and patients who received a transfusion of allogeneic packed cells (ICD-9-CM code 99.04 was used to identify the latter cohort).
In this study, normal distribution of the dataset was assumed, given the large sample size. The 2 cohorts were evaluated through bivariate analysis using the Pearson χ2 test for categorical data and the independent-samples t test for continuous data. The extent to which diagnosis, age, race, sex, and medical comorbidities were predictive of blood transfusion after TSA or HSA was evaluated through multivariate binary logistic regression analysis. Statistical significance was set at P < .05. All statistical analyses and data modeling were performed with SPSS Version 22.0.
Results
Using the NIS database, we stratified an estimated 422,371 patients who presented for shoulder arthroplasty between January 1, 2002, and December 31, 2011, into a TSA cohort (59.3%) and an HSA cohort (40.7%). Eight percent (33,889) of all patients received an ABT; the proportion of patients who received ABT was higher (P < .001) for the HSA cohort (55.6%) than the TSA cohort (39.4%). Further, the rate of ABT after shoulder arthroplasty showed an upward inclination (Figure).
Demographically, patients who received ABT tended (P < .001) to be older (74±11 years vs 68±11 years) and of a minority race (black or Hispanic) and to fall in either the lowest range of median household income (21.5% vs 20.7%; ≤$38,999) or the highest (27.3% vs 25.4%; ≥$63,000). Shoulder arthroplasty with ABT occurred more often (P < .001) at hospitals that were urban (13.3% vs 11.3%), medium in size (27.3% vs 23.4%), and nonteaching (56.2% vs 54.3%). In addition, ABT was used more often (P < .001) in patients with a primary diagnosis of fracture (43.1% vs 14.3%) or fracture nonunion (4.4% vs 2.1%). These groups also had a longer (P < .001) hospital stay (5.0±4.3 days vs 2.5±2.2 days). Table 1 summarizes these findings.
The 2 cohorts were then analyzed for presence of medical comorbidities (Table 2). Patients who required ABT during shoulder arthroplasty had a significantly (P < .001) higher prevalence of congestive heart failure, chronic lung disease, hypertension, uncomplicated and complicated diabetes mellitus, liver disease, renal failure, fluid and electrolyte disorders, pulmonary circulatory disease, weight loss, coagulopathy, and deficiency anemia.
In multivariate regression modeling (Table 3), demographic predictors of ABT (P < .001) included increasing age (odds ratio [OR], 1.03 per year; 95% confidence interval [95% CI], 1.03-1.03), female sex (OR, 1.55; 95% CI, 1.51-1.60), and minority race (black or Hispanic). Odds of requiring ABT were higher for patients with Medicare (OR, 1.25; 95% CI, 1.20-1.30) and patients with Medicaid (OR, 1.63; 95% CI, 1.51-1.77) than for patients with private insurance.
ABT was more likely to be required (P < .001) in patients with a primary diagnosis of fracture (OR, 4.49; 95% CI, 4.34-4.65), avascular necrosis (OR, 2.06; 95% CI, 1.91-2.22), rheumatoid arthritis (OR, 1.91; 95% CI, 1.72-2.12), fracture nonunion (OR, 3.55; 95% CI, 3.33-3.79), or rotator cuff arthropathy (OR, 1.47; 95% CI, 1.41-1.54) than for patients with osteoarthritis. Moreover, compared with patients having HSA, patients having TSA were more likely to require ABT (OR, 1.20; 95% CI, 1.17-1.24). According to the analysis restricted to the year 2011, compared with patients having anatomical TSAs, patients having reverse TSAs were 1.6 times more likely (P < .001) to require ABT (OR, 1.63; 95% CI, 1.50-1.79).
With the exception of obesity, all comorbidities were significant (P < .001) independent predictors of ABT after shoulder arthroplasty: deficiency anemia (OR, 3.42; 95% CI, 3.32-3.52), coagulopathy (OR, 2.54; 95% CI, 2.36-2.73), fluid and electrolyte disorders (OR, 1.91; 95% CI, 1.84-1.97), and weight loss (OR, 1.78; 95% CI, 1.58-2.00).
Patients who received ABT were more likely to experience adverse events (OR, 1.74; 95% CI, 1.68-1.81), prolonged hospital stay (OR, 3.21; 95% CI, 3.12-3.30), and nonroutine discharge (OR, 1.77; 95% CI, 1.72-1.82) (Table 4). There was no difference in mortality between the 2 cohorts.
Discussion
There is an abundance of literature on blood transfusions in hip and knee arthroplasty, but there are few articles on ABT in shoulder arthroplasty, and they all report data from single institutions with relatively low caseloads.1,2,11-13,15,21 In the present study, we investigated ABT in shoulder arthroplasty from the perspective of a multi-institutional database with a caseload of more than 400,000. Given the rapidly increasing rates of shoulder arthroplasty, it is important to further examine this issue to minimize unnecessary blood transfusion and its associated risks and costs.7
We found that 8% of patients who had shoulder arthroplasty received ABT, which is consistent with previously reported transfusion rates (range, 7%-43%).1-6 Rates of ABT after shoulder arthroplasty have continued to rise. The exception, a decrease during the year 2010, can be explained by increased efforts to more rigidly follow transfusion indication guidelines to reduce the number of potentially unnecessary ABTs.21-24 Our study also identified numerous significant independent predictors of ABT in shoulder arthroplasty: age, sex, race, insurance status, procedure type, primary diagnoses, and multiple medical comorbidities.
Demographics
According to our analysis, more than 80% of patients who received ABT were over age 65 years, which aligns with what several other studies have demonstrated: Increasing age is a predictor of ABT, despite higher rates of comorbidities and lower preoperative Hb levels in this population.1,2,4,5,25-27 Consistent with previous work, female sex was predictive of ABT.2,5 It has been suggested that females are more likely predisposed to ABT because of lower preoperative Hb and smaller blood mass.2,5,28 Interestingly, our study showed a higher likelihood of ABT in both black and Hispanic populations. Further, patients with Medicare or Medicaid were more likely to receive ABT.
Primary Diagnosis
Although patients with a primary diagnosis of osteoarthritis constitute the majority of patients who undergo shoulder arthroplasty, our analysis showed that patients with a diagnosis of proximal humerus fracture were more likely to receive ABT. This finding is reasonable given studies showing the high prevalence of proximal humerus fractures in elderly women.29,30 Similarly, patients with a humerus fracture nonunion were more likely to receive a blood transfusion, which is unsurprising given the increased complexity associated with arthroplasty in this predominately elderly population.31 Interestingly, compared with patients with osteoarthritis, patients with any one of the other primary diagnoses were more likely to require a transfusion—proximal humerus fracture being the most significant, followed by humerus fracture nonunion, avascular necrosis, rheumatoid arthritis, and rotator cuff arthropathy.
Type of Arthroplasty
Bivariate analysis revealed that 55.6% of the patients who received ABT underwent HSA; the other 44.4% underwent TSA. The effect of primary diagnosis on procedure choice likely played a role in this finding. HSA indications include humerus fracture, which has been associated with increased ABT, whereas patients with osteoarthritis requiring TSA are significantly less likely to require ABT, as reflected in this analysis.7,32-34 Previous studies have failed to show a difference in blood transfusion rates between TSA and HSA.2,4-6,35 Conversely, with confounding factors controlled for, multivariate logistic regression analysis showed that TSA was 1.2 times more likely than HSA to require ABT, which could be explained by the increased operative time, case complexity, and blood loss that may be associated with the glenoid exposure.36,37 With analysis restricted to the year 2011, patients with reverse TSAs were 1.6 times more likely than patients with anatomical TSAs to receive a blood transfusion (OR, 1.63; 95% CI, 1.50-1.79). Although this finding differs from what was previously reported, it fits given that patients having reverse TSAs are often older and may present with a more significant comorbidity profile.3 In addition, there are the increased technical surgical aspects associated with “salvage surgery” for challenging indications such as cuff arthropathy and failed previous arthroplasty.38-41
Medical Comorbidities
Patients who received ABT were more likely to present with numerous medical comorbidities. Previous studies have indicated that the presence of multiple medical comorbidities significantly increased blood transfusion rates, possibly by working synergistically.42 All studies of blood transfusion in shoulder arthroplasty concluded that lower preoperative Hb was an independent predictor.1-6 Schumer and colleagues4 reported a 4-fold increase in likelihood of blood transfusion in patients with a preoperative Hb level less than 12.5 g/dL. In addition, Millett and colleagues6 showed a 20-fold increase in likelihood of transfusion in patients with a preoperative Hb level less than 11.0 g/dL compared with patients with a level higher than 13.0 g/dL. Patients with a Hb level between 11.0 and 13.0 g/dL showed a 5-fold increase in likelihood of transfusion.6 We should note that correction of preoperative anemia through various pharmacologic methods (eg, erythropoietin, intravenous iron supplementation) has been shown to decrease postoperative transfusion rates.43,44 Although we could not include preoperative Hb levels in the present study, given inherent limitations in using NIS, our multivariate analysis showed that preoperative deficiency anemia and coagulopathy were the most significant predictors of ABT.
In addition, the multivariate logistic regression model showed that both cardiac disease and diabetes were independent predictors of ABT, confirming data reported by Ahmadi and colleagues.1 Although not as well characterized in other studies, in the current analysis multiple other medical comorbidities, including fluid and electrolyte abnormalities, weight loss, liver disease, renal failure, and chronic lung disease, had significant predictive value. Contrarily, obesity significantly decreased the odds of ABT, likely because of higher baseline blood volume in obese patients.
Patient Outcomes
Patients who undergo shoulder arthroplasty with ABT are more likely to experience adverse events or a prolonged hospital stay and are more often discharged to a nursing home or an extended-care facility. In this population, however, deaths did not occur at a significantly higher rate—similar to what was found for patients who underwent hip or knee arthroplasty with blood transfusions.45
Little has been done to investigate the effect of pharmacologic agents on the need for perioperative ABT for orthopedic shoulder procedures. Aprotinin, tranexamic acid, epoetin-α, and aminocaproic acid have all been effective in limiting ABT during the perioperative period in various orthopedic hip, knee, and spine procedures.9,46-53 Given the increased morbidity associated with ABT, it may be beneficial to use similar methods to limit blood loss in high-risk patients undergoing shoulder arthroplasty.
Study Limitations
NIS has intrinsic limitations. Given its massive volume, it is subject to errors in both data entry and clinical coding. Moreover, the database lacks data that would have been useful in our study: preoperative Hb levels, intraoperative course, number of units transfused, total blood loss, use of blood conservation techniques, transfusion protocols, and severity of comorbidities. Reverse TSA was given a unique ICD-9-CM code in October 2010, so 2011 was the only year we were able to examine the relationship between reverse TSA and transfusions. Further, our analysis was unable to identify any medications, including chronic anticoagulants or postoperative prophylaxis, that have been shown to significantly affect blood transfusion rates.54 Yet, there are obvious advantages to using the NIS database, as previously outlined across the medical landscape.
Conclusion
Our results confirmed previous findings and identified new predictors of ABT in shoulder arthroplasty in a large cohort. We examined demographics and perioperative complications while identifying predictors of ABT use. Patients who received ABT were older, female, and nonwhite and were covered by Medicare or Medicaid insurance, and many had a primary diagnosis of proximal humerus fracture. The ABT cohort had numerous medical comorbidities, including deficiency anemia and coagulopathy. Identifying this patient population is a prerequisite to educating patients while minimizing unnecessary risks and costs.
Using NIS data on a population of 422,371 patients who underwent shoulder arthroplasty, we identified the 5 likeliest predictors of ABT: fracture, fracture nonunion, deficiency anemia, coagulopathy, and avascular necrosis. Of the identified variables associated with ABT, deficiency anemia may be the most amenable to treatment; therefore, there may be benefit in delaying elective shoulder arthroplasty in this cohort. Given these findings, it is important to identify at-risk patients before surgery, with the intent to provide education and minimize risk.
In shoulder arthroplasty, it is not uncommon for patients to receive postoperative blood transfusions; rates range from 7% to 43%.1-6 Allogeneic blood transfusions (ABTs) are costly and not entirely free of risks.7 The risk for infection has decreased because of improved screening and risk reduction strategies, but there are still significant risks associated with ABTs, such as clerical errors, acute and delayed hemolytic reactions, graft-versus-host reactions, transfusion-related acute lung injury, and anaphylaxis.8-10 As use of shoulder arthroplasty continues to increase, the importance of minimizing unnecessary transfusions is growing as well.7
Predictive factors for ABT have been explored in other orthopedic settings, yet little has been done in shoulder arthroplasty.1-6,11-15 Previous shoulder arthroplasty studies have shown that low preoperative hemoglobin (Hb) levels are independent risk factors for postoperative blood transfusion. However, there is debate over the significance of other variables, such as procedure type, age, sex, and medical comorbidities. Further, prior studies were limited by relatively small samples from single institutions; the largest series included fewer than 600 patients.1-6
We conducted a study to determine predictors of ABT in a large cohort of patients admitted to US hospitals for shoulder arthroplasty. We also wanted to evaluate the effect of ABT on postoperative outcomes, including inpatient mortality, adverse events, prolonged hospital stay, and nonroutine discharge. According to the null hypothesis, in shoulder arthroplasty there will be no difference in risk factors between patients who require ABT and those who did not, after accounting for confounding variables.
Materials and Methods
This study was exempt from institutional review board approval, as all data were appropriately deidentified before use in this project. We used the Nationwide Inpatient Sample (NIS) to retrospectively study the period 2002–2011, from which all demographic, clinical, and resource use data were derived.16 NIS, an annual survey conducted by the Agency for Healthcare Research and Quality (AHRQ) since 1988, has generated a huge amount of data, forming the largest all-payer inpatient care database in the United States. Yearly samples contain discharge data from about 8 million hospital stays at more than 1000 hospitals across 46 states, approximating a 20% random sample of all hospital discharges at participating institutions.17 These data are then weighted to generate statistically valid national estimates.
The NIS database uses International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes to identify 15 medical diagnoses up to the year 2008 and a maximum of 25 medical diagnoses and 15 procedures thereafter. In addition, the database includes information on patient and hospital characteristics as well as inpatient outcomes such as length of stay, total hospitalization charges, and discharge disposition.18,19 Given its large sample size and data volume, NIS is a powerful tool in the analysis of data associated with a multitude of medical diagnoses and procedures.20
We used the NIS database to study a population of 422,371 patients (age, >18 years) who underwent total shoulder arthroplasty (TSA) or hemiarthroplasty (HSA) between 2002 and 2011. ICD-9-CM procedure codes for TSA (81.80, 81.88) and HSA (81.81) were used to identify this population. We also analyzed data for reverse TSA for the year 2011. Then we divided our target population into 2 different cohorts: patients who did not receive any blood transfusion products and patients who received a transfusion of allogeneic packed cells (ICD-9-CM code 99.04 was used to identify the latter cohort).
In this study, normal distribution of the dataset was assumed, given the large sample size. The 2 cohorts were evaluated through bivariate analysis using the Pearson χ2 test for categorical data and the independent-samples t test for continuous data. The extent to which diagnosis, age, race, sex, and medical comorbidities were predictive of blood transfusion after TSA or HSA was evaluated through multivariate binary logistic regression analysis. Statistical significance was set at P < .05. All statistical analyses and data modeling were performed with SPSS Version 22.0.
Results
Using the NIS database, we stratified an estimated 422,371 patients who presented for shoulder arthroplasty between January 1, 2002, and December 31, 2011, into a TSA cohort (59.3%) and an HSA cohort (40.7%). Eight percent (33,889) of all patients received an ABT; the proportion of patients who received ABT was higher (P < .001) for the HSA cohort (55.6%) than the TSA cohort (39.4%). Further, the rate of ABT after shoulder arthroplasty showed an upward inclination (Figure).
Demographically, patients who received ABT tended (P < .001) to be older (74±11 years vs 68±11 years) and of a minority race (black or Hispanic) and to fall in either the lowest range of median household income (21.5% vs 20.7%; ≤$38,999) or the highest (27.3% vs 25.4%; ≥$63,000). Shoulder arthroplasty with ABT occurred more often (P < .001) at hospitals that were urban (13.3% vs 11.3%), medium in size (27.3% vs 23.4%), and nonteaching (56.2% vs 54.3%). In addition, ABT was used more often (P < .001) in patients with a primary diagnosis of fracture (43.1% vs 14.3%) or fracture nonunion (4.4% vs 2.1%). These groups also had a longer (P < .001) hospital stay (5.0±4.3 days vs 2.5±2.2 days). Table 1 summarizes these findings.
The 2 cohorts were then analyzed for presence of medical comorbidities (Table 2). Patients who required ABT during shoulder arthroplasty had a significantly (P < .001) higher prevalence of congestive heart failure, chronic lung disease, hypertension, uncomplicated and complicated diabetes mellitus, liver disease, renal failure, fluid and electrolyte disorders, pulmonary circulatory disease, weight loss, coagulopathy, and deficiency anemia.
In multivariate regression modeling (Table 3), demographic predictors of ABT (P < .001) included increasing age (odds ratio [OR], 1.03 per year; 95% confidence interval [95% CI], 1.03-1.03), female sex (OR, 1.55; 95% CI, 1.51-1.60), and minority race (black or Hispanic). Odds of requiring ABT were higher for patients with Medicare (OR, 1.25; 95% CI, 1.20-1.30) and patients with Medicaid (OR, 1.63; 95% CI, 1.51-1.77) than for patients with private insurance.
ABT was more likely to be required (P < .001) in patients with a primary diagnosis of fracture (OR, 4.49; 95% CI, 4.34-4.65), avascular necrosis (OR, 2.06; 95% CI, 1.91-2.22), rheumatoid arthritis (OR, 1.91; 95% CI, 1.72-2.12), fracture nonunion (OR, 3.55; 95% CI, 3.33-3.79), or rotator cuff arthropathy (OR, 1.47; 95% CI, 1.41-1.54) than for patients with osteoarthritis. Moreover, compared with patients having HSA, patients having TSA were more likely to require ABT (OR, 1.20; 95% CI, 1.17-1.24). According to the analysis restricted to the year 2011, compared with patients having anatomical TSAs, patients having reverse TSAs were 1.6 times more likely (P < .001) to require ABT (OR, 1.63; 95% CI, 1.50-1.79).
With the exception of obesity, all comorbidities were significant (P < .001) independent predictors of ABT after shoulder arthroplasty: deficiency anemia (OR, 3.42; 95% CI, 3.32-3.52), coagulopathy (OR, 2.54; 95% CI, 2.36-2.73), fluid and electrolyte disorders (OR, 1.91; 95% CI, 1.84-1.97), and weight loss (OR, 1.78; 95% CI, 1.58-2.00).
Patients who received ABT were more likely to experience adverse events (OR, 1.74; 95% CI, 1.68-1.81), prolonged hospital stay (OR, 3.21; 95% CI, 3.12-3.30), and nonroutine discharge (OR, 1.77; 95% CI, 1.72-1.82) (Table 4). There was no difference in mortality between the 2 cohorts.
Discussion
There is an abundance of literature on blood transfusions in hip and knee arthroplasty, but there are few articles on ABT in shoulder arthroplasty, and they all report data from single institutions with relatively low caseloads.1,2,11-13,15,21 In the present study, we investigated ABT in shoulder arthroplasty from the perspective of a multi-institutional database with a caseload of more than 400,000. Given the rapidly increasing rates of shoulder arthroplasty, it is important to further examine this issue to minimize unnecessary blood transfusion and its associated risks and costs.7
We found that 8% of patients who had shoulder arthroplasty received ABT, which is consistent with previously reported transfusion rates (range, 7%-43%).1-6 Rates of ABT after shoulder arthroplasty have continued to rise. The exception, a decrease during the year 2010, can be explained by increased efforts to more rigidly follow transfusion indication guidelines to reduce the number of potentially unnecessary ABTs.21-24 Our study also identified numerous significant independent predictors of ABT in shoulder arthroplasty: age, sex, race, insurance status, procedure type, primary diagnoses, and multiple medical comorbidities.
Demographics
According to our analysis, more than 80% of patients who received ABT were over age 65 years, which aligns with what several other studies have demonstrated: Increasing age is a predictor of ABT, despite higher rates of comorbidities and lower preoperative Hb levels in this population.1,2,4,5,25-27 Consistent with previous work, female sex was predictive of ABT.2,5 It has been suggested that females are more likely predisposed to ABT because of lower preoperative Hb and smaller blood mass.2,5,28 Interestingly, our study showed a higher likelihood of ABT in both black and Hispanic populations. Further, patients with Medicare or Medicaid were more likely to receive ABT.
Primary Diagnosis
Although patients with a primary diagnosis of osteoarthritis constitute the majority of patients who undergo shoulder arthroplasty, our analysis showed that patients with a diagnosis of proximal humerus fracture were more likely to receive ABT. This finding is reasonable given studies showing the high prevalence of proximal humerus fractures in elderly women.29,30 Similarly, patients with a humerus fracture nonunion were more likely to receive a blood transfusion, which is unsurprising given the increased complexity associated with arthroplasty in this predominately elderly population.31 Interestingly, compared with patients with osteoarthritis, patients with any one of the other primary diagnoses were more likely to require a transfusion—proximal humerus fracture being the most significant, followed by humerus fracture nonunion, avascular necrosis, rheumatoid arthritis, and rotator cuff arthropathy.
Type of Arthroplasty
Bivariate analysis revealed that 55.6% of the patients who received ABT underwent HSA; the other 44.4% underwent TSA. The effect of primary diagnosis on procedure choice likely played a role in this finding. HSA indications include humerus fracture, which has been associated with increased ABT, whereas patients with osteoarthritis requiring TSA are significantly less likely to require ABT, as reflected in this analysis.7,32-34 Previous studies have failed to show a difference in blood transfusion rates between TSA and HSA.2,4-6,35 Conversely, with confounding factors controlled for, multivariate logistic regression analysis showed that TSA was 1.2 times more likely than HSA to require ABT, which could be explained by the increased operative time, case complexity, and blood loss that may be associated with the glenoid exposure.36,37 With analysis restricted to the year 2011, patients with reverse TSAs were 1.6 times more likely than patients with anatomical TSAs to receive a blood transfusion (OR, 1.63; 95% CI, 1.50-1.79). Although this finding differs from what was previously reported, it fits given that patients having reverse TSAs are often older and may present with a more significant comorbidity profile.3 In addition, there are the increased technical surgical aspects associated with “salvage surgery” for challenging indications such as cuff arthropathy and failed previous arthroplasty.38-41
Medical Comorbidities
Patients who received ABT were more likely to present with numerous medical comorbidities. Previous studies have indicated that the presence of multiple medical comorbidities significantly increased blood transfusion rates, possibly by working synergistically.42 All studies of blood transfusion in shoulder arthroplasty concluded that lower preoperative Hb was an independent predictor.1-6 Schumer and colleagues4 reported a 4-fold increase in likelihood of blood transfusion in patients with a preoperative Hb level less than 12.5 g/dL. In addition, Millett and colleagues6 showed a 20-fold increase in likelihood of transfusion in patients with a preoperative Hb level less than 11.0 g/dL compared with patients with a level higher than 13.0 g/dL. Patients with a Hb level between 11.0 and 13.0 g/dL showed a 5-fold increase in likelihood of transfusion.6 We should note that correction of preoperative anemia through various pharmacologic methods (eg, erythropoietin, intravenous iron supplementation) has been shown to decrease postoperative transfusion rates.43,44 Although we could not include preoperative Hb levels in the present study, given inherent limitations in using NIS, our multivariate analysis showed that preoperative deficiency anemia and coagulopathy were the most significant predictors of ABT.
In addition, the multivariate logistic regression model showed that both cardiac disease and diabetes were independent predictors of ABT, confirming data reported by Ahmadi and colleagues.1 Although not as well characterized in other studies, in the current analysis multiple other medical comorbidities, including fluid and electrolyte abnormalities, weight loss, liver disease, renal failure, and chronic lung disease, had significant predictive value. Contrarily, obesity significantly decreased the odds of ABT, likely because of higher baseline blood volume in obese patients.
Patient Outcomes
Patients who undergo shoulder arthroplasty with ABT are more likely to experience adverse events or a prolonged hospital stay and are more often discharged to a nursing home or an extended-care facility. In this population, however, deaths did not occur at a significantly higher rate—similar to what was found for patients who underwent hip or knee arthroplasty with blood transfusions.45
Little has been done to investigate the effect of pharmacologic agents on the need for perioperative ABT for orthopedic shoulder procedures. Aprotinin, tranexamic acid, epoetin-α, and aminocaproic acid have all been effective in limiting ABT during the perioperative period in various orthopedic hip, knee, and spine procedures.9,46-53 Given the increased morbidity associated with ABT, it may be beneficial to use similar methods to limit blood loss in high-risk patients undergoing shoulder arthroplasty.
Study Limitations
NIS has intrinsic limitations. Given its massive volume, it is subject to errors in both data entry and clinical coding. Moreover, the database lacks data that would have been useful in our study: preoperative Hb levels, intraoperative course, number of units transfused, total blood loss, use of blood conservation techniques, transfusion protocols, and severity of comorbidities. Reverse TSA was given a unique ICD-9-CM code in October 2010, so 2011 was the only year we were able to examine the relationship between reverse TSA and transfusions. Further, our analysis was unable to identify any medications, including chronic anticoagulants or postoperative prophylaxis, that have been shown to significantly affect blood transfusion rates.54 Yet, there are obvious advantages to using the NIS database, as previously outlined across the medical landscape.
Conclusion
Our results confirmed previous findings and identified new predictors of ABT in shoulder arthroplasty in a large cohort. We examined demographics and perioperative complications while identifying predictors of ABT use. Patients who received ABT were older, female, and nonwhite and were covered by Medicare or Medicaid insurance, and many had a primary diagnosis of proximal humerus fracture. The ABT cohort had numerous medical comorbidities, including deficiency anemia and coagulopathy. Identifying this patient population is a prerequisite to educating patients while minimizing unnecessary risks and costs.
Using NIS data on a population of 422,371 patients who underwent shoulder arthroplasty, we identified the 5 likeliest predictors of ABT: fracture, fracture nonunion, deficiency anemia, coagulopathy, and avascular necrosis. Of the identified variables associated with ABT, deficiency anemia may be the most amenable to treatment; therefore, there may be benefit in delaying elective shoulder arthroplasty in this cohort. Given these findings, it is important to identify at-risk patients before surgery, with the intent to provide education and minimize risk.
1. Ahmadi S, Lawrence TM, Sahota S, et al. The incidence and risk factors for blood transfusion in revision shoulder arthroplasty: our institution’s experience and review of the literature. J Shoulder Elbow Surg. 2014;23(1):43-48.
2. Sperling JW, Duncan SF, Cofield RH, Schleck CD, Harmsen WS. Incidence and risk factors for blood transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2005;14(6):599-601.
3. Hardy JC, Hung M, Snow BJ, et al. Blood transfusion associated with shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(2):233-239.
4. Schumer RA, Chae JS, Markert RJ, Sprott D, Crosby LA. Predicting transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2010;19(1):91-96.
5. Gruson KI, Accousti KJ, Parsons BO, Pillai G, Flatow EL. Transfusion after shoulder arthroplasty: an analysis of rates and risk factors. J Shoulder Elbow Surg. 2009;18(2):225-230.
6. Millett PJ, Porramatikul M, Chen N, Zurakowski D, Warner JJ. Analysis of transfusion predictors in shoulder arthroplasty. J Bone Joint Surg Am. 2006;88(6):1223-1230.
7. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011;93(24):2249-2254.
8. Ceccherini-Nelli L, Filipponi F, Mosca F, Campa M. The risk of contracting an infectious disease from blood transfusion. Transplantation Proc. 2004;36(3):680-682.
9. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014;96(4):272-278.
10. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000;82(1):89-100.
11. Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013;95(19):1777-1783.
12. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br. 2004;86(7):970-973.
13. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28(8 suppl):34-37.
14. Yoshihara H, Yoneoka D. Predictors of allogeneic blood transfusion in spinal fusion in the United States, 2004–2009. Spine. 2014;39(4):304-310.
15. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty. 2012;27(6):961-967.
16. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Obstructive sleep apnea as a risk factor after shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(12):e6-e9.
17. Maynard C, Sales AE. Changes in the use of coronary artery revascularization procedures in the Department of Veterans Affairs, the National Hospital Discharge Survey, and the Nationwide Inpatient Sample, 1991–1999. BMC Health Serv Res. 2003;3(1):12.
18. Pereira BM, Chan PH, Weinstein PR, Fishman RA. Cerebral protection during reperfusion with superoxide dismutase in focal cerebral ischemia. Adv Neurol. 1990;52:97-103.
19. Hambright D, Henderson RA, Cook C, Worrell T, Moorman CT, Bolognesi MP. A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. J Shoulder Elbow Surg. 2011;20(1):77-85.
20. Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(5):671-678.
21. Pierson JL, Hannon TJ, Earles DR. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am. 2004;86(7):1512-1518.
22. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth. 2007;99(6):794-800.
23. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br. 2003;85(4):484-489.
24. Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg Br. 2012;94(11 suppl A):8-10.
25. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263-2268.
26. Rogers MA, Blumberg N, Heal JM, Langa KM. Utilization of blood transfusion among older adults in the United States. Transfusion. 2011;51(4):710-718.
27. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfusion Med. 2007;17(1):1-15.
28. Fosco M, Di Fiore M. Factors predicting blood transfusion in different surgical procedures for degenerative spine disease. Eur Rev Med Pharmacol Sci. 2012;16(13):1853-1858.
29. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2012;12:CD000434.
30. Neuhaus V, Swellengrebel CH, Bossen JK, Ring D. What are the factors influencing outcome among patients admitted to a hospital with a proximal humeral fracture? Clin Orthop Relat Res. 2013;471(5):1698-1706.
31. Volgas DA, Stannard JP, Alonso JE. Nonunions of the humerus. Clin Orthop Relat Res. 2004;(419):46-50.
32. Chambers L, Dines JS, Lorich DG, Dines DM. Hemiarthroplasty for proximal humerus fractures. Curr Rev Musculoskeletal Med. 2013;6(1):57-62.
33. Jain NB, Hocker S, Pietrobon R, Guller U, Bathia N, Higgins LD. Total arthroplasty versus hemiarthroplasty for glenohumeral osteoarthritis: role of provider volume. J Shoulder Elbow Surg. 2005;14(4):361-367.
34. Izquierdo R, Voloshin I, Edwards S, et al. Treatment of glenohumeral osteoarthritis. J Am Acad Orthop Surg. 2010;18(6):375-382.
35. Shields E, Iannuzzi JC, Thorsness R, Noyes K, Voloshin I. Perioperative complications after hemiarthroplasty and total shoulder arthroplasty are equivalent. J Shoulder Elbow Surg. 2014;23(10):1449-1453.
36. Gartsman GM, Roddey TS, Hammerman SM. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis. J Bone Joint Surg Am. 2000;82(1):26-34.
37. Singh A, Yian EH, Dillon MT, Takayanagi M, Burke MF, Navarro RA. The effect of surgeon and hospital volume on shoulder arthroplasty perioperative quality metrics. J Shoulder Elbow Surg. 2014;23(8):1187-1194.
38. Groh GI, Groh GM. Complications rates, reoperation rates, and the learning curve in reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(3):388-394.
39. Boileau P, Gonzalez JF, Chuinard C, Bicknell R, Walch G. Reverse total shoulder arthroplasty after failed rotator cuff surgery. J Shoulder Elbow Surg. 2009;18(4):600-606.
40. Boileau P, Watkinson D, Hatzidakis AM, Hovorka I. Neer Award 2005: the Grammont reverse shoulder prosthesis: results in cuff tear arthritis, fracture sequelae, and revision arthroplasty. J Shoulder Elbow Surg. 2006;15(5):527-540.
41. Boileau P, Watkinson DJ, Hatzidakis AM, Balg F. Grammont reverse prosthesis: design, rationale, and biomechanics. J Shoulder Elbow Surg. 2005;14(1 suppl S):147S-161S.
42. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2004;86(1):57-61.
43. Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Med Rev. 2013;27(4):221-234.
44. Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289-299.
45. Danninger T, Rasul R, Poeran J, et al. Blood transfusions in total hip and knee arthroplasty: an analysis of outcomes. ScientificWorldJournal. 2014;2014:623460.
46. Baldus CR, Bridwell KH, Lenke LG, Okubadejo GO. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls. Spine. 2010;35(2):235-239.
47. Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res. 2014;472(5):1552-1557.
48. Delasotta LA, Orozco F, Jafari SM, Blair JL, Ong A. Should we use preoperative epoetin-alpha in the mildly anemic patient undergoing simultaneous total knee arthroplasty? Open Orthop J. 2013;7:47-50.
49. Delasotta LA, Rangavajjula A, Frank ML, Blair J, Orozco F, Ong A. The use of preoperative epoetin-alpha in revision hip arthroplasty. Open Orthop J. 2012;6:179-183.
50. Kelley TC, Tucker KK, Adams MJ, Dalury DF. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion. 2014;54(1):26-30.
51. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty. 2014;29(5):889-894.
52. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev. 2008(3):CD006883.
53. Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1742-1752.
54. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty. 2004;19(3):281-287.
1. Ahmadi S, Lawrence TM, Sahota S, et al. The incidence and risk factors for blood transfusion in revision shoulder arthroplasty: our institution’s experience and review of the literature. J Shoulder Elbow Surg. 2014;23(1):43-48.
2. Sperling JW, Duncan SF, Cofield RH, Schleck CD, Harmsen WS. Incidence and risk factors for blood transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2005;14(6):599-601.
3. Hardy JC, Hung M, Snow BJ, et al. Blood transfusion associated with shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(2):233-239.
4. Schumer RA, Chae JS, Markert RJ, Sprott D, Crosby LA. Predicting transfusion in shoulder arthroplasty. J Shoulder Elbow Surg. 2010;19(1):91-96.
5. Gruson KI, Accousti KJ, Parsons BO, Pillai G, Flatow EL. Transfusion after shoulder arthroplasty: an analysis of rates and risk factors. J Shoulder Elbow Surg. 2009;18(2):225-230.
6. Millett PJ, Porramatikul M, Chen N, Zurakowski D, Warner JJ. Analysis of transfusion predictors in shoulder arthroplasty. J Bone Joint Surg Am. 2006;88(6):1223-1230.
7. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011;93(24):2249-2254.
8. Ceccherini-Nelli L, Filipponi F, Mosca F, Campa M. The risk of contracting an infectious disease from blood transfusion. Transplantation Proc. 2004;36(3):680-682.
9. Friedman R, Homering M, Holberg G, Berkowitz SD. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014;96(4):272-278.
10. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000;82(1):89-100.
11. Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013;95(19):1777-1783.
12. Aderinto J, Brenkel IJ. Pre-operative predictors of the requirement for blood transfusion following total hip replacement. J Bone Joint Surg Br. 2004;86(7):970-973.
13. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28(8 suppl):34-37.
14. Yoshihara H, Yoneoka D. Predictors of allogeneic blood transfusion in spinal fusion in the United States, 2004–2009. Spine. 2014;39(4):304-310.
15. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty. 2012;27(6):961-967.
16. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Obstructive sleep apnea as a risk factor after shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(12):e6-e9.
17. Maynard C, Sales AE. Changes in the use of coronary artery revascularization procedures in the Department of Veterans Affairs, the National Hospital Discharge Survey, and the Nationwide Inpatient Sample, 1991–1999. BMC Health Serv Res. 2003;3(1):12.
18. Pereira BM, Chan PH, Weinstein PR, Fishman RA. Cerebral protection during reperfusion with superoxide dismutase in focal cerebral ischemia. Adv Neurol. 1990;52:97-103.
19. Hambright D, Henderson RA, Cook C, Worrell T, Moorman CT, Bolognesi MP. A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. J Shoulder Elbow Surg. 2011;20(1):77-85.
20. Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(5):671-678.
21. Pierson JL, Hannon TJ, Earles DR. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone Joint Surg Am. 2004;86(7):1512-1518.
22. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth. 2007;99(6):794-800.
23. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br. 2003;85(4):484-489.
24. Watts CD, Pagnano MW. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Joint Surg Br. 2012;94(11 suppl A):8-10.
25. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263-2268.
26. Rogers MA, Blumberg N, Heal JM, Langa KM. Utilization of blood transfusion among older adults in the United States. Transfusion. 2011;51(4):710-718.
27. Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfusion Med. 2007;17(1):1-15.
28. Fosco M, Di Fiore M. Factors predicting blood transfusion in different surgical procedures for degenerative spine disease. Eur Rev Med Pharmacol Sci. 2012;16(13):1853-1858.
29. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2012;12:CD000434.
30. Neuhaus V, Swellengrebel CH, Bossen JK, Ring D. What are the factors influencing outcome among patients admitted to a hospital with a proximal humeral fracture? Clin Orthop Relat Res. 2013;471(5):1698-1706.
31. Volgas DA, Stannard JP, Alonso JE. Nonunions of the humerus. Clin Orthop Relat Res. 2004;(419):46-50.
32. Chambers L, Dines JS, Lorich DG, Dines DM. Hemiarthroplasty for proximal humerus fractures. Curr Rev Musculoskeletal Med. 2013;6(1):57-62.
33. Jain NB, Hocker S, Pietrobon R, Guller U, Bathia N, Higgins LD. Total arthroplasty versus hemiarthroplasty for glenohumeral osteoarthritis: role of provider volume. J Shoulder Elbow Surg. 2005;14(4):361-367.
34. Izquierdo R, Voloshin I, Edwards S, et al. Treatment of glenohumeral osteoarthritis. J Am Acad Orthop Surg. 2010;18(6):375-382.
35. Shields E, Iannuzzi JC, Thorsness R, Noyes K, Voloshin I. Perioperative complications after hemiarthroplasty and total shoulder arthroplasty are equivalent. J Shoulder Elbow Surg. 2014;23(10):1449-1453.
36. Gartsman GM, Roddey TS, Hammerman SM. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis. J Bone Joint Surg Am. 2000;82(1):26-34.
37. Singh A, Yian EH, Dillon MT, Takayanagi M, Burke MF, Navarro RA. The effect of surgeon and hospital volume on shoulder arthroplasty perioperative quality metrics. J Shoulder Elbow Surg. 2014;23(8):1187-1194.
38. Groh GI, Groh GM. Complications rates, reoperation rates, and the learning curve in reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(3):388-394.
39. Boileau P, Gonzalez JF, Chuinard C, Bicknell R, Walch G. Reverse total shoulder arthroplasty after failed rotator cuff surgery. J Shoulder Elbow Surg. 2009;18(4):600-606.
40. Boileau P, Watkinson D, Hatzidakis AM, Hovorka I. Neer Award 2005: the Grammont reverse shoulder prosthesis: results in cuff tear arthritis, fracture sequelae, and revision arthroplasty. J Shoulder Elbow Surg. 2006;15(5):527-540.
41. Boileau P, Watkinson DJ, Hatzidakis AM, Balg F. Grammont reverse prosthesis: design, rationale, and biomechanics. J Shoulder Elbow Surg. 2005;14(1 suppl S):147S-161S.
42. Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2004;86(1):57-61.
43. Lin DM, Lin ES, Tran MH. Efficacy and safety of erythropoietin and intravenous iron in perioperative blood management: a systematic review. Transfusion Med Rev. 2013;27(4):221-234.
44. Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289-299.
45. Danninger T, Rasul R, Poeran J, et al. Blood transfusions in total hip and knee arthroplasty: an analysis of outcomes. ScientificWorldJournal. 2014;2014:623460.
46. Baldus CR, Bridwell KH, Lenke LG, Okubadejo GO. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls. Spine. 2010;35(2):235-239.
47. Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res. 2014;472(5):1552-1557.
48. Delasotta LA, Orozco F, Jafari SM, Blair JL, Ong A. Should we use preoperative epoetin-alpha in the mildly anemic patient undergoing simultaneous total knee arthroplasty? Open Orthop J. 2013;7:47-50.
49. Delasotta LA, Rangavajjula A, Frank ML, Blair J, Orozco F, Ong A. The use of preoperative epoetin-alpha in revision hip arthroplasty. Open Orthop J. 2012;6:179-183.
50. Kelley TC, Tucker KK, Adams MJ, Dalury DF. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion. 2014;54(1):26-30.
51. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH. Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty. 2014;29(5):889-894.
52. Tzortzopoulou A, Cepeda MS, Schumann R, Carr DB. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev. 2008(3):CD006883.
53. Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1742-1752.
54. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty. 2004;19(3):281-287.
Is the Orthopedic Fellowship Interview Process Broken? A Survey of Program Directors and Residents
Over the past several decades, an increasing number of orthopedic surgery residents have pursued fellowship training.1 This inclination parallels market trends toward subspecialization.2-5 In 1984, 83% of orthopedics job announcements were for general orthopedists. Twenty-five years later, almost 70% of orthopedic opportunities were for fellowship-trained surgeons.6 Further, between 1990 and 2006, the proportion of practicing orthopedic generalists decreased from 44% to 29%.3 In 2007, the American Academy of Orthopaedic Surgery (AAOS) reported 90% of graduating residents were planning to pursue fellowship training.7 Reasons for the explosion in subspecialty training are plentiful and well documented.2-5 Subspecialty positions now dominate the job market, further reinforcing incentives for residents to pursue fellowship training.
The past several decades have seen numerous changes in the orthopedic fellowship interview process. Early on, it was largely unregulated, dependent on personal and professional connections, and flush with the classic “exploding offer” (residents were given a fellowship offer that expired within hours or days). In the 1980s, as the number of fellowship applications surged, the Accreditation Council for Graduate Medical Education (ACGME) pushed for a more regulated process.8 To further standardize the system, the American Orthopaedic Association (AOA), the AAOS, and several other specialty organizations created the Orthopaedic Fellowship Match Program Initiative in 2008.9 Currently, all orthopedic specialties are represented in either the San Francisco Match Program or National Residency Match Program.
As the system currently stands, postgraduate year 4 (PGY-4) residents are required to interview across the country to secure postgraduate training. This process necessitates residents’ absence from their program, reducing educational opportunities and placing potential continuity-of-care constraints on the residency program. Despite the growing competitiveness for fellowship positions, the increasing number of fellowships available, the rising educational debt of residents, and the limitations of the 80-hour work week, the impact of the interview process on both residents and residency programs has received minimal attention.
We conducted a study to elucidate the impact of the fellowship interview process on residents and residency programs. We hypothesized the time and financial costs for fellowship interviews would be substantial.
Materials and Methods
We obtained institutional review board (IRB) approval for this study. Then, in April 2014, we sent 2 mixed-response questionnaires to orthopedic surgery residency directors and residents. There were 8 items on the director questionnaire and 11 on the resident questionnaire. The surveys were designed to determine the impact of the fellowship interview process on residents and residency programs with respect to finances, time, education, and continuity of care. Each survey had at least 1 free-response question, providing the opportunity to recommend changes to the interview process. The surveys were reviewed and approved by our IRB.
An email was sent to 155 orthopedic surgery program directors or their secretaries. The email asked that the director complete the director questionnaire and that the resident questionnaire be forwarded to senior-level residents, PGY-4s and PGY-5s, who had completed the fellowship interview process. Forty-five (29%) of the 155 directors responded, as did 129 (estimated 9.5%) of an estimated 1354 potential PGY-4s and PGY-5s.10
The Survey Monkey surveys could be completed over a 3-week period. All responses were anonymous. Using Survey Monkey, we aggregated individual responses into predefined clusters before performing statistical analysis. Descriptive statistics were generated with Microsoft Excel.
Results
Survey respondents represented all the orthopedic subspecialties (Table). Seventy-eight percent of residents applied to at least 13 programs (average, 19) (Figure 1). Ninety-two percent received at least 8 interview offers (average, 14). Eighty-three percent attended 8 or more interviews (average, 11). Seventy-one percent of all interviews were granted when requested, and 79% of all interviews were attended when offered.
Residents spent an average of $5875 (range, $500-$12,000+) on the fellowship interview process (Figure 2). The highest percentage of respondents, 39.5%, selected an average expense between $4000 and $6000. Forty-nine percent of residents borrowed money (from credit cards, additional loans, family members) to pay their expenses.
Average number of days away from residency programs was 11, with 86% of residents missing more than 8 days (Figure 1). About one-third of residents reported being away from their home program for almost 2 weeks during the interview season. Further, 74% of residents wanted changes made to the fellowship application process.
Thirty-seven (82%) of the 45 program directors were from academic programs, the other 8 from community-based programs. Average number of residents in programs per year was 4 (73% of the programs had 4-6 residents per year). Respondents rated the disruption caused by residents’ interview absences from 1 (least disruptive) to 10 (most disruptive) (Figure 3); the average rating was over 7 (high level of disruption). Although 9% of directors thought the process caused little or no disruption (rating, 1-3), 62% thought it extremely disruptive (rating, 8-10).
Thirty-one (69%) of the 45 directors agreed that the fellowship interview process should undergo fundamental change. Asked about possible solutions to current complaints, 60% of the directors agreed that interviews should be conducted in a central location. Of the directors who thought fundamental change was needed, 59% indicated AAOS and other specialty societies together should lead the change in the fellowship interview process.
Both residents and program directors were given the opportunity to write in suggestions regarding how to improve the fellowship interview process. Suggestions were made by 85 (66%) of the 129 residents and 24 (53%) of the 45 directors (Appendix).
Discussion
Graduating residents are entering a health care environment in which they must be financially conscious because of increasing education debt and decreasing reimbursement prospects.3 Nevertheless, an overwhelming majority of residents delay entering practice to pursue fellowship training—an estimated opportunity cost of $350,000.3 Minimal attention has been given to the potential costs of the fellowship interview process.
Our study results highlight that time away from residency training, financial costs associated with the fellowship interview process, and disruption of the residency program are substantial. On average, residents applied to 19 programs, received 14 interview offers, attended 11 interviews, were away from residency training 11 days, and spent $5875 on travel. The great majority of both residents and program directors wanted changes in the current paradigm governing the orthopedic fellowship interview process.
It is reasonable to think that the number of days residents spend away on interviews would reduce the time available for education and patient care. Although unknown, it is plausible that residents of programs outside major metropolitan centers and residents who apply to more competitive fellowships may be forced to spend even more time away from training. Outside the focus of this study are the impact that residents’ absence might have on their education and the impact of this absence on the people who do the residents’ work while they are away.
Mean fellowship expense was similar to that reported by residents pursuing a pediatric general surgery fellowship ($6974) or a plastic surgery fellowship ($6100).11,12 Unfortunately, we were unable to determine if average cost is influenced by choice of fellowship specialty or location of residency program. Regardless, fellowship cost may impose an additional financial burden on residents. According to the Association of American Medical Colleges (AAMC), the median salary for PGY-4 residents was $56,380 in 2013. Therefore, on average, the fellowship process consumes more than 10% of a resident’s pretax salary. For perspective, this equates to more than $40,000 for a practicing orthopedic surgeon with a median salary of $413,000.13 With an average medical student graduate debt of $175,000 and continuing decreases in reimbursement, further financial hardships to newly graduating residents cannot be understated.5,11,12
Almost 70% of program directors thought the fellowship process significantly disrupted their program. Reasons given for this disruption mainly involved residents’ time away from the program and the resulting strains placed on maintaining adequate coverage for patient care. The overall disruption score of 7.4 out of 10 was consistent with the great majority thinking that the fellowship process negatively affects their residency program. Altering the fellowship interview process may provide unintended benefits to programs and program directors.
Both program directors and residents communicated that change is needed, but there was little consensus regarding how to effect change and who should lead. This lack of consensus highlights how important it is for the various orthopedic leadership committees to actively and collectively participate in discussions about redefining the system. It has been proposed that it would be ideal for the AOA to lead the change, as the AOA consists of a representative cohort of academic orthopedists and leaders across the spectrum of all fellowship specialties.14 Given the abundant concern of both residents and program directors, we find it prudent to issue a call to arms of sorts to the AAOS and the individual orthopedic subspecialty societies to work together on a common goal that would benefit residents, programs, and subspecialties within orthopedics.
In trying to understand the challenges that residents, program directors, and programs face, as well as the inherent complexity of the current system, we incorporated respondents’ write-in comments into suggested ways of improving the fellowship interview process. These comments had broad perspectives but overall were consistent with the survey results (Appendix).
Technology
Health care is continually finding new ways to take advantage of technological advances. This is occurring with the fellowship interview schema. Numerous disciplines are using videoconferencing platforms (eg, Skype) to conduct interviews. This practice is becoming more commonplace in the business sector. In a recent survey, more than 60% of human resource managers reported conducting video interviews.15 Two independent residency programs have used video interviews with mixed success.16,17
Another technological change requested by residents is the creation and updating of fellowship web pages with standardized information. Such a service may prove useful to residents researching a program and may even lead to limiting the number of programs residents apply to, as they may be able to dial in on exactly what distinguishes one program from another before traveling for an interview. A recent study of orthopedic sports medicine fellowship programs found that most of these programs lacked pertinent information on their websites.18 Important information regarding case logs from current and former fellows; number of faculty, residents, and fellows; and schedules and facilities of interview sites are a few of the online data points that may help residents differentiate particular programs.19,20 Questions like these are often asked at interviews and site visits. Having accurate information easily available online may reduce or eliminate the need to travel to a site for such information. Standardizing information would also increase transparency among available fellowships. Although not specifically mentioned, organizational software that improves the productivity of the process may help limit the large number of programs applied to, the interviews offered and attended, the days away, and the financial costs without reducing the match rate.
Timing and Location
The issue of timing—with respect to geographical or meteorological concerns—was another recurring theme among respondents. Numerous respondents indicated that certain programs located in geographic proximity tried to minimize travel by offering interviews around the same time. This coordination potentially minimizes travel expenses and time away from the residency program by allowing residents to interview at multiple locations during a single trip per region. The sports medicine fellowship process was identified as a good example of aligning interviews based on geography. Several respondents suggested an option that also reflects the practice of nonsurgical fellowships—delaying the interview season to bypass potential weather concerns. Winter 2013–2014 saw the most flight delays or cancellations in more than a decade; about 50% of all flights scheduled between December and February were delayed or canceled.21 Beyond the additional factor of more time away or missing an interview because of the weather are safety concerns related to the weather. One resident reported having a motor vehicle accident while traveling to an interview in poor weather conditions (Appendix).
National Meetings
Each orthopedic subspecialty has numerous national meetings. Many programs offer applicants the opportunity to interview at these meetings. One respondent mentioned that the annual meeting of the Orthopaedic Trauma Association offers trauma applicants the opportunity to interview with multiple programs. It might be beneficial to endorse this practice on a larger scale to help reduce travel and time away. We recognize that visiting individual programs is an important aspect of the match process, but doing so on a targeted level may make more sense, increasing financial efficiency and reducing time away from programs.
Proposed Solution
A combined proposed solution that can be implemented without a radical overhaul or significant investments might involve moving the interview season to early spring, switching to a 2-tiered system with a centralized first round of interview screening coinciding with subspecialty national meetings or the AAOS annual meeting, and standardizing online information for all orthopedic fellowship programs. A 2-tiered interview process would allow programs and candidates to obtain exposure to a significant number of programs in the first round without incurring significant costs and then would impose a cap on the number of programs to visit. This would level the playing field between candidates with more time and money and candidates who are more constrained in their training environment and finances. A stopgap or adjunct to residents or fellowship programs unable to attend a centralized meeting would be to combine technological tools, such as Internet-based videoconferencing (Skype), before site visits by residents. After this first round of introductions and interviews, residents could then decide on a limited number of programs to formally visit, attend, and ultimately rank. This proposed system would still be able to function within the confines of the match, and it would benefit from the protections offered to residents and programs. Although capping the number of interviews attended by residents clearly can lower costs across the board, we recognize the difficulty of enforcing such a requirement. These potential changes to the system are not exhaustive, and we hope this work will serve as a springboard to further discussion.
Our study had several inherent weaknesses. Our data came from survey responses, which reflect the perspectives only of the responding residents and program directors. Unfortunately, a small number of orthopedic residents responded to this survey, so there was a potential for bias. However, we think the central themes discovered in this survey are only echoes of the concerns of the larger population of residents and program directors. Our hope in designing such a study was to bring to light some of the discrepancies in the fellowship interview process, the goal being to stimulate interest among the orthopedic leadership representing future orthopedic surgeons. More study is needed to clarify if these issues are reflective of a larger segment of residents and program directors. In addition, action may be needed to fully elucidate the intricate interworking of the fellowship process in order to maximize the interest of the orthopedic surgeons who are seeking fellowship training. Another study limitation was the potential for recall bias in the more senior PGY-5 residents, who were further from the interview process than PGY-4 respondents were. Because of the need for anonymity with the surveys, we could not link some findings (eg, program impact, cost, time away) to individual programs or different specialty fellowships. Although it appears there is a desire for a more cost-effective system, given the financial pressures on medical students and residents, the desire to match increases costs because students are likely to attend more interviews than actually needed. Our proposed solution does not take into account residents’ behavior with respect to the current match system. For example, the prevailing thought is that interviewing at more programs increases the likelihood of matching into a desired subspecialty. Despite these study limitations, we think our results identified important points for discussion, investigation, and potential action by orthopedic leadership.
Conclusion
The challenge of critiquing and improving the orthopedic fellowship process requires the same courageous leadership that was recommended almost a decade ago.14 In this study, we tried to elucidate the impact of the PGY-4 fellowship interview process with respect to residents and residency programs. Our results highlight that time away from residency training, financial costs associated with the fellowship interview process, and disruption of the residency program are substantial and that both residents and program directors want changes made. Leadership needs to further investigate alternatives to the current process to lessen the impact on all parties in this important process.
1. Simon MA. Evolution of the present status of orthopaedic surgery fellowships. J Bone Joint Surg Am. 1998;80(12):1826-1829.
2. Brunworth LS, Chintalapani SR, Gray RR, Cardoso R, Owens PW. Resident selection of hand surgery fellowships: a survey of the 2011, 2012, and 2013 hand fellowship graduates. Hand. 2013;8(2):164-171.
3. Gaskill T, Cook C, Nunley J, Mather RC. The financial impact of orthopaedic fellowship training. J Bone Joint Surg Am. 2009;91(7):1814-1821.
4. Sarmiento A. Additional thoughts on orthopedic residency and fellowships. Orthopedics. 2010;33(10):712-713.
5. Griffin SM, Stoneback JW. Navigating the Orthopaedic Trauma Fellowship Match from a candidate’s perspective. J Orthop Trauma. 2011;25(suppl 3):S101-S103.
6. Morrell NT, Mercer DM, Moneim MS. Trends in the orthopedic job market and the importance of fellowship subspecialty training. Orthopedics. 2012;35(4):e555-e560.
7. Iorio R, Robb WJ, Healy WL, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90(7):1598-1605.
8. Emery SE, Guss D, Kuremsky MA, Hamlin BR, Herndon JH, Rubash HE. Resident education versus fellowship training—conflict or synergy? AOA critical issues. J Bone Joint Surg Am. 2012;94(21):e159.
9. Harner CD, Ranawat AS, Niederle M, et al. AOA symposium. Current state of fellowship hiring: is a universal match necessary? Is it possible? J Bone Joint Surg Am. 2008;90(6):1375-1384.
10. Ranawat A, Nunley RM, Genuario JW, Sharan AD, Mehta S; Washington Health Policy Fellows. Current state of the fellowship hiring process: Are we in 1957 or 2007? AAOS Now. 2007;1(8).
11. Little DC, Yoder SM, Grikscheit TC, et al. Cost considerations and applicant characteristics for the Pediatric Surgery Match. J Pediatr Surg. 2005;40(1):69-73.
12. Claiborne JR, Crantford JC, Swett KR, David LR. The Plastic Surgery Match: predicting success and improving the process. Ann Plast Surg. 2013;70(6):698-703.
13. Kane L, Peckham C. Medscape Physician Compensation Report 2014. http://www.medscape.com/features/slideshow/compensation/2014/public/overview. Published April 15, 2014. Accessed September 26, 2015.
14. Swiontkowski MF. A simple formula for continued improvement in orthopaedic surgery postgraduate training: courageous leadership. J Bone Joint Surg Am. 2008;90(6):1175.
15. Survey: six in 10 companies conduct video job interviews [news release]. http://www.prnewswire.com/news-releases/survey-six-in-10-companies-conduct-video-job-interviews-167973406.html. Published August 30, 2012. Accessed September 26, 2015.
16. Kerfoot BP, Asher KP, McCullough DL. Financial and educational costs of the residency interview process for urology applicants. Urology. 2008;71(6):990-994.
17. Edje L, Miller C, Kiefer J, Oram D. Using Skype as an alternative for residency selection interviews. J Grad Med Educ. 2013;5(3):503-505.
18. Mulcahey MK, Gosselin MM, Fadale PD. Evaluation of the content and accessibility of web sites for accredited orthopaedic sports medicine fellowships. J Bone Joint Surg Am. 2013;95(12):e85.
19. Gaeta TJ, Birkhahn RH, Lamont D, Banga N, Bove JJ. Aspects of residency programs’ web sites important to student applicants. Acad Emerg Med. 2005;12(1):89-92.
20. Mahler SA, Wagner MJ, Church A, Sokolosky M, Cline DM. Importance of residency program web sites to emergency medicine applicants. J Emerg Med. 2009;36(1):83-88.
21. Davies A. Winter’s toll: 1 million flights cancelled or delayed, costing travelers $5.3 billion. Business Insider. http://www.businessinsider.com/winter-flights-cancelled-delayed-cost-2014-3. Published March 3, 2014. Accessed September 26, 2015.
Over the past several decades, an increasing number of orthopedic surgery residents have pursued fellowship training.1 This inclination parallels market trends toward subspecialization.2-5 In 1984, 83% of orthopedics job announcements were for general orthopedists. Twenty-five years later, almost 70% of orthopedic opportunities were for fellowship-trained surgeons.6 Further, between 1990 and 2006, the proportion of practicing orthopedic generalists decreased from 44% to 29%.3 In 2007, the American Academy of Orthopaedic Surgery (AAOS) reported 90% of graduating residents were planning to pursue fellowship training.7 Reasons for the explosion in subspecialty training are plentiful and well documented.2-5 Subspecialty positions now dominate the job market, further reinforcing incentives for residents to pursue fellowship training.
The past several decades have seen numerous changes in the orthopedic fellowship interview process. Early on, it was largely unregulated, dependent on personal and professional connections, and flush with the classic “exploding offer” (residents were given a fellowship offer that expired within hours or days). In the 1980s, as the number of fellowship applications surged, the Accreditation Council for Graduate Medical Education (ACGME) pushed for a more regulated process.8 To further standardize the system, the American Orthopaedic Association (AOA), the AAOS, and several other specialty organizations created the Orthopaedic Fellowship Match Program Initiative in 2008.9 Currently, all orthopedic specialties are represented in either the San Francisco Match Program or National Residency Match Program.
As the system currently stands, postgraduate year 4 (PGY-4) residents are required to interview across the country to secure postgraduate training. This process necessitates residents’ absence from their program, reducing educational opportunities and placing potential continuity-of-care constraints on the residency program. Despite the growing competitiveness for fellowship positions, the increasing number of fellowships available, the rising educational debt of residents, and the limitations of the 80-hour work week, the impact of the interview process on both residents and residency programs has received minimal attention.
We conducted a study to elucidate the impact of the fellowship interview process on residents and residency programs. We hypothesized the time and financial costs for fellowship interviews would be substantial.
Materials and Methods
We obtained institutional review board (IRB) approval for this study. Then, in April 2014, we sent 2 mixed-response questionnaires to orthopedic surgery residency directors and residents. There were 8 items on the director questionnaire and 11 on the resident questionnaire. The surveys were designed to determine the impact of the fellowship interview process on residents and residency programs with respect to finances, time, education, and continuity of care. Each survey had at least 1 free-response question, providing the opportunity to recommend changes to the interview process. The surveys were reviewed and approved by our IRB.
An email was sent to 155 orthopedic surgery program directors or their secretaries. The email asked that the director complete the director questionnaire and that the resident questionnaire be forwarded to senior-level residents, PGY-4s and PGY-5s, who had completed the fellowship interview process. Forty-five (29%) of the 155 directors responded, as did 129 (estimated 9.5%) of an estimated 1354 potential PGY-4s and PGY-5s.10
The Survey Monkey surveys could be completed over a 3-week period. All responses were anonymous. Using Survey Monkey, we aggregated individual responses into predefined clusters before performing statistical analysis. Descriptive statistics were generated with Microsoft Excel.
Results
Survey respondents represented all the orthopedic subspecialties (Table). Seventy-eight percent of residents applied to at least 13 programs (average, 19) (Figure 1). Ninety-two percent received at least 8 interview offers (average, 14). Eighty-three percent attended 8 or more interviews (average, 11). Seventy-one percent of all interviews were granted when requested, and 79% of all interviews were attended when offered.
Residents spent an average of $5875 (range, $500-$12,000+) on the fellowship interview process (Figure 2). The highest percentage of respondents, 39.5%, selected an average expense between $4000 and $6000. Forty-nine percent of residents borrowed money (from credit cards, additional loans, family members) to pay their expenses.
Average number of days away from residency programs was 11, with 86% of residents missing more than 8 days (Figure 1). About one-third of residents reported being away from their home program for almost 2 weeks during the interview season. Further, 74% of residents wanted changes made to the fellowship application process.
Thirty-seven (82%) of the 45 program directors were from academic programs, the other 8 from community-based programs. Average number of residents in programs per year was 4 (73% of the programs had 4-6 residents per year). Respondents rated the disruption caused by residents’ interview absences from 1 (least disruptive) to 10 (most disruptive) (Figure 3); the average rating was over 7 (high level of disruption). Although 9% of directors thought the process caused little or no disruption (rating, 1-3), 62% thought it extremely disruptive (rating, 8-10).
Thirty-one (69%) of the 45 directors agreed that the fellowship interview process should undergo fundamental change. Asked about possible solutions to current complaints, 60% of the directors agreed that interviews should be conducted in a central location. Of the directors who thought fundamental change was needed, 59% indicated AAOS and other specialty societies together should lead the change in the fellowship interview process.
Both residents and program directors were given the opportunity to write in suggestions regarding how to improve the fellowship interview process. Suggestions were made by 85 (66%) of the 129 residents and 24 (53%) of the 45 directors (Appendix).
Discussion
Graduating residents are entering a health care environment in which they must be financially conscious because of increasing education debt and decreasing reimbursement prospects.3 Nevertheless, an overwhelming majority of residents delay entering practice to pursue fellowship training—an estimated opportunity cost of $350,000.3 Minimal attention has been given to the potential costs of the fellowship interview process.
Our study results highlight that time away from residency training, financial costs associated with the fellowship interview process, and disruption of the residency program are substantial. On average, residents applied to 19 programs, received 14 interview offers, attended 11 interviews, were away from residency training 11 days, and spent $5875 on travel. The great majority of both residents and program directors wanted changes in the current paradigm governing the orthopedic fellowship interview process.
It is reasonable to think that the number of days residents spend away on interviews would reduce the time available for education and patient care. Although unknown, it is plausible that residents of programs outside major metropolitan centers and residents who apply to more competitive fellowships may be forced to spend even more time away from training. Outside the focus of this study are the impact that residents’ absence might have on their education and the impact of this absence on the people who do the residents’ work while they are away.
Mean fellowship expense was similar to that reported by residents pursuing a pediatric general surgery fellowship ($6974) or a plastic surgery fellowship ($6100).11,12 Unfortunately, we were unable to determine if average cost is influenced by choice of fellowship specialty or location of residency program. Regardless, fellowship cost may impose an additional financial burden on residents. According to the Association of American Medical Colleges (AAMC), the median salary for PGY-4 residents was $56,380 in 2013. Therefore, on average, the fellowship process consumes more than 10% of a resident’s pretax salary. For perspective, this equates to more than $40,000 for a practicing orthopedic surgeon with a median salary of $413,000.13 With an average medical student graduate debt of $175,000 and continuing decreases in reimbursement, further financial hardships to newly graduating residents cannot be understated.5,11,12
Almost 70% of program directors thought the fellowship process significantly disrupted their program. Reasons given for this disruption mainly involved residents’ time away from the program and the resulting strains placed on maintaining adequate coverage for patient care. The overall disruption score of 7.4 out of 10 was consistent with the great majority thinking that the fellowship process negatively affects their residency program. Altering the fellowship interview process may provide unintended benefits to programs and program directors.
Both program directors and residents communicated that change is needed, but there was little consensus regarding how to effect change and who should lead. This lack of consensus highlights how important it is for the various orthopedic leadership committees to actively and collectively participate in discussions about redefining the system. It has been proposed that it would be ideal for the AOA to lead the change, as the AOA consists of a representative cohort of academic orthopedists and leaders across the spectrum of all fellowship specialties.14 Given the abundant concern of both residents and program directors, we find it prudent to issue a call to arms of sorts to the AAOS and the individual orthopedic subspecialty societies to work together on a common goal that would benefit residents, programs, and subspecialties within orthopedics.
In trying to understand the challenges that residents, program directors, and programs face, as well as the inherent complexity of the current system, we incorporated respondents’ write-in comments into suggested ways of improving the fellowship interview process. These comments had broad perspectives but overall were consistent with the survey results (Appendix).
Technology
Health care is continually finding new ways to take advantage of technological advances. This is occurring with the fellowship interview schema. Numerous disciplines are using videoconferencing platforms (eg, Skype) to conduct interviews. This practice is becoming more commonplace in the business sector. In a recent survey, more than 60% of human resource managers reported conducting video interviews.15 Two independent residency programs have used video interviews with mixed success.16,17
Another technological change requested by residents is the creation and updating of fellowship web pages with standardized information. Such a service may prove useful to residents researching a program and may even lead to limiting the number of programs residents apply to, as they may be able to dial in on exactly what distinguishes one program from another before traveling for an interview. A recent study of orthopedic sports medicine fellowship programs found that most of these programs lacked pertinent information on their websites.18 Important information regarding case logs from current and former fellows; number of faculty, residents, and fellows; and schedules and facilities of interview sites are a few of the online data points that may help residents differentiate particular programs.19,20 Questions like these are often asked at interviews and site visits. Having accurate information easily available online may reduce or eliminate the need to travel to a site for such information. Standardizing information would also increase transparency among available fellowships. Although not specifically mentioned, organizational software that improves the productivity of the process may help limit the large number of programs applied to, the interviews offered and attended, the days away, and the financial costs without reducing the match rate.
Timing and Location
The issue of timing—with respect to geographical or meteorological concerns—was another recurring theme among respondents. Numerous respondents indicated that certain programs located in geographic proximity tried to minimize travel by offering interviews around the same time. This coordination potentially minimizes travel expenses and time away from the residency program by allowing residents to interview at multiple locations during a single trip per region. The sports medicine fellowship process was identified as a good example of aligning interviews based on geography. Several respondents suggested an option that also reflects the practice of nonsurgical fellowships—delaying the interview season to bypass potential weather concerns. Winter 2013–2014 saw the most flight delays or cancellations in more than a decade; about 50% of all flights scheduled between December and February were delayed or canceled.21 Beyond the additional factor of more time away or missing an interview because of the weather are safety concerns related to the weather. One resident reported having a motor vehicle accident while traveling to an interview in poor weather conditions (Appendix).
National Meetings
Each orthopedic subspecialty has numerous national meetings. Many programs offer applicants the opportunity to interview at these meetings. One respondent mentioned that the annual meeting of the Orthopaedic Trauma Association offers trauma applicants the opportunity to interview with multiple programs. It might be beneficial to endorse this practice on a larger scale to help reduce travel and time away. We recognize that visiting individual programs is an important aspect of the match process, but doing so on a targeted level may make more sense, increasing financial efficiency and reducing time away from programs.
Proposed Solution
A combined proposed solution that can be implemented without a radical overhaul or significant investments might involve moving the interview season to early spring, switching to a 2-tiered system with a centralized first round of interview screening coinciding with subspecialty national meetings or the AAOS annual meeting, and standardizing online information for all orthopedic fellowship programs. A 2-tiered interview process would allow programs and candidates to obtain exposure to a significant number of programs in the first round without incurring significant costs and then would impose a cap on the number of programs to visit. This would level the playing field between candidates with more time and money and candidates who are more constrained in their training environment and finances. A stopgap or adjunct to residents or fellowship programs unable to attend a centralized meeting would be to combine technological tools, such as Internet-based videoconferencing (Skype), before site visits by residents. After this first round of introductions and interviews, residents could then decide on a limited number of programs to formally visit, attend, and ultimately rank. This proposed system would still be able to function within the confines of the match, and it would benefit from the protections offered to residents and programs. Although capping the number of interviews attended by residents clearly can lower costs across the board, we recognize the difficulty of enforcing such a requirement. These potential changes to the system are not exhaustive, and we hope this work will serve as a springboard to further discussion.
Our study had several inherent weaknesses. Our data came from survey responses, which reflect the perspectives only of the responding residents and program directors. Unfortunately, a small number of orthopedic residents responded to this survey, so there was a potential for bias. However, we think the central themes discovered in this survey are only echoes of the concerns of the larger population of residents and program directors. Our hope in designing such a study was to bring to light some of the discrepancies in the fellowship interview process, the goal being to stimulate interest among the orthopedic leadership representing future orthopedic surgeons. More study is needed to clarify if these issues are reflective of a larger segment of residents and program directors. In addition, action may be needed to fully elucidate the intricate interworking of the fellowship process in order to maximize the interest of the orthopedic surgeons who are seeking fellowship training. Another study limitation was the potential for recall bias in the more senior PGY-5 residents, who were further from the interview process than PGY-4 respondents were. Because of the need for anonymity with the surveys, we could not link some findings (eg, program impact, cost, time away) to individual programs or different specialty fellowships. Although it appears there is a desire for a more cost-effective system, given the financial pressures on medical students and residents, the desire to match increases costs because students are likely to attend more interviews than actually needed. Our proposed solution does not take into account residents’ behavior with respect to the current match system. For example, the prevailing thought is that interviewing at more programs increases the likelihood of matching into a desired subspecialty. Despite these study limitations, we think our results identified important points for discussion, investigation, and potential action by orthopedic leadership.
Conclusion
The challenge of critiquing and improving the orthopedic fellowship process requires the same courageous leadership that was recommended almost a decade ago.14 In this study, we tried to elucidate the impact of the PGY-4 fellowship interview process with respect to residents and residency programs. Our results highlight that time away from residency training, financial costs associated with the fellowship interview process, and disruption of the residency program are substantial and that both residents and program directors want changes made. Leadership needs to further investigate alternatives to the current process to lessen the impact on all parties in this important process.
Over the past several decades, an increasing number of orthopedic surgery residents have pursued fellowship training.1 This inclination parallels market trends toward subspecialization.2-5 In 1984, 83% of orthopedics job announcements were for general orthopedists. Twenty-five years later, almost 70% of orthopedic opportunities were for fellowship-trained surgeons.6 Further, between 1990 and 2006, the proportion of practicing orthopedic generalists decreased from 44% to 29%.3 In 2007, the American Academy of Orthopaedic Surgery (AAOS) reported 90% of graduating residents were planning to pursue fellowship training.7 Reasons for the explosion in subspecialty training are plentiful and well documented.2-5 Subspecialty positions now dominate the job market, further reinforcing incentives for residents to pursue fellowship training.
The past several decades have seen numerous changes in the orthopedic fellowship interview process. Early on, it was largely unregulated, dependent on personal and professional connections, and flush with the classic “exploding offer” (residents were given a fellowship offer that expired within hours or days). In the 1980s, as the number of fellowship applications surged, the Accreditation Council for Graduate Medical Education (ACGME) pushed for a more regulated process.8 To further standardize the system, the American Orthopaedic Association (AOA), the AAOS, and several other specialty organizations created the Orthopaedic Fellowship Match Program Initiative in 2008.9 Currently, all orthopedic specialties are represented in either the San Francisco Match Program or National Residency Match Program.
As the system currently stands, postgraduate year 4 (PGY-4) residents are required to interview across the country to secure postgraduate training. This process necessitates residents’ absence from their program, reducing educational opportunities and placing potential continuity-of-care constraints on the residency program. Despite the growing competitiveness for fellowship positions, the increasing number of fellowships available, the rising educational debt of residents, and the limitations of the 80-hour work week, the impact of the interview process on both residents and residency programs has received minimal attention.
We conducted a study to elucidate the impact of the fellowship interview process on residents and residency programs. We hypothesized the time and financial costs for fellowship interviews would be substantial.
Materials and Methods
We obtained institutional review board (IRB) approval for this study. Then, in April 2014, we sent 2 mixed-response questionnaires to orthopedic surgery residency directors and residents. There were 8 items on the director questionnaire and 11 on the resident questionnaire. The surveys were designed to determine the impact of the fellowship interview process on residents and residency programs with respect to finances, time, education, and continuity of care. Each survey had at least 1 free-response question, providing the opportunity to recommend changes to the interview process. The surveys were reviewed and approved by our IRB.
An email was sent to 155 orthopedic surgery program directors or their secretaries. The email asked that the director complete the director questionnaire and that the resident questionnaire be forwarded to senior-level residents, PGY-4s and PGY-5s, who had completed the fellowship interview process. Forty-five (29%) of the 155 directors responded, as did 129 (estimated 9.5%) of an estimated 1354 potential PGY-4s and PGY-5s.10
The Survey Monkey surveys could be completed over a 3-week period. All responses were anonymous. Using Survey Monkey, we aggregated individual responses into predefined clusters before performing statistical analysis. Descriptive statistics were generated with Microsoft Excel.
Results
Survey respondents represented all the orthopedic subspecialties (Table). Seventy-eight percent of residents applied to at least 13 programs (average, 19) (Figure 1). Ninety-two percent received at least 8 interview offers (average, 14). Eighty-three percent attended 8 or more interviews (average, 11). Seventy-one percent of all interviews were granted when requested, and 79% of all interviews were attended when offered.
Residents spent an average of $5875 (range, $500-$12,000+) on the fellowship interview process (Figure 2). The highest percentage of respondents, 39.5%, selected an average expense between $4000 and $6000. Forty-nine percent of residents borrowed money (from credit cards, additional loans, family members) to pay their expenses.
Average number of days away from residency programs was 11, with 86% of residents missing more than 8 days (Figure 1). About one-third of residents reported being away from their home program for almost 2 weeks during the interview season. Further, 74% of residents wanted changes made to the fellowship application process.
Thirty-seven (82%) of the 45 program directors were from academic programs, the other 8 from community-based programs. Average number of residents in programs per year was 4 (73% of the programs had 4-6 residents per year). Respondents rated the disruption caused by residents’ interview absences from 1 (least disruptive) to 10 (most disruptive) (Figure 3); the average rating was over 7 (high level of disruption). Although 9% of directors thought the process caused little or no disruption (rating, 1-3), 62% thought it extremely disruptive (rating, 8-10).
Thirty-one (69%) of the 45 directors agreed that the fellowship interview process should undergo fundamental change. Asked about possible solutions to current complaints, 60% of the directors agreed that interviews should be conducted in a central location. Of the directors who thought fundamental change was needed, 59% indicated AAOS and other specialty societies together should lead the change in the fellowship interview process.
Both residents and program directors were given the opportunity to write in suggestions regarding how to improve the fellowship interview process. Suggestions were made by 85 (66%) of the 129 residents and 24 (53%) of the 45 directors (Appendix).
Discussion
Graduating residents are entering a health care environment in which they must be financially conscious because of increasing education debt and decreasing reimbursement prospects.3 Nevertheless, an overwhelming majority of residents delay entering practice to pursue fellowship training—an estimated opportunity cost of $350,000.3 Minimal attention has been given to the potential costs of the fellowship interview process.
Our study results highlight that time away from residency training, financial costs associated with the fellowship interview process, and disruption of the residency program are substantial. On average, residents applied to 19 programs, received 14 interview offers, attended 11 interviews, were away from residency training 11 days, and spent $5875 on travel. The great majority of both residents and program directors wanted changes in the current paradigm governing the orthopedic fellowship interview process.
It is reasonable to think that the number of days residents spend away on interviews would reduce the time available for education and patient care. Although unknown, it is plausible that residents of programs outside major metropolitan centers and residents who apply to more competitive fellowships may be forced to spend even more time away from training. Outside the focus of this study are the impact that residents’ absence might have on their education and the impact of this absence on the people who do the residents’ work while they are away.
Mean fellowship expense was similar to that reported by residents pursuing a pediatric general surgery fellowship ($6974) or a plastic surgery fellowship ($6100).11,12 Unfortunately, we were unable to determine if average cost is influenced by choice of fellowship specialty or location of residency program. Regardless, fellowship cost may impose an additional financial burden on residents. According to the Association of American Medical Colleges (AAMC), the median salary for PGY-4 residents was $56,380 in 2013. Therefore, on average, the fellowship process consumes more than 10% of a resident’s pretax salary. For perspective, this equates to more than $40,000 for a practicing orthopedic surgeon with a median salary of $413,000.13 With an average medical student graduate debt of $175,000 and continuing decreases in reimbursement, further financial hardships to newly graduating residents cannot be understated.5,11,12
Almost 70% of program directors thought the fellowship process significantly disrupted their program. Reasons given for this disruption mainly involved residents’ time away from the program and the resulting strains placed on maintaining adequate coverage for patient care. The overall disruption score of 7.4 out of 10 was consistent with the great majority thinking that the fellowship process negatively affects their residency program. Altering the fellowship interview process may provide unintended benefits to programs and program directors.
Both program directors and residents communicated that change is needed, but there was little consensus regarding how to effect change and who should lead. This lack of consensus highlights how important it is for the various orthopedic leadership committees to actively and collectively participate in discussions about redefining the system. It has been proposed that it would be ideal for the AOA to lead the change, as the AOA consists of a representative cohort of academic orthopedists and leaders across the spectrum of all fellowship specialties.14 Given the abundant concern of both residents and program directors, we find it prudent to issue a call to arms of sorts to the AAOS and the individual orthopedic subspecialty societies to work together on a common goal that would benefit residents, programs, and subspecialties within orthopedics.
In trying to understand the challenges that residents, program directors, and programs face, as well as the inherent complexity of the current system, we incorporated respondents’ write-in comments into suggested ways of improving the fellowship interview process. These comments had broad perspectives but overall were consistent with the survey results (Appendix).
Technology
Health care is continually finding new ways to take advantage of technological advances. This is occurring with the fellowship interview schema. Numerous disciplines are using videoconferencing platforms (eg, Skype) to conduct interviews. This practice is becoming more commonplace in the business sector. In a recent survey, more than 60% of human resource managers reported conducting video interviews.15 Two independent residency programs have used video interviews with mixed success.16,17
Another technological change requested by residents is the creation and updating of fellowship web pages with standardized information. Such a service may prove useful to residents researching a program and may even lead to limiting the number of programs residents apply to, as they may be able to dial in on exactly what distinguishes one program from another before traveling for an interview. A recent study of orthopedic sports medicine fellowship programs found that most of these programs lacked pertinent information on their websites.18 Important information regarding case logs from current and former fellows; number of faculty, residents, and fellows; and schedules and facilities of interview sites are a few of the online data points that may help residents differentiate particular programs.19,20 Questions like these are often asked at interviews and site visits. Having accurate information easily available online may reduce or eliminate the need to travel to a site for such information. Standardizing information would also increase transparency among available fellowships. Although not specifically mentioned, organizational software that improves the productivity of the process may help limit the large number of programs applied to, the interviews offered and attended, the days away, and the financial costs without reducing the match rate.
Timing and Location
The issue of timing—with respect to geographical or meteorological concerns—was another recurring theme among respondents. Numerous respondents indicated that certain programs located in geographic proximity tried to minimize travel by offering interviews around the same time. This coordination potentially minimizes travel expenses and time away from the residency program by allowing residents to interview at multiple locations during a single trip per region. The sports medicine fellowship process was identified as a good example of aligning interviews based on geography. Several respondents suggested an option that also reflects the practice of nonsurgical fellowships—delaying the interview season to bypass potential weather concerns. Winter 2013–2014 saw the most flight delays or cancellations in more than a decade; about 50% of all flights scheduled between December and February were delayed or canceled.21 Beyond the additional factor of more time away or missing an interview because of the weather are safety concerns related to the weather. One resident reported having a motor vehicle accident while traveling to an interview in poor weather conditions (Appendix).
National Meetings
Each orthopedic subspecialty has numerous national meetings. Many programs offer applicants the opportunity to interview at these meetings. One respondent mentioned that the annual meeting of the Orthopaedic Trauma Association offers trauma applicants the opportunity to interview with multiple programs. It might be beneficial to endorse this practice on a larger scale to help reduce travel and time away. We recognize that visiting individual programs is an important aspect of the match process, but doing so on a targeted level may make more sense, increasing financial efficiency and reducing time away from programs.
Proposed Solution
A combined proposed solution that can be implemented without a radical overhaul or significant investments might involve moving the interview season to early spring, switching to a 2-tiered system with a centralized first round of interview screening coinciding with subspecialty national meetings or the AAOS annual meeting, and standardizing online information for all orthopedic fellowship programs. A 2-tiered interview process would allow programs and candidates to obtain exposure to a significant number of programs in the first round without incurring significant costs and then would impose a cap on the number of programs to visit. This would level the playing field between candidates with more time and money and candidates who are more constrained in their training environment and finances. A stopgap or adjunct to residents or fellowship programs unable to attend a centralized meeting would be to combine technological tools, such as Internet-based videoconferencing (Skype), before site visits by residents. After this first round of introductions and interviews, residents could then decide on a limited number of programs to formally visit, attend, and ultimately rank. This proposed system would still be able to function within the confines of the match, and it would benefit from the protections offered to residents and programs. Although capping the number of interviews attended by residents clearly can lower costs across the board, we recognize the difficulty of enforcing such a requirement. These potential changes to the system are not exhaustive, and we hope this work will serve as a springboard to further discussion.
Our study had several inherent weaknesses. Our data came from survey responses, which reflect the perspectives only of the responding residents and program directors. Unfortunately, a small number of orthopedic residents responded to this survey, so there was a potential for bias. However, we think the central themes discovered in this survey are only echoes of the concerns of the larger population of residents and program directors. Our hope in designing such a study was to bring to light some of the discrepancies in the fellowship interview process, the goal being to stimulate interest among the orthopedic leadership representing future orthopedic surgeons. More study is needed to clarify if these issues are reflective of a larger segment of residents and program directors. In addition, action may be needed to fully elucidate the intricate interworking of the fellowship process in order to maximize the interest of the orthopedic surgeons who are seeking fellowship training. Another study limitation was the potential for recall bias in the more senior PGY-5 residents, who were further from the interview process than PGY-4 respondents were. Because of the need for anonymity with the surveys, we could not link some findings (eg, program impact, cost, time away) to individual programs or different specialty fellowships. Although it appears there is a desire for a more cost-effective system, given the financial pressures on medical students and residents, the desire to match increases costs because students are likely to attend more interviews than actually needed. Our proposed solution does not take into account residents’ behavior with respect to the current match system. For example, the prevailing thought is that interviewing at more programs increases the likelihood of matching into a desired subspecialty. Despite these study limitations, we think our results identified important points for discussion, investigation, and potential action by orthopedic leadership.
Conclusion
The challenge of critiquing and improving the orthopedic fellowship process requires the same courageous leadership that was recommended almost a decade ago.14 In this study, we tried to elucidate the impact of the PGY-4 fellowship interview process with respect to residents and residency programs. Our results highlight that time away from residency training, financial costs associated with the fellowship interview process, and disruption of the residency program are substantial and that both residents and program directors want changes made. Leadership needs to further investigate alternatives to the current process to lessen the impact on all parties in this important process.
1. Simon MA. Evolution of the present status of orthopaedic surgery fellowships. J Bone Joint Surg Am. 1998;80(12):1826-1829.
2. Brunworth LS, Chintalapani SR, Gray RR, Cardoso R, Owens PW. Resident selection of hand surgery fellowships: a survey of the 2011, 2012, and 2013 hand fellowship graduates. Hand. 2013;8(2):164-171.
3. Gaskill T, Cook C, Nunley J, Mather RC. The financial impact of orthopaedic fellowship training. J Bone Joint Surg Am. 2009;91(7):1814-1821.
4. Sarmiento A. Additional thoughts on orthopedic residency and fellowships. Orthopedics. 2010;33(10):712-713.
5. Griffin SM, Stoneback JW. Navigating the Orthopaedic Trauma Fellowship Match from a candidate’s perspective. J Orthop Trauma. 2011;25(suppl 3):S101-S103.
6. Morrell NT, Mercer DM, Moneim MS. Trends in the orthopedic job market and the importance of fellowship subspecialty training. Orthopedics. 2012;35(4):e555-e560.
7. Iorio R, Robb WJ, Healy WL, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90(7):1598-1605.
8. Emery SE, Guss D, Kuremsky MA, Hamlin BR, Herndon JH, Rubash HE. Resident education versus fellowship training—conflict or synergy? AOA critical issues. J Bone Joint Surg Am. 2012;94(21):e159.
9. Harner CD, Ranawat AS, Niederle M, et al. AOA symposium. Current state of fellowship hiring: is a universal match necessary? Is it possible? J Bone Joint Surg Am. 2008;90(6):1375-1384.
10. Ranawat A, Nunley RM, Genuario JW, Sharan AD, Mehta S; Washington Health Policy Fellows. Current state of the fellowship hiring process: Are we in 1957 or 2007? AAOS Now. 2007;1(8).
11. Little DC, Yoder SM, Grikscheit TC, et al. Cost considerations and applicant characteristics for the Pediatric Surgery Match. J Pediatr Surg. 2005;40(1):69-73.
12. Claiborne JR, Crantford JC, Swett KR, David LR. The Plastic Surgery Match: predicting success and improving the process. Ann Plast Surg. 2013;70(6):698-703.
13. Kane L, Peckham C. Medscape Physician Compensation Report 2014. http://www.medscape.com/features/slideshow/compensation/2014/public/overview. Published April 15, 2014. Accessed September 26, 2015.
14. Swiontkowski MF. A simple formula for continued improvement in orthopaedic surgery postgraduate training: courageous leadership. J Bone Joint Surg Am. 2008;90(6):1175.
15. Survey: six in 10 companies conduct video job interviews [news release]. http://www.prnewswire.com/news-releases/survey-six-in-10-companies-conduct-video-job-interviews-167973406.html. Published August 30, 2012. Accessed September 26, 2015.
16. Kerfoot BP, Asher KP, McCullough DL. Financial and educational costs of the residency interview process for urology applicants. Urology. 2008;71(6):990-994.
17. Edje L, Miller C, Kiefer J, Oram D. Using Skype as an alternative for residency selection interviews. J Grad Med Educ. 2013;5(3):503-505.
18. Mulcahey MK, Gosselin MM, Fadale PD. Evaluation of the content and accessibility of web sites for accredited orthopaedic sports medicine fellowships. J Bone Joint Surg Am. 2013;95(12):e85.
19. Gaeta TJ, Birkhahn RH, Lamont D, Banga N, Bove JJ. Aspects of residency programs’ web sites important to student applicants. Acad Emerg Med. 2005;12(1):89-92.
20. Mahler SA, Wagner MJ, Church A, Sokolosky M, Cline DM. Importance of residency program web sites to emergency medicine applicants. J Emerg Med. 2009;36(1):83-88.
21. Davies A. Winter’s toll: 1 million flights cancelled or delayed, costing travelers $5.3 billion. Business Insider. http://www.businessinsider.com/winter-flights-cancelled-delayed-cost-2014-3. Published March 3, 2014. Accessed September 26, 2015.
1. Simon MA. Evolution of the present status of orthopaedic surgery fellowships. J Bone Joint Surg Am. 1998;80(12):1826-1829.
2. Brunworth LS, Chintalapani SR, Gray RR, Cardoso R, Owens PW. Resident selection of hand surgery fellowships: a survey of the 2011, 2012, and 2013 hand fellowship graduates. Hand. 2013;8(2):164-171.
3. Gaskill T, Cook C, Nunley J, Mather RC. The financial impact of orthopaedic fellowship training. J Bone Joint Surg Am. 2009;91(7):1814-1821.
4. Sarmiento A. Additional thoughts on orthopedic residency and fellowships. Orthopedics. 2010;33(10):712-713.
5. Griffin SM, Stoneback JW. Navigating the Orthopaedic Trauma Fellowship Match from a candidate’s perspective. J Orthop Trauma. 2011;25(suppl 3):S101-S103.
6. Morrell NT, Mercer DM, Moneim MS. Trends in the orthopedic job market and the importance of fellowship subspecialty training. Orthopedics. 2012;35(4):e555-e560.
7. Iorio R, Robb WJ, Healy WL, et al. Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the United States: preparing for an epidemic. J Bone Joint Surg Am. 2008;90(7):1598-1605.
8. Emery SE, Guss D, Kuremsky MA, Hamlin BR, Herndon JH, Rubash HE. Resident education versus fellowship training—conflict or synergy? AOA critical issues. J Bone Joint Surg Am. 2012;94(21):e159.
9. Harner CD, Ranawat AS, Niederle M, et al. AOA symposium. Current state of fellowship hiring: is a universal match necessary? Is it possible? J Bone Joint Surg Am. 2008;90(6):1375-1384.
10. Ranawat A, Nunley RM, Genuario JW, Sharan AD, Mehta S; Washington Health Policy Fellows. Current state of the fellowship hiring process: Are we in 1957 or 2007? AAOS Now. 2007;1(8).
11. Little DC, Yoder SM, Grikscheit TC, et al. Cost considerations and applicant characteristics for the Pediatric Surgery Match. J Pediatr Surg. 2005;40(1):69-73.
12. Claiborne JR, Crantford JC, Swett KR, David LR. The Plastic Surgery Match: predicting success and improving the process. Ann Plast Surg. 2013;70(6):698-703.
13. Kane L, Peckham C. Medscape Physician Compensation Report 2014. http://www.medscape.com/features/slideshow/compensation/2014/public/overview. Published April 15, 2014. Accessed September 26, 2015.
14. Swiontkowski MF. A simple formula for continued improvement in orthopaedic surgery postgraduate training: courageous leadership. J Bone Joint Surg Am. 2008;90(6):1175.
15. Survey: six in 10 companies conduct video job interviews [news release]. http://www.prnewswire.com/news-releases/survey-six-in-10-companies-conduct-video-job-interviews-167973406.html. Published August 30, 2012. Accessed September 26, 2015.
16. Kerfoot BP, Asher KP, McCullough DL. Financial and educational costs of the residency interview process for urology applicants. Urology. 2008;71(6):990-994.
17. Edje L, Miller C, Kiefer J, Oram D. Using Skype as an alternative for residency selection interviews. J Grad Med Educ. 2013;5(3):503-505.
18. Mulcahey MK, Gosselin MM, Fadale PD. Evaluation of the content and accessibility of web sites for accredited orthopaedic sports medicine fellowships. J Bone Joint Surg Am. 2013;95(12):e85.
19. Gaeta TJ, Birkhahn RH, Lamont D, Banga N, Bove JJ. Aspects of residency programs’ web sites important to student applicants. Acad Emerg Med. 2005;12(1):89-92.
20. Mahler SA, Wagner MJ, Church A, Sokolosky M, Cline DM. Importance of residency program web sites to emergency medicine applicants. J Emerg Med. 2009;36(1):83-88.
21. Davies A. Winter’s toll: 1 million flights cancelled or delayed, costing travelers $5.3 billion. Business Insider. http://www.businessinsider.com/winter-flights-cancelled-delayed-cost-2014-3. Published March 3, 2014. Accessed September 26, 2015.
Arthroscopic Treatment of Tibial Spine Malunion With Resorbable Screws
Anterior tibial spine fractures are rare, occurring with an incidence of 3 per 100,000 per year.1,2 Historically, this fracture has occurred more frequently in children,3-5 and was considered a condition of skeletal immaturity and the pediatric equivalent of an anterior cruciate ligament (ACL) rupture.6 However, recent literature indicates that this fracture is more common in the adult population than previously thought.7 The tibial spine is an attachment point for the ACL and an avulsion may produce ACL laxity,8 predisposing to further symptomatic laxity and premature osteoarthritis. Nearly 40% of these fractures are associated with concomitant injuries to surrounding structures.9
Meyers and McKeever10,11 originally classified these fractures into 3 groups on the basis of displacement. Type I fractures present with no significant displacement of the anterior margin, type II involve displacement and are hinged, while type III have complete displacement.10,11 More recently, a type IV fracture has been added, involving comminution of the displaced fragment. Nondisplaced fractures are commonly treated with immobilization in varying degrees of extension; this allows the femoral condyles to compress and to reduce the fracture while arthroscopic or open reduction is the preferred method for displaced fractures of the tibial spine.2,4,8,10
We report the case of an 11-year-old boy with a tibial spine fracture that failed conservative management. He developed a subsequent malunion with impingement anteriorly of the tibial spine on the notch, and residual instability of the ACL. The patient’s parents provided written informed consent for print and electronic publication of this case report.
Case Report
An 11-year-old Caucasian boy was referred to our office for evaluation of right knee injury. He sustained the injury approximately 3 months earlier, and it was determined that he had a tibial spine fracture. Conservative management with immobilization in extension and activity modification was undertaken; however, he was referred for further evaluation because of healing in a malreduced position and residual ACL laxity. Physical examination showed a grade 2A Lachman test (contralateral limb with negative Lachman examination), negative McMurray test, and pain with forced hyperextension; range-of-motion examination showed lack of the terminal 5º of extension. Magnetic resonance and computed tomography imaging from an outside facility showed a skeletally immature individual with a large tibial spine fracture that had healed in a malunited position with the fragment extended on a posterior hinge, creating a large prominence anteriorly (Figures 1A, 1B). Magnetic resonance imaging showed that the ACL fibers were likely to remain intact but would lack appropriate tension secondary to the displacement of the tibial insertion.
Because of healing in a displaced position, lack of terminal extension, ACL laxity, and subjective complaints of pain, we discussed surgery with the patient and his parents (Figures 2A, 2B). Four months after the initial injury, the patient underwent surgery for a right tibial spine malunion arthroscopic takedown and repair, as well as an intraoperative evaluation of the ACL. Standard arthroscopy was performed, using anterolateral and anteromedial arthroscopic portals, and an accessory medial peripatellar portal. During surgery, a large prominence was noted in the region of the anterior tibial spine (Figure 3A). The ACL fibers maintained a slack position secondary to the elevation of the tibial insertion point, and intraoperative Lachman examination showed anterior translation of the tibia on the femur as the slack was removed from the ACL. During surgery, impingement of the anterior tibial spine along the femoral notch was shown to be significant by taking the knee into near-full extension (Figure 3B). A cam-like effect was noted at the time of impingement with the posterior soft tissues relaxing to accommodate slight further extension.
Based on these findings, we chose to take down the malunited fracture and repair it (Figure 3C). PDS suture (Ethicon, Somerville, New Jersey) was temporarily placed along the intermeniscal ligament and anterior horns of the medial and lateral menisci, using a system of spinal needles to facilitate suture passage. Surgical clamps were hung from the suture to provide traction on the sutures throughout the case, allowing the intermeniscal ligament and menisci to recede anteriorly to improve working space and aid in preventing iatrogenic injury. These sutures were removed at the conclusion of the case. Using a combination of curettes, elevator, and small shaver, we were able to meticulously remove interposed malunited callus to allow for mobilization of the displaced fragment. After removal of the excess bone formation, a typical donor site was created, allowing the displaced spine fragment to be hinged into appropriate alignment (Figure 3D). We were able to maintain a posterior cortical hinge to facilitate this process.
Then, we placed Kirschner wires (K-wires) across the fracture in an antegrade fashion, anterior to the trochlea and notch, using an accessory medial peripatellar starting point percutaneously, under direct visualization to avoid iatrogenic chondral injury. The tibial spine fragment was temporarily maintained in a reduced position with an arthroscopic probe and pinned in place with two 0.062-in K-wires. The fracture was stabilized with 8 resorbable 1.6-mm poly-L-lactic/polyglycolic acid (PLLA/PGA) nails, in varying lengths from 18 mm to 22 mm. Excellent fixation was obtained, and range of motion was tested from 0º to 80º, without movement of the fracture site (Figure 3E). Fluoroscopy with multi-axial views verified adequate fixation and reduction. Further, we examined and noted a taut ACL after fixation. The patient was placed in a long leg cast for 3 weeks at 30º, based upon intraoperative determination of the position of least tension on the fracture fragment.
At 3-week follow-up, the patient was progressing well and transitioned from a long leg cast to a hinged knee brace, to allow for early range of motion. Radiographs showed appropriate alignment of the tibial spine fracture with no significant loss of fixation (Figures 4A, 4B). Physical therapy was initiated between 0º and 30º, and flexion was progressively increased over the course of the first 3 weeks. Active and active-assist, closed-chain activities were maintained. Seven weeks postoperatively, the patient displayed continued clinical progression. Radiographs showed interval healing with slight lucency over the anterolateral aspect of the fracture fragment, likely related to the early resorptive process of healing. Physical examination showed movement between 0º and 120º, stable Lachman test, and stable anterior drawer. Crutches were discontinued and hinged knee brace was converted to an ACL brace. By the 11th week, motion had increased to 140º, and radiographs continued to show acceptable alignment and healing (Figures 5A, 5B). The patient was released to return to play as tolerated; however, an ACL brace was recommended during his initial return to provide additional support.
Discussion
In this report, we present an approach for arthroscopic reduction of a malunited tibial spine fracture using resorbable PLLA/PGA nails. The number of polyglycolic nails employed is individualized per case, dependent on the surface area and the quality of the bone within the fractured fragment. Preoperative templating allows for measurements from the fractured fragment to the level of the proximal tibial physis. Based on these measurements, nails are chosen to maximize fixation length and avoid the physis. Despite studies that have examined the effect of transphyseal K-wire pinning or drilling on subsequent growth, there is no consensus about optimal technique. Experiments in animal models indicate that drill injuries destroying less than 8% to 9% of the physis do not impact total bone growth.12,13 Further, temporary crossing of the physeal plate for internal fixation of dislocated joint injuries has not been shown to result in bone bridging or growth disturbance.14,15
Each nail is 1.6 mm in diameter, leaving a small footprint. The nails are used judiciously to provide effective stabilization of the fragment and to maintain a cost-conscious approach. An accessory superomedial peripatellar portal allows an appropriate angle for nail placement. This portal allows access to all regions of the fractured fragment, while an anteromedial and anterolateral portal are used as working and camera portals, respectively. Nails are placed to provide an axis perpendicular to the fracture line to allow appropriate compression. By virtue of the shape of the typical fragment in a tibial spine fracture, the nails vary in insertion angle.
The occurrence of anterior tibial spine fractures is rare, and while several techniques have been described to repair this fracture, there remains a great deal of uncertainty regarding the best course of treatment. A review of the literature finds arthroscopic and open approaches, as well as techniques employing K-wire fixation, metal screw fixation, staple fixation, absorbable fixation, and fixation with sutures passed through the tibial tunnel.16-18
Avulsion fractures of the tibial eminence were treated with open fixation until McLennan8 first reported the benefits of reduction with an arthroscope. Open reduction and internal fixation provide the benefit of direct visualization,9 while arthroscopic reduction offers decreased morbidity and an accelerated recovery of knee functions,8 despite the fact that a higher rate of range-of-motion deficits were seen in patients treated arthroscopically.19 We feel that with proper early rehabilitation to achieve range of motion, the risk of this can be minimal.
Various arthroscopic approaches that improve the accuracy of the reduction and decrease surgical invasiveness have been described. Suture and screw fixation are among the most common methods, and both have resulted in positive outcomes.20-24 Suture fixation of the tibial eminence is technically demanding but offers secure fixation without the need for follow-up hardware removal. Screw fixation results in secure fixation; however, numerous hardware-related issues may necessitate removal. Furthermore, in skeletally immature patients, screw fixation may disturb the growth plate if it crosses an open physis.9
Hunter and Willis25 retrospectively reviewed patients with tibial eminence fractures treated with either screw or suture fixation and found a 44% reoperation rate in the screw-fixation group. Removal was often recommended as a result of hardware-related issues. There was a 13% reoperation rate in the suture-fixation group, which resulted largely from stiffness.25 In a recent review, Gans and colleagues19 reviewed 6 publications comparing screw and suture fixation of tibial eminence fractures and found 82.4% of screw patients had laxity on both the anterior drawer and Lachman tests, compared with 18.8% in the suture-fixation group. This study also noted a slightly higher rate of arthrofibrosis in patients treated with suture fixation.19 Biomechanical studies indicate that suture fixation imparts greater strength under cyclic-loading conditions;26 however, there does not appear to be a difference in ultimate force required for fixation failure.27
Ultimately, both suture and screw fixation result in secure methods of fixation; however, there are often greater issues with screw fixation because of the persistent hardware. Metal has been the most popular method for fracture fixation, and while biodegradable materials have been alluring, adverse tissue reactions have slowed implementation. However, these implants have become increasingly sophisticated, thereby reducing disadvantages.28 Previous biodegradable devices were often composed of a single polymer, and many caused adverse reactions by degrading too quickly or provided no real advantages because they degraded too slowly.29 As the number of polymers approved for internal use and surgical applications continues to rise, so too will the benefits of employing this technology. Furthermore, by including multiple polymers in these implants, one is better able to control the degradation rate, limiting the tissue response.
In this study, we employed PLLA/PGA nails. Studies of PGA implants indicate this molecule degrades at a fast rate resulting in adverse tissue reactions. Adverse reactions in studies of PLLA implants are less frequent because of their slower rate of degradation.29,30 Combining these monomers results in appropriate strength and a controlled degradation rate, reducing the likelihood of adverse reactions. Furthermore, numerous studies have reported that inflammatory responses in children are rare and mild in nature.31,32 Absorbable implants have displayed efficacy in numerous orthopedic settings33-36 and are beneficial in procedures that are not suitable for repeated surgeries, such as reconstruction of the ACL.37 There is some concern about the use of absorbable implants in synovial joints. Polyglycolic acid use in synovial joints may cause foreign-body reactions and may increase the risk of intra-articular dissemination of polymeric debris;38 however, use of a multipolymer construct decreases the likelihood of this occurrence.
Polyglycolic nails confer the advantage over nonresorbable screw fixation because further procedure for hardware removal is not required. Although suture fixation has proved to be beneficial over nonresorbable screw fixation, implantation of resorbable nails appears to have several advantages. In Dr. Estes’ experience, placement of resorbable screws through an accessory superomedial portal is far less technically demanding than placement of suture through the fracture fragment. Further, as sutures are passed from the extra-articular to the intra-articular region of the joint, capsular layers of the knee may inadvertently be bound up in the fixation, predisposing to arthrofibrosis.
At the same time, biodegradable devices are often more costly than alternative forms of treatment; however, a true cost-to-benefit analysis requires consideration of other factors. One of the benefits of biodegradable hardware is that there is no need for follow-up hardware removal. Reports have indicated that up to 91% of patients thought that hardware removal was the most negative aspect of metal implants.39 It is estimated that if the removal rate for metallic implants is higher than 19% to 54%, resorbable implants would be more cost-effective.40 The cost of sutures and screws is variable, however; they are invariably less expensive than biodegradable nails. A study of fracture patients determined that biodegradable implants were cheaper on average after considering the cost of implant removal.40 Ultimately, the hardware choice depends on numerous factors, including surgeon’s discretion; however, biodegradable hardware should not be discounted for financial reasons because the difference in cost is likely negligible.
Conclusion
The approach described in this report offers efficient and secure fixation with resorbable hardware without a reduction in range of motion. Resorbable implants may prove beneficial in the treatment of tibial eminence fractures by offering robust fixation without the concerns associated with permanent hardware.
1. Hargrove R, Parsons S, Payne R. Anterior tibial spine fracture – an easy fracture to miss. Accid Emerg Nurs. 2004;12(3):173-175.
2. Aderinto J, Walmsley P, Keating JF. Fractures of the tibial spine: epidemiology and outcome. Knee. 2008;15(3):164-167.
3. Driessen MJ, Winkelman PA. Fractures of the intercondylar eminence of the tibia in childhood. Neth J Surg. 1984;36(3):69-72.
4. Zaricznyj B. Avulsion fracture of the tibial eminence: treatment by open reduction and pinning. J Bone Joint Surg Am. 1977;59(8):1111-1114.
5. Molander ML, Wallin G, Wikstad I. Fracture of the intercondylar eminence of the tibia: a review of 35 patients. J Bone Joint Surg Br. 1981;63(1):89-91.
6. Kieser DC, Gwynne-Jones D, Dreyer S. Displaced tibial intercondylar eminence fractures. J Orthop Surg. 2011;19(3):292-296.
7. Ishibashi Y, Tsuda E, Sasaki T, Toh S. Magnetic resonance imaging AIDS in detecting concomitant injuries in patients with tibial spine fractures. Clin Orthop. 2005;(434):207-212.
8. McLennan JG. The role of arthroscopic surgery in the treatment of fractures of the intercondylar eminence of the tibia. J Bone Joint Surg Br. 1982;64(4):477-480.
9. Lafrance RM, Giordano B, Goldblatt J, Voloshin I, Maloney M. Pediatric tibial eminence fractures: evaluation and management. J Am Acad Orthop Surg. 2010;18(7):395-405.
10. Meyers MH, McKeever FM. Fracture of the intercondylar eminence of the tibia. J Bone Joint Surg Am. 1959;41(2):209-220.
11. Meyers MH, McKeever FM. Fracture of the intercondylar eminence of the tibia. J Bone Joint Surg Am. 1970;52(8):1677-1684.
12. Garcés GL, Mugica-Garay I, López-González Coviella N, Guerado E. Growth-plate modifications after drilling. J Pediatr Orthop. 1994;14(2):225-228.
13. Janarv PM, Wikström B, Hirsch G. The influence of transphyseal drilling and tendon grafting on bone growth: an experimental study in the rabbit. J Pediatr Orthop. 1998;18(2):149-154.
14. Boelitz R, Dallek M, Meenen NM, Jungbluth KH. Reaction of the epiphyseal groove to groove-crossing bore-wire osteosynthesis. Results of a histomorphologic small animal study. Unfallchirurgie. 1994;20(3):131-137.
15. Yung PS, Lam CY, Ng BK, Lam TP, Cheng JC. Percutaneous transphyseal intramedullary Kirschner wire pinning: a safe and effective procedure for treatment of displaced diaphyseal forearm fracture in children. J Pediatr Orthop. 2004;24(1):7-12.
16. Bong MR, Romero A, Kubiak E, et al. Suture versus screw fixation of displaced tibial eminence fractures: a biomechanical comparison. Arthroscopy. 2005;21(10):1172-1176.
17. Vega JR, Irribarra LA, Baar AK, Iñiguez M, Salgado M, Gana N. Arthroscopic fixation of displaced tibial eminence fractures: a new growth plate-sparing method. Arthroscopy. 2008;24(11):1239-1243.
18. Shepley RW. Arthroscopic treatment of type III tibial spine fractures using absorbable fixation. Orthopedics. 2004;27(7):767-769.
19. Gans I, Baldwin KD, Ganley TJ. Treatment and management outcomes of tibial eminence fractures in pediatric patients: a systematic review. Am J Sports Med. 2013;42(7):1743-1750.
20. Delcogliano A, Chiossi S, Caporaso A, Menghi A, Rinonapoli G. Tibial intercondylar eminence fractures in adults: arthroscopic treatment. Knee Surg Sports Traumatol Arthrosc. 2003;11(4):255-259.
21. Mulhall KJ, Dowdall J, Grannell M, McCabe JP. Tibial spine fractures: an analysis of outcome in surgically treated type III injuries. Injury. 1999;30(4):289-292.
22. Geissler WB, Matthews DE. Arthroscopic suture fixation of displaced tibial eminence fractures. Orthopedics. 1993;16(3):331-333.
23. Mah JY, Otsuka NY, McLean J. An arthroscopic technique for the reduction and fixation of tibial-eminence fractures. J Pediatr Orthop. 1996;16(1):119-121.
24. Reynders P, Reynders K, Broos P. Pediatric and adolescent tibial eminence fractures: arthroscopic cannulated screw fixation. J Trauma. 2002;53(1):49-54.
25. Hunter RE, Willis JA. Arthroscopic fixation of avulsion fractures of the tibial eminence: technique and outcome. Arthroscopy. 2004;20(2):113-121.
26. Eggers AK, Becker C, Weimann A, et al. Biomechanical evaluation of different fixation methods for tibial eminence fractures. Am J Sports Med. 2007;35(3):404-410.
27. Mahar AT, Duncan D, Oka R, Lowry A, Gillingham B, Chambers H. Biomechanical comparison of four different fixation techniques for pediatric tibial eminence avulsion fractures. J Pediatr Orthop. 2008;28(2):159-162.
28. Toro C, Robiony M, Zerman N, Politi M. Resorbable plates in maxillary fixation. A 5-year experience. Minerva Stomatol. 2005;54(4):199-206.
29. Andriano KP, Pohjonen T, Törmälä P. Processing and characterization of absorbable polylactide polymers for use in surgical implants. J Appl Biomater.1994;5(2):133-140.
30. Böstman O, Pihlajamäki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials. 2000;21(24):2615-2621.
31. Rokkanen PU, Böstman O, Hirvensalo E, et al. Bioabsorbable fixation in orthopaedic surgery and traumatology. Biomaterials. 2000;21(24):2607-2613.
32. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials. 1996;17(2):93-102.
33. Li ZH, Yu AX, Guo XP, Qi BW, Zhou M, Wang WY. Absorbable implants versus metal implants for the treatment of ankle fractures: A meta-analysis. Exp Ther Med. 2013;5(5):1531-1537.
34. Singh G, Mohammad S, Chak RK, Lepcha N, Singh N, Malkunje LR. Bio-resorbable plates as effective implant in paediatric mandibular fracture. J Maxillofac Oral Surg. 2012;11(4):400-406.
35. Sakamoto Y, Shimizu Y, Nagasao T, Kishi K. Combined use of resorbable poly-L-lactic acid-polyglycolic acid implant and bone cement for treating large orbital floor fractures. J Plast Reconstr Aesthet Surg. 2014;67(3):e88-e90.
36. Benz G, Kallieris D, Seeböck T, McIntosh A, Daum R. Bioresorbable pins and screws in paediatric traumatology. Eur J Pediatr Surg. 1994;4(2):103-107.
37. Gaweda K, Walawski J, Weglowski R, Krzyzanowski W. Comparison of bioabsorbable interference screws and posts for distal fixation in anterior cruciate ligament reconstruction. Int Orthop. 2009;33(1):123-127.
38. Böstman OM. Osteoarthritis of the ankle after foreign-body reaction to absorbable pins and screws: a three- to nine-year follow-up study. J Bone Joint Surg Br. 1998;80(2):333-338.
39. Mittal R, Morley J, Dinopoulos H, Drakoulakis EG, Vermani E, Giannoudis PV. Use of bio-resorbable implants for stabilisation of distal radius fractures: the United Kingdom patients’ perspective. Injury. 2005;36(2):333-338.
40. Böstman OM. Metallic or absorbable fracture fixation devices. A cost minimization analysis. Clin Orthop. 1996;(329):233-239.
Anterior tibial spine fractures are rare, occurring with an incidence of 3 per 100,000 per year.1,2 Historically, this fracture has occurred more frequently in children,3-5 and was considered a condition of skeletal immaturity and the pediatric equivalent of an anterior cruciate ligament (ACL) rupture.6 However, recent literature indicates that this fracture is more common in the adult population than previously thought.7 The tibial spine is an attachment point for the ACL and an avulsion may produce ACL laxity,8 predisposing to further symptomatic laxity and premature osteoarthritis. Nearly 40% of these fractures are associated with concomitant injuries to surrounding structures.9
Meyers and McKeever10,11 originally classified these fractures into 3 groups on the basis of displacement. Type I fractures present with no significant displacement of the anterior margin, type II involve displacement and are hinged, while type III have complete displacement.10,11 More recently, a type IV fracture has been added, involving comminution of the displaced fragment. Nondisplaced fractures are commonly treated with immobilization in varying degrees of extension; this allows the femoral condyles to compress and to reduce the fracture while arthroscopic or open reduction is the preferred method for displaced fractures of the tibial spine.2,4,8,10
We report the case of an 11-year-old boy with a tibial spine fracture that failed conservative management. He developed a subsequent malunion with impingement anteriorly of the tibial spine on the notch, and residual instability of the ACL. The patient’s parents provided written informed consent for print and electronic publication of this case report.
Case Report
An 11-year-old Caucasian boy was referred to our office for evaluation of right knee injury. He sustained the injury approximately 3 months earlier, and it was determined that he had a tibial spine fracture. Conservative management with immobilization in extension and activity modification was undertaken; however, he was referred for further evaluation because of healing in a malreduced position and residual ACL laxity. Physical examination showed a grade 2A Lachman test (contralateral limb with negative Lachman examination), negative McMurray test, and pain with forced hyperextension; range-of-motion examination showed lack of the terminal 5º of extension. Magnetic resonance and computed tomography imaging from an outside facility showed a skeletally immature individual with a large tibial spine fracture that had healed in a malunited position with the fragment extended on a posterior hinge, creating a large prominence anteriorly (Figures 1A, 1B). Magnetic resonance imaging showed that the ACL fibers were likely to remain intact but would lack appropriate tension secondary to the displacement of the tibial insertion.
Because of healing in a displaced position, lack of terminal extension, ACL laxity, and subjective complaints of pain, we discussed surgery with the patient and his parents (Figures 2A, 2B). Four months after the initial injury, the patient underwent surgery for a right tibial spine malunion arthroscopic takedown and repair, as well as an intraoperative evaluation of the ACL. Standard arthroscopy was performed, using anterolateral and anteromedial arthroscopic portals, and an accessory medial peripatellar portal. During surgery, a large prominence was noted in the region of the anterior tibial spine (Figure 3A). The ACL fibers maintained a slack position secondary to the elevation of the tibial insertion point, and intraoperative Lachman examination showed anterior translation of the tibia on the femur as the slack was removed from the ACL. During surgery, impingement of the anterior tibial spine along the femoral notch was shown to be significant by taking the knee into near-full extension (Figure 3B). A cam-like effect was noted at the time of impingement with the posterior soft tissues relaxing to accommodate slight further extension.
Based on these findings, we chose to take down the malunited fracture and repair it (Figure 3C). PDS suture (Ethicon, Somerville, New Jersey) was temporarily placed along the intermeniscal ligament and anterior horns of the medial and lateral menisci, using a system of spinal needles to facilitate suture passage. Surgical clamps were hung from the suture to provide traction on the sutures throughout the case, allowing the intermeniscal ligament and menisci to recede anteriorly to improve working space and aid in preventing iatrogenic injury. These sutures were removed at the conclusion of the case. Using a combination of curettes, elevator, and small shaver, we were able to meticulously remove interposed malunited callus to allow for mobilization of the displaced fragment. After removal of the excess bone formation, a typical donor site was created, allowing the displaced spine fragment to be hinged into appropriate alignment (Figure 3D). We were able to maintain a posterior cortical hinge to facilitate this process.
Then, we placed Kirschner wires (K-wires) across the fracture in an antegrade fashion, anterior to the trochlea and notch, using an accessory medial peripatellar starting point percutaneously, under direct visualization to avoid iatrogenic chondral injury. The tibial spine fragment was temporarily maintained in a reduced position with an arthroscopic probe and pinned in place with two 0.062-in K-wires. The fracture was stabilized with 8 resorbable 1.6-mm poly-L-lactic/polyglycolic acid (PLLA/PGA) nails, in varying lengths from 18 mm to 22 mm. Excellent fixation was obtained, and range of motion was tested from 0º to 80º, without movement of the fracture site (Figure 3E). Fluoroscopy with multi-axial views verified adequate fixation and reduction. Further, we examined and noted a taut ACL after fixation. The patient was placed in a long leg cast for 3 weeks at 30º, based upon intraoperative determination of the position of least tension on the fracture fragment.
At 3-week follow-up, the patient was progressing well and transitioned from a long leg cast to a hinged knee brace, to allow for early range of motion. Radiographs showed appropriate alignment of the tibial spine fracture with no significant loss of fixation (Figures 4A, 4B). Physical therapy was initiated between 0º and 30º, and flexion was progressively increased over the course of the first 3 weeks. Active and active-assist, closed-chain activities were maintained. Seven weeks postoperatively, the patient displayed continued clinical progression. Radiographs showed interval healing with slight lucency over the anterolateral aspect of the fracture fragment, likely related to the early resorptive process of healing. Physical examination showed movement between 0º and 120º, stable Lachman test, and stable anterior drawer. Crutches were discontinued and hinged knee brace was converted to an ACL brace. By the 11th week, motion had increased to 140º, and radiographs continued to show acceptable alignment and healing (Figures 5A, 5B). The patient was released to return to play as tolerated; however, an ACL brace was recommended during his initial return to provide additional support.
Discussion
In this report, we present an approach for arthroscopic reduction of a malunited tibial spine fracture using resorbable PLLA/PGA nails. The number of polyglycolic nails employed is individualized per case, dependent on the surface area and the quality of the bone within the fractured fragment. Preoperative templating allows for measurements from the fractured fragment to the level of the proximal tibial physis. Based on these measurements, nails are chosen to maximize fixation length and avoid the physis. Despite studies that have examined the effect of transphyseal K-wire pinning or drilling on subsequent growth, there is no consensus about optimal technique. Experiments in animal models indicate that drill injuries destroying less than 8% to 9% of the physis do not impact total bone growth.12,13 Further, temporary crossing of the physeal plate for internal fixation of dislocated joint injuries has not been shown to result in bone bridging or growth disturbance.14,15
Each nail is 1.6 mm in diameter, leaving a small footprint. The nails are used judiciously to provide effective stabilization of the fragment and to maintain a cost-conscious approach. An accessory superomedial peripatellar portal allows an appropriate angle for nail placement. This portal allows access to all regions of the fractured fragment, while an anteromedial and anterolateral portal are used as working and camera portals, respectively. Nails are placed to provide an axis perpendicular to the fracture line to allow appropriate compression. By virtue of the shape of the typical fragment in a tibial spine fracture, the nails vary in insertion angle.
The occurrence of anterior tibial spine fractures is rare, and while several techniques have been described to repair this fracture, there remains a great deal of uncertainty regarding the best course of treatment. A review of the literature finds arthroscopic and open approaches, as well as techniques employing K-wire fixation, metal screw fixation, staple fixation, absorbable fixation, and fixation with sutures passed through the tibial tunnel.16-18
Avulsion fractures of the tibial eminence were treated with open fixation until McLennan8 first reported the benefits of reduction with an arthroscope. Open reduction and internal fixation provide the benefit of direct visualization,9 while arthroscopic reduction offers decreased morbidity and an accelerated recovery of knee functions,8 despite the fact that a higher rate of range-of-motion deficits were seen in patients treated arthroscopically.19 We feel that with proper early rehabilitation to achieve range of motion, the risk of this can be minimal.
Various arthroscopic approaches that improve the accuracy of the reduction and decrease surgical invasiveness have been described. Suture and screw fixation are among the most common methods, and both have resulted in positive outcomes.20-24 Suture fixation of the tibial eminence is technically demanding but offers secure fixation without the need for follow-up hardware removal. Screw fixation results in secure fixation; however, numerous hardware-related issues may necessitate removal. Furthermore, in skeletally immature patients, screw fixation may disturb the growth plate if it crosses an open physis.9
Hunter and Willis25 retrospectively reviewed patients with tibial eminence fractures treated with either screw or suture fixation and found a 44% reoperation rate in the screw-fixation group. Removal was often recommended as a result of hardware-related issues. There was a 13% reoperation rate in the suture-fixation group, which resulted largely from stiffness.25 In a recent review, Gans and colleagues19 reviewed 6 publications comparing screw and suture fixation of tibial eminence fractures and found 82.4% of screw patients had laxity on both the anterior drawer and Lachman tests, compared with 18.8% in the suture-fixation group. This study also noted a slightly higher rate of arthrofibrosis in patients treated with suture fixation.19 Biomechanical studies indicate that suture fixation imparts greater strength under cyclic-loading conditions;26 however, there does not appear to be a difference in ultimate force required for fixation failure.27
Ultimately, both suture and screw fixation result in secure methods of fixation; however, there are often greater issues with screw fixation because of the persistent hardware. Metal has been the most popular method for fracture fixation, and while biodegradable materials have been alluring, adverse tissue reactions have slowed implementation. However, these implants have become increasingly sophisticated, thereby reducing disadvantages.28 Previous biodegradable devices were often composed of a single polymer, and many caused adverse reactions by degrading too quickly or provided no real advantages because they degraded too slowly.29 As the number of polymers approved for internal use and surgical applications continues to rise, so too will the benefits of employing this technology. Furthermore, by including multiple polymers in these implants, one is better able to control the degradation rate, limiting the tissue response.
In this study, we employed PLLA/PGA nails. Studies of PGA implants indicate this molecule degrades at a fast rate resulting in adverse tissue reactions. Adverse reactions in studies of PLLA implants are less frequent because of their slower rate of degradation.29,30 Combining these monomers results in appropriate strength and a controlled degradation rate, reducing the likelihood of adverse reactions. Furthermore, numerous studies have reported that inflammatory responses in children are rare and mild in nature.31,32 Absorbable implants have displayed efficacy in numerous orthopedic settings33-36 and are beneficial in procedures that are not suitable for repeated surgeries, such as reconstruction of the ACL.37 There is some concern about the use of absorbable implants in synovial joints. Polyglycolic acid use in synovial joints may cause foreign-body reactions and may increase the risk of intra-articular dissemination of polymeric debris;38 however, use of a multipolymer construct decreases the likelihood of this occurrence.
Polyglycolic nails confer the advantage over nonresorbable screw fixation because further procedure for hardware removal is not required. Although suture fixation has proved to be beneficial over nonresorbable screw fixation, implantation of resorbable nails appears to have several advantages. In Dr. Estes’ experience, placement of resorbable screws through an accessory superomedial portal is far less technically demanding than placement of suture through the fracture fragment. Further, as sutures are passed from the extra-articular to the intra-articular region of the joint, capsular layers of the knee may inadvertently be bound up in the fixation, predisposing to arthrofibrosis.
At the same time, biodegradable devices are often more costly than alternative forms of treatment; however, a true cost-to-benefit analysis requires consideration of other factors. One of the benefits of biodegradable hardware is that there is no need for follow-up hardware removal. Reports have indicated that up to 91% of patients thought that hardware removal was the most negative aspect of metal implants.39 It is estimated that if the removal rate for metallic implants is higher than 19% to 54%, resorbable implants would be more cost-effective.40 The cost of sutures and screws is variable, however; they are invariably less expensive than biodegradable nails. A study of fracture patients determined that biodegradable implants were cheaper on average after considering the cost of implant removal.40 Ultimately, the hardware choice depends on numerous factors, including surgeon’s discretion; however, biodegradable hardware should not be discounted for financial reasons because the difference in cost is likely negligible.
Conclusion
The approach described in this report offers efficient and secure fixation with resorbable hardware without a reduction in range of motion. Resorbable implants may prove beneficial in the treatment of tibial eminence fractures by offering robust fixation without the concerns associated with permanent hardware.
Anterior tibial spine fractures are rare, occurring with an incidence of 3 per 100,000 per year.1,2 Historically, this fracture has occurred more frequently in children,3-5 and was considered a condition of skeletal immaturity and the pediatric equivalent of an anterior cruciate ligament (ACL) rupture.6 However, recent literature indicates that this fracture is more common in the adult population than previously thought.7 The tibial spine is an attachment point for the ACL and an avulsion may produce ACL laxity,8 predisposing to further symptomatic laxity and premature osteoarthritis. Nearly 40% of these fractures are associated with concomitant injuries to surrounding structures.9
Meyers and McKeever10,11 originally classified these fractures into 3 groups on the basis of displacement. Type I fractures present with no significant displacement of the anterior margin, type II involve displacement and are hinged, while type III have complete displacement.10,11 More recently, a type IV fracture has been added, involving comminution of the displaced fragment. Nondisplaced fractures are commonly treated with immobilization in varying degrees of extension; this allows the femoral condyles to compress and to reduce the fracture while arthroscopic or open reduction is the preferred method for displaced fractures of the tibial spine.2,4,8,10
We report the case of an 11-year-old boy with a tibial spine fracture that failed conservative management. He developed a subsequent malunion with impingement anteriorly of the tibial spine on the notch, and residual instability of the ACL. The patient’s parents provided written informed consent for print and electronic publication of this case report.
Case Report
An 11-year-old Caucasian boy was referred to our office for evaluation of right knee injury. He sustained the injury approximately 3 months earlier, and it was determined that he had a tibial spine fracture. Conservative management with immobilization in extension and activity modification was undertaken; however, he was referred for further evaluation because of healing in a malreduced position and residual ACL laxity. Physical examination showed a grade 2A Lachman test (contralateral limb with negative Lachman examination), negative McMurray test, and pain with forced hyperextension; range-of-motion examination showed lack of the terminal 5º of extension. Magnetic resonance and computed tomography imaging from an outside facility showed a skeletally immature individual with a large tibial spine fracture that had healed in a malunited position with the fragment extended on a posterior hinge, creating a large prominence anteriorly (Figures 1A, 1B). Magnetic resonance imaging showed that the ACL fibers were likely to remain intact but would lack appropriate tension secondary to the displacement of the tibial insertion.
Because of healing in a displaced position, lack of terminal extension, ACL laxity, and subjective complaints of pain, we discussed surgery with the patient and his parents (Figures 2A, 2B). Four months after the initial injury, the patient underwent surgery for a right tibial spine malunion arthroscopic takedown and repair, as well as an intraoperative evaluation of the ACL. Standard arthroscopy was performed, using anterolateral and anteromedial arthroscopic portals, and an accessory medial peripatellar portal. During surgery, a large prominence was noted in the region of the anterior tibial spine (Figure 3A). The ACL fibers maintained a slack position secondary to the elevation of the tibial insertion point, and intraoperative Lachman examination showed anterior translation of the tibia on the femur as the slack was removed from the ACL. During surgery, impingement of the anterior tibial spine along the femoral notch was shown to be significant by taking the knee into near-full extension (Figure 3B). A cam-like effect was noted at the time of impingement with the posterior soft tissues relaxing to accommodate slight further extension.
Based on these findings, we chose to take down the malunited fracture and repair it (Figure 3C). PDS suture (Ethicon, Somerville, New Jersey) was temporarily placed along the intermeniscal ligament and anterior horns of the medial and lateral menisci, using a system of spinal needles to facilitate suture passage. Surgical clamps were hung from the suture to provide traction on the sutures throughout the case, allowing the intermeniscal ligament and menisci to recede anteriorly to improve working space and aid in preventing iatrogenic injury. These sutures were removed at the conclusion of the case. Using a combination of curettes, elevator, and small shaver, we were able to meticulously remove interposed malunited callus to allow for mobilization of the displaced fragment. After removal of the excess bone formation, a typical donor site was created, allowing the displaced spine fragment to be hinged into appropriate alignment (Figure 3D). We were able to maintain a posterior cortical hinge to facilitate this process.
Then, we placed Kirschner wires (K-wires) across the fracture in an antegrade fashion, anterior to the trochlea and notch, using an accessory medial peripatellar starting point percutaneously, under direct visualization to avoid iatrogenic chondral injury. The tibial spine fragment was temporarily maintained in a reduced position with an arthroscopic probe and pinned in place with two 0.062-in K-wires. The fracture was stabilized with 8 resorbable 1.6-mm poly-L-lactic/polyglycolic acid (PLLA/PGA) nails, in varying lengths from 18 mm to 22 mm. Excellent fixation was obtained, and range of motion was tested from 0º to 80º, without movement of the fracture site (Figure 3E). Fluoroscopy with multi-axial views verified adequate fixation and reduction. Further, we examined and noted a taut ACL after fixation. The patient was placed in a long leg cast for 3 weeks at 30º, based upon intraoperative determination of the position of least tension on the fracture fragment.
At 3-week follow-up, the patient was progressing well and transitioned from a long leg cast to a hinged knee brace, to allow for early range of motion. Radiographs showed appropriate alignment of the tibial spine fracture with no significant loss of fixation (Figures 4A, 4B). Physical therapy was initiated between 0º and 30º, and flexion was progressively increased over the course of the first 3 weeks. Active and active-assist, closed-chain activities were maintained. Seven weeks postoperatively, the patient displayed continued clinical progression. Radiographs showed interval healing with slight lucency over the anterolateral aspect of the fracture fragment, likely related to the early resorptive process of healing. Physical examination showed movement between 0º and 120º, stable Lachman test, and stable anterior drawer. Crutches were discontinued and hinged knee brace was converted to an ACL brace. By the 11th week, motion had increased to 140º, and radiographs continued to show acceptable alignment and healing (Figures 5A, 5B). The patient was released to return to play as tolerated; however, an ACL brace was recommended during his initial return to provide additional support.
Discussion
In this report, we present an approach for arthroscopic reduction of a malunited tibial spine fracture using resorbable PLLA/PGA nails. The number of polyglycolic nails employed is individualized per case, dependent on the surface area and the quality of the bone within the fractured fragment. Preoperative templating allows for measurements from the fractured fragment to the level of the proximal tibial physis. Based on these measurements, nails are chosen to maximize fixation length and avoid the physis. Despite studies that have examined the effect of transphyseal K-wire pinning or drilling on subsequent growth, there is no consensus about optimal technique. Experiments in animal models indicate that drill injuries destroying less than 8% to 9% of the physis do not impact total bone growth.12,13 Further, temporary crossing of the physeal plate for internal fixation of dislocated joint injuries has not been shown to result in bone bridging or growth disturbance.14,15
Each nail is 1.6 mm in diameter, leaving a small footprint. The nails are used judiciously to provide effective stabilization of the fragment and to maintain a cost-conscious approach. An accessory superomedial peripatellar portal allows an appropriate angle for nail placement. This portal allows access to all regions of the fractured fragment, while an anteromedial and anterolateral portal are used as working and camera portals, respectively. Nails are placed to provide an axis perpendicular to the fracture line to allow appropriate compression. By virtue of the shape of the typical fragment in a tibial spine fracture, the nails vary in insertion angle.
The occurrence of anterior tibial spine fractures is rare, and while several techniques have been described to repair this fracture, there remains a great deal of uncertainty regarding the best course of treatment. A review of the literature finds arthroscopic and open approaches, as well as techniques employing K-wire fixation, metal screw fixation, staple fixation, absorbable fixation, and fixation with sutures passed through the tibial tunnel.16-18
Avulsion fractures of the tibial eminence were treated with open fixation until McLennan8 first reported the benefits of reduction with an arthroscope. Open reduction and internal fixation provide the benefit of direct visualization,9 while arthroscopic reduction offers decreased morbidity and an accelerated recovery of knee functions,8 despite the fact that a higher rate of range-of-motion deficits were seen in patients treated arthroscopically.19 We feel that with proper early rehabilitation to achieve range of motion, the risk of this can be minimal.
Various arthroscopic approaches that improve the accuracy of the reduction and decrease surgical invasiveness have been described. Suture and screw fixation are among the most common methods, and both have resulted in positive outcomes.20-24 Suture fixation of the tibial eminence is technically demanding but offers secure fixation without the need for follow-up hardware removal. Screw fixation results in secure fixation; however, numerous hardware-related issues may necessitate removal. Furthermore, in skeletally immature patients, screw fixation may disturb the growth plate if it crosses an open physis.9
Hunter and Willis25 retrospectively reviewed patients with tibial eminence fractures treated with either screw or suture fixation and found a 44% reoperation rate in the screw-fixation group. Removal was often recommended as a result of hardware-related issues. There was a 13% reoperation rate in the suture-fixation group, which resulted largely from stiffness.25 In a recent review, Gans and colleagues19 reviewed 6 publications comparing screw and suture fixation of tibial eminence fractures and found 82.4% of screw patients had laxity on both the anterior drawer and Lachman tests, compared with 18.8% in the suture-fixation group. This study also noted a slightly higher rate of arthrofibrosis in patients treated with suture fixation.19 Biomechanical studies indicate that suture fixation imparts greater strength under cyclic-loading conditions;26 however, there does not appear to be a difference in ultimate force required for fixation failure.27
Ultimately, both suture and screw fixation result in secure methods of fixation; however, there are often greater issues with screw fixation because of the persistent hardware. Metal has been the most popular method for fracture fixation, and while biodegradable materials have been alluring, adverse tissue reactions have slowed implementation. However, these implants have become increasingly sophisticated, thereby reducing disadvantages.28 Previous biodegradable devices were often composed of a single polymer, and many caused adverse reactions by degrading too quickly or provided no real advantages because they degraded too slowly.29 As the number of polymers approved for internal use and surgical applications continues to rise, so too will the benefits of employing this technology. Furthermore, by including multiple polymers in these implants, one is better able to control the degradation rate, limiting the tissue response.
In this study, we employed PLLA/PGA nails. Studies of PGA implants indicate this molecule degrades at a fast rate resulting in adverse tissue reactions. Adverse reactions in studies of PLLA implants are less frequent because of their slower rate of degradation.29,30 Combining these monomers results in appropriate strength and a controlled degradation rate, reducing the likelihood of adverse reactions. Furthermore, numerous studies have reported that inflammatory responses in children are rare and mild in nature.31,32 Absorbable implants have displayed efficacy in numerous orthopedic settings33-36 and are beneficial in procedures that are not suitable for repeated surgeries, such as reconstruction of the ACL.37 There is some concern about the use of absorbable implants in synovial joints. Polyglycolic acid use in synovial joints may cause foreign-body reactions and may increase the risk of intra-articular dissemination of polymeric debris;38 however, use of a multipolymer construct decreases the likelihood of this occurrence.
Polyglycolic nails confer the advantage over nonresorbable screw fixation because further procedure for hardware removal is not required. Although suture fixation has proved to be beneficial over nonresorbable screw fixation, implantation of resorbable nails appears to have several advantages. In Dr. Estes’ experience, placement of resorbable screws through an accessory superomedial portal is far less technically demanding than placement of suture through the fracture fragment. Further, as sutures are passed from the extra-articular to the intra-articular region of the joint, capsular layers of the knee may inadvertently be bound up in the fixation, predisposing to arthrofibrosis.
At the same time, biodegradable devices are often more costly than alternative forms of treatment; however, a true cost-to-benefit analysis requires consideration of other factors. One of the benefits of biodegradable hardware is that there is no need for follow-up hardware removal. Reports have indicated that up to 91% of patients thought that hardware removal was the most negative aspect of metal implants.39 It is estimated that if the removal rate for metallic implants is higher than 19% to 54%, resorbable implants would be more cost-effective.40 The cost of sutures and screws is variable, however; they are invariably less expensive than biodegradable nails. A study of fracture patients determined that biodegradable implants were cheaper on average after considering the cost of implant removal.40 Ultimately, the hardware choice depends on numerous factors, including surgeon’s discretion; however, biodegradable hardware should not be discounted for financial reasons because the difference in cost is likely negligible.
Conclusion
The approach described in this report offers efficient and secure fixation with resorbable hardware without a reduction in range of motion. Resorbable implants may prove beneficial in the treatment of tibial eminence fractures by offering robust fixation without the concerns associated with permanent hardware.
1. Hargrove R, Parsons S, Payne R. Anterior tibial spine fracture – an easy fracture to miss. Accid Emerg Nurs. 2004;12(3):173-175.
2. Aderinto J, Walmsley P, Keating JF. Fractures of the tibial spine: epidemiology and outcome. Knee. 2008;15(3):164-167.
3. Driessen MJ, Winkelman PA. Fractures of the intercondylar eminence of the tibia in childhood. Neth J Surg. 1984;36(3):69-72.
4. Zaricznyj B. Avulsion fracture of the tibial eminence: treatment by open reduction and pinning. J Bone Joint Surg Am. 1977;59(8):1111-1114.
5. Molander ML, Wallin G, Wikstad I. Fracture of the intercondylar eminence of the tibia: a review of 35 patients. J Bone Joint Surg Br. 1981;63(1):89-91.
6. Kieser DC, Gwynne-Jones D, Dreyer S. Displaced tibial intercondylar eminence fractures. J Orthop Surg. 2011;19(3):292-296.
7. Ishibashi Y, Tsuda E, Sasaki T, Toh S. Magnetic resonance imaging AIDS in detecting concomitant injuries in patients with tibial spine fractures. Clin Orthop. 2005;(434):207-212.
8. McLennan JG. The role of arthroscopic surgery in the treatment of fractures of the intercondylar eminence of the tibia. J Bone Joint Surg Br. 1982;64(4):477-480.
9. Lafrance RM, Giordano B, Goldblatt J, Voloshin I, Maloney M. Pediatric tibial eminence fractures: evaluation and management. J Am Acad Orthop Surg. 2010;18(7):395-405.
10. Meyers MH, McKeever FM. Fracture of the intercondylar eminence of the tibia. J Bone Joint Surg Am. 1959;41(2):209-220.
11. Meyers MH, McKeever FM. Fracture of the intercondylar eminence of the tibia. J Bone Joint Surg Am. 1970;52(8):1677-1684.
12. Garcés GL, Mugica-Garay I, López-González Coviella N, Guerado E. Growth-plate modifications after drilling. J Pediatr Orthop. 1994;14(2):225-228.
13. Janarv PM, Wikström B, Hirsch G. The influence of transphyseal drilling and tendon grafting on bone growth: an experimental study in the rabbit. J Pediatr Orthop. 1998;18(2):149-154.
14. Boelitz R, Dallek M, Meenen NM, Jungbluth KH. Reaction of the epiphyseal groove to groove-crossing bore-wire osteosynthesis. Results of a histomorphologic small animal study. Unfallchirurgie. 1994;20(3):131-137.
15. Yung PS, Lam CY, Ng BK, Lam TP, Cheng JC. Percutaneous transphyseal intramedullary Kirschner wire pinning: a safe and effective procedure for treatment of displaced diaphyseal forearm fracture in children. J Pediatr Orthop. 2004;24(1):7-12.
16. Bong MR, Romero A, Kubiak E, et al. Suture versus screw fixation of displaced tibial eminence fractures: a biomechanical comparison. Arthroscopy. 2005;21(10):1172-1176.
17. Vega JR, Irribarra LA, Baar AK, Iñiguez M, Salgado M, Gana N. Arthroscopic fixation of displaced tibial eminence fractures: a new growth plate-sparing method. Arthroscopy. 2008;24(11):1239-1243.
18. Shepley RW. Arthroscopic treatment of type III tibial spine fractures using absorbable fixation. Orthopedics. 2004;27(7):767-769.
19. Gans I, Baldwin KD, Ganley TJ. Treatment and management outcomes of tibial eminence fractures in pediatric patients: a systematic review. Am J Sports Med. 2013;42(7):1743-1750.
20. Delcogliano A, Chiossi S, Caporaso A, Menghi A, Rinonapoli G. Tibial intercondylar eminence fractures in adults: arthroscopic treatment. Knee Surg Sports Traumatol Arthrosc. 2003;11(4):255-259.
21. Mulhall KJ, Dowdall J, Grannell M, McCabe JP. Tibial spine fractures: an analysis of outcome in surgically treated type III injuries. Injury. 1999;30(4):289-292.
22. Geissler WB, Matthews DE. Arthroscopic suture fixation of displaced tibial eminence fractures. Orthopedics. 1993;16(3):331-333.
23. Mah JY, Otsuka NY, McLean J. An arthroscopic technique for the reduction and fixation of tibial-eminence fractures. J Pediatr Orthop. 1996;16(1):119-121.
24. Reynders P, Reynders K, Broos P. Pediatric and adolescent tibial eminence fractures: arthroscopic cannulated screw fixation. J Trauma. 2002;53(1):49-54.
25. Hunter RE, Willis JA. Arthroscopic fixation of avulsion fractures of the tibial eminence: technique and outcome. Arthroscopy. 2004;20(2):113-121.
26. Eggers AK, Becker C, Weimann A, et al. Biomechanical evaluation of different fixation methods for tibial eminence fractures. Am J Sports Med. 2007;35(3):404-410.
27. Mahar AT, Duncan D, Oka R, Lowry A, Gillingham B, Chambers H. Biomechanical comparison of four different fixation techniques for pediatric tibial eminence avulsion fractures. J Pediatr Orthop. 2008;28(2):159-162.
28. Toro C, Robiony M, Zerman N, Politi M. Resorbable plates in maxillary fixation. A 5-year experience. Minerva Stomatol. 2005;54(4):199-206.
29. Andriano KP, Pohjonen T, Törmälä P. Processing and characterization of absorbable polylactide polymers for use in surgical implants. J Appl Biomater.1994;5(2):133-140.
30. Böstman O, Pihlajamäki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials. 2000;21(24):2615-2621.
31. Rokkanen PU, Böstman O, Hirvensalo E, et al. Bioabsorbable fixation in orthopaedic surgery and traumatology. Biomaterials. 2000;21(24):2607-2613.
32. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials. 1996;17(2):93-102.
33. Li ZH, Yu AX, Guo XP, Qi BW, Zhou M, Wang WY. Absorbable implants versus metal implants for the treatment of ankle fractures: A meta-analysis. Exp Ther Med. 2013;5(5):1531-1537.
34. Singh G, Mohammad S, Chak RK, Lepcha N, Singh N, Malkunje LR. Bio-resorbable plates as effective implant in paediatric mandibular fracture. J Maxillofac Oral Surg. 2012;11(4):400-406.
35. Sakamoto Y, Shimizu Y, Nagasao T, Kishi K. Combined use of resorbable poly-L-lactic acid-polyglycolic acid implant and bone cement for treating large orbital floor fractures. J Plast Reconstr Aesthet Surg. 2014;67(3):e88-e90.
36. Benz G, Kallieris D, Seeböck T, McIntosh A, Daum R. Bioresorbable pins and screws in paediatric traumatology. Eur J Pediatr Surg. 1994;4(2):103-107.
37. Gaweda K, Walawski J, Weglowski R, Krzyzanowski W. Comparison of bioabsorbable interference screws and posts for distal fixation in anterior cruciate ligament reconstruction. Int Orthop. 2009;33(1):123-127.
38. Böstman OM. Osteoarthritis of the ankle after foreign-body reaction to absorbable pins and screws: a three- to nine-year follow-up study. J Bone Joint Surg Br. 1998;80(2):333-338.
39. Mittal R, Morley J, Dinopoulos H, Drakoulakis EG, Vermani E, Giannoudis PV. Use of bio-resorbable implants for stabilisation of distal radius fractures: the United Kingdom patients’ perspective. Injury. 2005;36(2):333-338.
40. Böstman OM. Metallic or absorbable fracture fixation devices. A cost minimization analysis. Clin Orthop. 1996;(329):233-239.
1. Hargrove R, Parsons S, Payne R. Anterior tibial spine fracture – an easy fracture to miss. Accid Emerg Nurs. 2004;12(3):173-175.
2. Aderinto J, Walmsley P, Keating JF. Fractures of the tibial spine: epidemiology and outcome. Knee. 2008;15(3):164-167.
3. Driessen MJ, Winkelman PA. Fractures of the intercondylar eminence of the tibia in childhood. Neth J Surg. 1984;36(3):69-72.
4. Zaricznyj B. Avulsion fracture of the tibial eminence: treatment by open reduction and pinning. J Bone Joint Surg Am. 1977;59(8):1111-1114.
5. Molander ML, Wallin G, Wikstad I. Fracture of the intercondylar eminence of the tibia: a review of 35 patients. J Bone Joint Surg Br. 1981;63(1):89-91.
6. Kieser DC, Gwynne-Jones D, Dreyer S. Displaced tibial intercondylar eminence fractures. J Orthop Surg. 2011;19(3):292-296.
7. Ishibashi Y, Tsuda E, Sasaki T, Toh S. Magnetic resonance imaging AIDS in detecting concomitant injuries in patients with tibial spine fractures. Clin Orthop. 2005;(434):207-212.
8. McLennan JG. The role of arthroscopic surgery in the treatment of fractures of the intercondylar eminence of the tibia. J Bone Joint Surg Br. 1982;64(4):477-480.
9. Lafrance RM, Giordano B, Goldblatt J, Voloshin I, Maloney M. Pediatric tibial eminence fractures: evaluation and management. J Am Acad Orthop Surg. 2010;18(7):395-405.
10. Meyers MH, McKeever FM. Fracture of the intercondylar eminence of the tibia. J Bone Joint Surg Am. 1959;41(2):209-220.
11. Meyers MH, McKeever FM. Fracture of the intercondylar eminence of the tibia. J Bone Joint Surg Am. 1970;52(8):1677-1684.
12. Garcés GL, Mugica-Garay I, López-González Coviella N, Guerado E. Growth-plate modifications after drilling. J Pediatr Orthop. 1994;14(2):225-228.
13. Janarv PM, Wikström B, Hirsch G. The influence of transphyseal drilling and tendon grafting on bone growth: an experimental study in the rabbit. J Pediatr Orthop. 1998;18(2):149-154.
14. Boelitz R, Dallek M, Meenen NM, Jungbluth KH. Reaction of the epiphyseal groove to groove-crossing bore-wire osteosynthesis. Results of a histomorphologic small animal study. Unfallchirurgie. 1994;20(3):131-137.
15. Yung PS, Lam CY, Ng BK, Lam TP, Cheng JC. Percutaneous transphyseal intramedullary Kirschner wire pinning: a safe and effective procedure for treatment of displaced diaphyseal forearm fracture in children. J Pediatr Orthop. 2004;24(1):7-12.
16. Bong MR, Romero A, Kubiak E, et al. Suture versus screw fixation of displaced tibial eminence fractures: a biomechanical comparison. Arthroscopy. 2005;21(10):1172-1176.
17. Vega JR, Irribarra LA, Baar AK, Iñiguez M, Salgado M, Gana N. Arthroscopic fixation of displaced tibial eminence fractures: a new growth plate-sparing method. Arthroscopy. 2008;24(11):1239-1243.
18. Shepley RW. Arthroscopic treatment of type III tibial spine fractures using absorbable fixation. Orthopedics. 2004;27(7):767-769.
19. Gans I, Baldwin KD, Ganley TJ. Treatment and management outcomes of tibial eminence fractures in pediatric patients: a systematic review. Am J Sports Med. 2013;42(7):1743-1750.
20. Delcogliano A, Chiossi S, Caporaso A, Menghi A, Rinonapoli G. Tibial intercondylar eminence fractures in adults: arthroscopic treatment. Knee Surg Sports Traumatol Arthrosc. 2003;11(4):255-259.
21. Mulhall KJ, Dowdall J, Grannell M, McCabe JP. Tibial spine fractures: an analysis of outcome in surgically treated type III injuries. Injury. 1999;30(4):289-292.
22. Geissler WB, Matthews DE. Arthroscopic suture fixation of displaced tibial eminence fractures. Orthopedics. 1993;16(3):331-333.
23. Mah JY, Otsuka NY, McLean J. An arthroscopic technique for the reduction and fixation of tibial-eminence fractures. J Pediatr Orthop. 1996;16(1):119-121.
24. Reynders P, Reynders K, Broos P. Pediatric and adolescent tibial eminence fractures: arthroscopic cannulated screw fixation. J Trauma. 2002;53(1):49-54.
25. Hunter RE, Willis JA. Arthroscopic fixation of avulsion fractures of the tibial eminence: technique and outcome. Arthroscopy. 2004;20(2):113-121.
26. Eggers AK, Becker C, Weimann A, et al. Biomechanical evaluation of different fixation methods for tibial eminence fractures. Am J Sports Med. 2007;35(3):404-410.
27. Mahar AT, Duncan D, Oka R, Lowry A, Gillingham B, Chambers H. Biomechanical comparison of four different fixation techniques for pediatric tibial eminence avulsion fractures. J Pediatr Orthop. 2008;28(2):159-162.
28. Toro C, Robiony M, Zerman N, Politi M. Resorbable plates in maxillary fixation. A 5-year experience. Minerva Stomatol. 2005;54(4):199-206.
29. Andriano KP, Pohjonen T, Törmälä P. Processing and characterization of absorbable polylactide polymers for use in surgical implants. J Appl Biomater.1994;5(2):133-140.
30. Böstman O, Pihlajamäki H. Clinical biocompatibility of biodegradable orthopaedic implants for internal fixation: a review. Biomaterials. 2000;21(24):2615-2621.
31. Rokkanen PU, Böstman O, Hirvensalo E, et al. Bioabsorbable fixation in orthopaedic surgery and traumatology. Biomaterials. 2000;21(24):2607-2613.
32. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials. 1996;17(2):93-102.
33. Li ZH, Yu AX, Guo XP, Qi BW, Zhou M, Wang WY. Absorbable implants versus metal implants for the treatment of ankle fractures: A meta-analysis. Exp Ther Med. 2013;5(5):1531-1537.
34. Singh G, Mohammad S, Chak RK, Lepcha N, Singh N, Malkunje LR. Bio-resorbable plates as effective implant in paediatric mandibular fracture. J Maxillofac Oral Surg. 2012;11(4):400-406.
35. Sakamoto Y, Shimizu Y, Nagasao T, Kishi K. Combined use of resorbable poly-L-lactic acid-polyglycolic acid implant and bone cement for treating large orbital floor fractures. J Plast Reconstr Aesthet Surg. 2014;67(3):e88-e90.
36. Benz G, Kallieris D, Seeböck T, McIntosh A, Daum R. Bioresorbable pins and screws in paediatric traumatology. Eur J Pediatr Surg. 1994;4(2):103-107.
37. Gaweda K, Walawski J, Weglowski R, Krzyzanowski W. Comparison of bioabsorbable interference screws and posts for distal fixation in anterior cruciate ligament reconstruction. Int Orthop. 2009;33(1):123-127.
38. Böstman OM. Osteoarthritis of the ankle after foreign-body reaction to absorbable pins and screws: a three- to nine-year follow-up study. J Bone Joint Surg Br. 1998;80(2):333-338.
39. Mittal R, Morley J, Dinopoulos H, Drakoulakis EG, Vermani E, Giannoudis PV. Use of bio-resorbable implants for stabilisation of distal radius fractures: the United Kingdom patients’ perspective. Injury. 2005;36(2):333-338.
40. Böstman OM. Metallic or absorbable fracture fixation devices. A cost minimization analysis. Clin Orthop. 1996;(329):233-239.
Risk Factors for In-Hospital Myocardial Infarction After Shoulder Arthroplasty
The incidence of shoulder arthroplasty in the United States is increasing annually,1-3 and the majority of these operations occur in older patients.4-6 Elderly patients with cardiovascular, pulmonary, cerebral, renal, and hepatic disease are increasingly susceptible to numerous surgical complications.4 Myocardial infarction (MI) is a complication that occurs in 0.7% of noncardiac surgeries. This figure increases to 1.1% in patients with coronary artery disease.7-11 Perioperative MI increases morbidity and mortality,8 and perioperative cardiac morbidity is the leading cause of death after anesthesia and surgery.12 The financial effects of perioperative cardiac morbidity and mortality must also be considered. A 2009 claims analysis study estimated charges associated with a perioperative MI at $15,000 and the cost of cardiac death at $21,909.13
Cardiovascular complications are associated with a significant degree of morbidity and mortality in patients who undergo arthroplasty.14-16 Although studies have elucidated 30- and 90-day morbidity and mortality rates after shoulder arthroplasty, in hip and knee arthroplasty17-19 little has been done to determine predictors of perioperative MI in a representative database of patients. Given the increasing incidence of shoulder arthroplasty in the United States, the elective nature of this procedure, and the percentage of the US population with cardiovascular risk factors,20 it is important to establish predictors of perioperative MI to ensure patients and physicians have the necessary resources to make informed decisions.
We conducted a study to examine the risk factors for perioperative MI in a large cohort of patients admitted for shoulder arthroplasty to US hospitals. We wanted to evaluate the association between perioperative MI and shoulder arthroplasty with respect to demographics, primary diagnosis, medical comorbidities, and perioperative complications. Specifically, we tested the null hypothesis that, among patients undergoing shoulder arthroplasty, and accounting for confounding variables, there would be no difference in risk factors for patients who have a perioperative MI.
Materials and Methods
This study was exempt from approval by our institutional review board. All data used in this project were deidentified before use.
Nationwide Inpatient Sample (NIS)
The Nationwide Inpatient Sample (NIS), an annual survey of hospitals, is conducted by the Healthcare Cost and Utilization Project (HCUP) and sponsored by the Agency for Healthcare Research and Quality (AHRQ). This database is the largest publicly available all-payer inpatient discharge database in the United States.21 Sampling 8 million hospital stays each year, NIS includes information from a representative batch of 20% of US hospitals. In 2011, 46 states and 1045 hospitals contributed information to the database, representing 97% of the US population.22 This large sample allows researchers to analyze a robust set of medical conditions and uncommon treatments. The survey, conducted each year since 1988, includes demographic, clinical, and resource use data.23 Discharge weight files are provided by NIS to arrive at valid national estimates.
This database is particularly useful because it provides information on up to 25 medical diagnoses and 15 procedures, which are recorded with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Researchers can use this database to analyze patient and hospital characteristics as well as inpatient outcomes.24,25 Numerous studies have used NIS to address pertinent queries across the medical landscape.22,26
Patient Selection and Analysis
We used NIS to isolate a population of 422,371 adults (≥18 years old) who underwent total shoulder arthroplasty (TSA) or hemi–shoulder arthroplasty (HSA) between January 1, 2002 and December 31, 2011. We then placed the patients in this population into 1 of 2 cohorts. The first cohort had an acute MI during the perioperative period after TSA, and the second, larger cohort did not have an acute MI after TSA. Acute MI was identified using ICD-9-CM code 410.xx. To identify a population of shoulder arthroplasty patients, we included discharges with an ICD-9-CM procedure code of 81.80 or 81.88 (both TSA) or 81.81 (HSA) in the sample. We then considered the degree to which each of 5 variables—primary diagnosis, age, sex, race, and select medical comorbidities—was predictive of in-hospital MI after TSA.
Statistical Analysis
Given the large sample used in this study, normal distribution of data was assumed. Using bivariate analysis, Pearson χ2 test for categorical data, and independent-samples t test for continuous data, we compared the nonacute MI and acute MI groups. Multivariable binary logistic regression analyses allowed us to isolate the extent that primary diagnosis, age, sex, race, and medical comorbidities were predictors of acute MI after shoulder arthroplasty. Statistical significance was set at P < .05. SPSS Version 22.0 (SPSS, Chicago, Illinois) was used for all statistical analyses and data modeling.
Results
Between January 1, 2002 and December 31, 2011, an estimated total of 422,371 patients underwent shoulder arthroplasty (59.3% TSA, 40.7% HSA). Of these patients, 1174 (0.28%) had a perioperative MI, and 421,197 (99.72%) did not (Table 1). Patients with a primary diagnosis of proximal humerus fracture (33.8% vs 16.6%; P < .001) or rotator cuff arthropathy (10.1% vs 9.9%; P < .001) were more likely than patients with other diagnoses to have an in-hospital MI.
Our review of the demographics found that patients who underwent shoulder arthroplasty and had a perioperative MI were likely older (75±8.9 years vs 69±11 years; P < .001), Caucasian (94.2% vs 91.9%; P = .002), male (43.2% vs 39.7%; P = .013), in the highest median household income bracket of $63,000 or more (30.8% vs 25.6%; P < .001), and using Medicare (80.9% vs 66.3%; P < .001). They were more likely to be treated in a medical center of medium size (25.6% vs 23.7%; P = .042) or larger (61.8% vs 61.2%; P = .042). MIs occurred more often in urban environments (91.4% vs 88.5%; P = .002) and in HSA patients (55% vs 40.6%; P < .001), resulting in longer hospital stays (9.4±7.9 days vs 2.7±2.5 days; P < .001) and higher probability of death (6.5% vs 0.1%; P < .001).
We then analyzed the 2 cohorts for medical comorbidities (Table 2). Patients in the MI cohort presented with a significantly higher incidence of congestive heart failure, previous MI, angina pectoris, chronic lung disease, hypertension, diabetes, renal failure, fluid and electrolyte disorders, pulmonary circulatory disease, coagulopathy, and deficiency anemia (P < .001) but not liver disease and obesity. Bivariate analysis of perioperative outcomes (Table 3) indicated that these patients also had a statistically higher rate of numerous other complications: pulmonary embolism (4.9% vs 0.2%; P < .001), pneumonia (15.1% vs 1.2%; P < .001), deep venous thrombosis (2.6% vs 0.2%; P < .001), cerebrovascular event (1.6% vs 0.1%; P < .001), acute renal failure (15.1% vs 1.2%; P < .001), gastrointestinal complication (1.2% vs 0.3%; P < .001), mechanical ventilation (1.2% vs 0.3%; P < .001), transfusion (33.4% vs 8.8%; P < .001), and nonroutine discharge (73.3% vs 36.0%; P < .001).
Multivariable logistic regression analysis was performed to determine independent predictors of perioperative MI after shoulder arthroplasty (Table 4). Patients with a primary diagnosis of proximal humerus fracture (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.15-1.65; P < .001) were more likely than patients with a primary diagnosis of osteoarthritis to have an MI. The odds of postoperative MI increased with age (OR, 1.04 per year; 95% CI, 1.03-1.05; P < .001) and were higher in males (OR, 1.72; 95% CI, 1.52-1.96; P < .001). Compared with Caucasians, African Americans (OR, 0.19; 95% CI, 0.09-0.40; P < .001) were less likely to have an in-hospital MI after shoulder arthroplasty. After shoulder arthroplasty, the odds of MI in the perioperative period increased with each subsequent day of care (OR, 1.10; 95% CI, 1.10-1.11; P < .001).
Regarding independent comorbidities, multivariable logistic regression analysis also determined that history of congestive heart failure (OR, 4.86; 95% CI, 4.20-5.61; P < .001), angina pectoris (OR, 2.90; 95% CI, 2.02-4.17; P < .001), complicated diabetes (OR, 1.96; 95% CI, 1.49-2.57; P < .001), renal failure (OR, 1.42; 95% CI, 1.17-1.72; P < .001), fluid and electrolyte disorders (OR, 1.42; 95% CI, 1.21-1.67; P < .001), and deficiency anemia (OR, 1.62; 95% CI, 1.40-1.88; P < .001) were significant predictors of perioperative MI after shoulder arthroplasty.
Discussion
Results of other studies have elucidated 30- and 90-day mortality rates and postoperative complications after shoulder arthroplasty, but, relative to hip and knee arthroplasty,17-19 little has been done to determine predictors of perioperative MI in a large sample of shoulder arthroplasty patients. Given the increasing rates of shoulder arthroplasty1-3 and the demographics of this population,4-6 it is likely that postoperative cardiovascular events will increase in frequency. We found that, in order of decreasing significance, the top 4 risk predictors for acute MI after shoulder arthroplasty were congestive heart failure, angina pectoralis, complicated diabetes mellitus, and male sex. Other pertinent risk factors included older age, Caucasian ethnicity, and a primary diagnosis of proximal humerus fracture. The rate of acute MI in patients who were older than 75 years when they underwent HSA for proximal humerus fracture was 0.80%.
Demographics
We found that patients who had an acute MI after shoulder arthroplasty were likely older, male, and Caucasian. Age and male sex are well-established risk factors for increased cardiac complications after arthroplasty.27-29 Previous studies have indicated that the rate of cardiac events increases in arthroplasty patients older than 65 years.19,28,29 In our study, more than 50% of the patients who had an acute perioperative MI were older than 85 years. Less explainable is the increased occurrence of acute MI in Caucasian patients and wealthy patients, given that minorities in the United States have higher rates of cardiovascular disease.30 Shoulder arthroplasty is an elective procedure, more likely to be undertaken by Caucasians. Therefore, at-risk minority groups and financially challenged groups may be less likely to have this procedure.
Primary Diagnosis
In this series, patients with a primary diagnosis of proximal humerus fracture were more likely to have an in-hospital MI. This finding is consistent with previous studies indicating a higher rate of complications for proximal humerus fracture patients than for shoulder arthroplasty patients.31,32 Given that more than 75% of patients who present with a proximal humerus fracture are older than 70 years, it would be prudent to examine operative indications after this diagnosis,33 particularly as benefit from surgery for fractures has not been definitively demonstrated.34-37
Comorbidities
Many of the patients in our MI cohort presented with congestive heart failure, angina pectoris, complicated diabetes, renal failure, fluid and electrolyte disorders, or deficiency anemia. This is in keeping with other studies indicating that preexisting cardiovascular morbidity increases the rate of MI after various forms of arthroplasty.7-11 Patients in our MI cohort were also susceptible to a variety of post-MI perioperative complications, including pulmonary embolism, pneumonia, deep venous thrombosis, cerebrovascular event, acute renal failure, gastrointestinal complication, mechanical ventilation, transfusion, and nonroutine discharge, and their incidence of death was higher. These findings are consistent with reports that postoperative cardiovascular complications increase the degree of morbidity and mortality in arthroplasty patients.14-16 It is also worth noting that the odds of MI in the perioperative period increase with each subsequent day of care. This is understandable given that patients presenting with numerous comorbidities are at increased risk for perioperative complications38 resulting in hospital readmission.39
The literature indicates that MI occurs as a complication in 0.7% of patients who undergo noncardiac surgery,7 though some series have shown it is more prevalent after arthroplasty procedures.28,40 MI significantly increases the rate of perioperative morbidity and mortality,8 and perioperative cardiac morbidity is a leading cause of death after anesthesia and surgery.12 Furthermore, the most common cause of death after lower extremity arthroplasty is cardiovascular-related.41,42 In patients who presented for elective hip arthroplasty, cardiorespiratory disease was one of the main risk factors (with older age and male sex) shown to increase perioperative mortality.43
Perioperative cardiovascular complications increase postoperative morbidity and mortality.12 The rate of cardiovascular complications after shoulder arthroplasty ranges from 0.8% to 2.6%, and the incidence of MI hovers between 0.3% and 0.9%.17,19,28,40,44 A recent study in 793 patients found that, over a 30-day period, cardiovascular complications accounted for more than one-fourth of all complications.17 Singh and colleagues19 analyzed cardiopulmonary complications after primary shoulder arthroplasty in a total of 3480 patients (4019 arthroplasties) and found this group had a 90-day cardiac morbidity (MI, congestive heart failure, arrhythmia) rate of 2.6%. In that study, a Deyo-Charlson index of 1 or more was a significant independent risk factor for cardiac complications following surgery. Scores on this weighted index of 17 comorbidities are used to assess the complexities of a patient population. Given the severity of cardiovascular perioperative complications, it is important to preoperatively identify high-risk population groups and sufficiently study and optimize patients before shoulder arthroplasty.
There is much debate about the effectiveness of perioperative β-blockers in reducing perioperative cardiac morbidity and mortality.45-48 Such a discussion is outside of the scope of this article, but it may be prudent to seek a cardiology consultation for patients presenting with risk factors for perioperative MI. β-Blockers may prove useful in reducing cardiac morbidity in high-risk patients after noncardiac surgery.45,49
Many limitations are inherent in studies that use a nationally represented database such as NIS, which we used in this study. It is highly likely that NIS does not capture all potential postoperative complications, as this database is very large and subject to errors in data entry and clinical coding. In addition, detailed clinical information (eg, severity of certain comorbid diseases before shoulder arthroplasty, details about the intraoperative course) was not readily available for analysis. Another limitation, which may have led to an underestimate of complication rates, was our not being able to obtain information about postdischarge complications.
Despite these limitations, NIS and other databases have helped researchers answer questions about low-incidence conditions and generalize findings to a national population. In the present study, we analyzed 2 cohorts, patients with and without acute MI after shoulder arthroplasty, to determine predictors for and complications of postarthroplasty MI. We identified numerous predictors for acute MI: congestive heart failure, angina pectoris, complicated diabetes, renal failure, fluid and electrolyte disorders, and deficiency anemia prior to arthroplasty. As perioperative MI is associated with significant morbidity,14-16 it would be wise to screen patients for such comorbid conditions, assess the severity of these conditions, and offer shoulder arthroplasty with prudence.
Conclusion
The top 4 predictors for acute MI after shoulder arthroplasty were congestive heart failure, angina pectoralis, complicated diabetes mellitus, and male sex. Other pertinent risk factors included older age, Caucasian ethnicity, and primary diagnosis of proximal humerus fracture. Surgeons and patients must be aware of predictors for adverse surgical outcomes such as perioperative MI and understand the extent to which these events increase perioperative morbidity and mortality.
1. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM. Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg. 2010;19(8):1115-1120.
2. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011;93(24):2249-2254.
3. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop. 2009;467(10):2606-2612.
4. Boettcher WG. Total hip arthroplasties in the elderly. Morbidity, mortality, and cost effectiveness. Clin Orthop. 1992;(274):30-34.
5. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993;31(2):141-154.
6. Kreder HJ, Williams JI, Jaglal S, Hu R, Axcell T, Stephen D. Are complication rates for elective primary total hip arthroplasty in Ontario related to surgeon and hospital volumes? A preliminary investigation. Can J Surg. 1998;41(6):431-437.
7. Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564-578.
8. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 1990;323(26):1781-1788.
9. Tarhan S, Moffitt EA, Taylor WF, Giuliani ER. Myocardial infarction after general anesthesia. JAMA. 1972;220(11):1451-1454.
10. Landesberg G, Mosseri M, Zahger D, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol. 2001;37(7):1839-1845.
11. van Waes JA, Nathoe HM, de Graaff JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation. 2013;127(23):2264-2271.
12. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72(1):153-184.
13. Fleisher LA, Corbett W, Berry C, Poldermans D. Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients. J Cardiothorac Vasc Anesth. 2004;18(1):7-13.
14. Aynardi M, Pulido L, Parvizi J, Sharkey PF, Rothman RH. Early mortality after modern total hip arthroplasty. Clin Orthop. 2009;467(1):213-218.
15. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45(2):335-341.
16. Baser O, Supina D, Sengupta N, Wang L, Kwong L. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. Am J Health Syst Pharm. 2010;67(17):1438-1445.
17. Fehringer EV, Mikuls TR, Michaud KD, Henderson WG, O’Dell JR. Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans. Clin Orthop. 2010;468(3):717-722.
18. Farmer KW, Hammond JW, Queale WS, Keyurapan E, McFarland EG. Shoulder arthroplasty versus hip and knee arthroplasties: a comparison of outcomes. Clin Orthop. 2007;(455):183-189.
19. Singh JA, Sperling JW, Cofield RH. Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study. Semin Arthritis Rheum. 2012;41(5):689-697.
20. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
21. Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95(11):1028-1036.
22. Maynard C, Sales AE. Changes in the use of coronary artery revascularization procedures in the Department of Veterans Affairs, the National Hospital Discharge Survey, and the Nationwide Inpatient Sample, 1991–1999. BMC Health Serv Res. 2003;3(1):12.
23. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Obstructive sleep apnea as a risk factor after shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(12):e6-e9.
24. Hambright D, Henderson RA, Cook C, Worrell T, Moorman CT, Bolognesi MP. A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. J Shoulder Elbow Surg. 2011;20(1):77-85.
25. Odum SM, Troyer JL, Kelly MP, Dedini RD, Bozic KJ. A cost-utility analysis comparing the cost-effectiveness of simultaneous and staged bilateral total knee arthroplasty. J Bone Joint Surg Am. 2013;95(16):1441-1449.
26. Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(5):671-678.
27. Alfonso DT, Toussaint RJ, Alfonso BD, Strauss EJ, Steiger DT, Di Cesare PE. Nonsurgical complications after total hip and knee arthroplasty. Am J Orthop. 2006;35(11):503-510.
28. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96(5):1140-1146.
29. Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011;70(12):2082-2088.
30. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17(1):143-152.
31. Zhang AL, Schairer WW, Feeley BT. Hospital readmissions after surgical treatment of proximal humerus fractures: is arthroplasty safer than open reduction internal fixation? Clin Orthop. 2014;472(8):2317-2324.
32. Schairer WW, Zhang AL, Feeley BT. Hospital readmissions after primary shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(9):1349-1355.
33. de Kruijf M, Vroemen JP, de Leur K, van der Voort EA, Vos DI, Van der Laan L. Proximal fractures of the humerus in patients older than 75 years of age: should we consider operative treatment? J Orthop Traumatol. 2014;15(2):111-115.
34. Hauschild O, Konrad G, Audige L, et al. Operative versus non-operative treatment for two-part surgical neck fractures of the proximal humerus. Arch Orthop Trauma Surg. 2013;133(10):1385-1393.
35. Hanson B, Neidenbach P, de Boer P, Stengel D. Functional outcomes after nonoperative management of fractures of the proximal humerus. J Shoulder Elbow Surg. 2009;18(4):612-621.
36. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2012;12:CD000434.
37. Court-Brown CM, Cattermole H, McQueen MM. Impacted valgus fractures (B1.1) of the proximal humerus. The results of non-operative treatment. J Bone Joint Surg Br. 2002;84(4):504-508.
38. Chalmers PN, Gupta AK, Rahman Z, Bruce B, Romeo AA, Nicholson GP. Predictors of early complications of total shoulder arthroplasty. J Arthroplasty. 2014;29(4):856-860.
39. Mahoney A, Bosco JA 3rd, Zuckerman JD. Readmission after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(3):377-381.
40. Khan SK, Malviya A, Muller SD, et al. Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop. 2014;85(1):26-31.
41. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Causes of death after total hip arthroplasty: a nationwide cohort study with 24,638 patients. J Arthroplasty. 2002;17(3):274-281.
42. Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD Jr. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg. 1995;80(2):242-248.
43. Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG. Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am. 2001;83(10):1524-1528.
44. Morris MJ, Molli RG, Berend KR, Lombardi AV Jr. Mortality and perioperative complications after unicompartmental knee arthroplasty. Knee. 2013;20(3):218-220.
45. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361.
46. Wijeysundera DN, Beattie WS, Wijeysundera HC, Yun L, Austin PC, Ko DT. Duration of preoperative beta-blockade and outcomes after major elective noncardiac surgery. Can J Cardiol. 2014;30(2):217-223.
47. Andersson C, Merie C, Jorgensen M, et al. Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Int Med. 2014;174(3):336-344.
48. Bakker EJ, Ravensbergen NJ, Poldermans D. Perioperative cardiac evaluation, monitoring, and risk reduction strategies in noncardiac surgery patients. Curr Opin Crit Care. 2011;17(5):409-415.
49. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287(11):1435-1444.
The incidence of shoulder arthroplasty in the United States is increasing annually,1-3 and the majority of these operations occur in older patients.4-6 Elderly patients with cardiovascular, pulmonary, cerebral, renal, and hepatic disease are increasingly susceptible to numerous surgical complications.4 Myocardial infarction (MI) is a complication that occurs in 0.7% of noncardiac surgeries. This figure increases to 1.1% in patients with coronary artery disease.7-11 Perioperative MI increases morbidity and mortality,8 and perioperative cardiac morbidity is the leading cause of death after anesthesia and surgery.12 The financial effects of perioperative cardiac morbidity and mortality must also be considered. A 2009 claims analysis study estimated charges associated with a perioperative MI at $15,000 and the cost of cardiac death at $21,909.13
Cardiovascular complications are associated with a significant degree of morbidity and mortality in patients who undergo arthroplasty.14-16 Although studies have elucidated 30- and 90-day morbidity and mortality rates after shoulder arthroplasty, in hip and knee arthroplasty17-19 little has been done to determine predictors of perioperative MI in a representative database of patients. Given the increasing incidence of shoulder arthroplasty in the United States, the elective nature of this procedure, and the percentage of the US population with cardiovascular risk factors,20 it is important to establish predictors of perioperative MI to ensure patients and physicians have the necessary resources to make informed decisions.
We conducted a study to examine the risk factors for perioperative MI in a large cohort of patients admitted for shoulder arthroplasty to US hospitals. We wanted to evaluate the association between perioperative MI and shoulder arthroplasty with respect to demographics, primary diagnosis, medical comorbidities, and perioperative complications. Specifically, we tested the null hypothesis that, among patients undergoing shoulder arthroplasty, and accounting for confounding variables, there would be no difference in risk factors for patients who have a perioperative MI.
Materials and Methods
This study was exempt from approval by our institutional review board. All data used in this project were deidentified before use.
Nationwide Inpatient Sample (NIS)
The Nationwide Inpatient Sample (NIS), an annual survey of hospitals, is conducted by the Healthcare Cost and Utilization Project (HCUP) and sponsored by the Agency for Healthcare Research and Quality (AHRQ). This database is the largest publicly available all-payer inpatient discharge database in the United States.21 Sampling 8 million hospital stays each year, NIS includes information from a representative batch of 20% of US hospitals. In 2011, 46 states and 1045 hospitals contributed information to the database, representing 97% of the US population.22 This large sample allows researchers to analyze a robust set of medical conditions and uncommon treatments. The survey, conducted each year since 1988, includes demographic, clinical, and resource use data.23 Discharge weight files are provided by NIS to arrive at valid national estimates.
This database is particularly useful because it provides information on up to 25 medical diagnoses and 15 procedures, which are recorded with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Researchers can use this database to analyze patient and hospital characteristics as well as inpatient outcomes.24,25 Numerous studies have used NIS to address pertinent queries across the medical landscape.22,26
Patient Selection and Analysis
We used NIS to isolate a population of 422,371 adults (≥18 years old) who underwent total shoulder arthroplasty (TSA) or hemi–shoulder arthroplasty (HSA) between January 1, 2002 and December 31, 2011. We then placed the patients in this population into 1 of 2 cohorts. The first cohort had an acute MI during the perioperative period after TSA, and the second, larger cohort did not have an acute MI after TSA. Acute MI was identified using ICD-9-CM code 410.xx. To identify a population of shoulder arthroplasty patients, we included discharges with an ICD-9-CM procedure code of 81.80 or 81.88 (both TSA) or 81.81 (HSA) in the sample. We then considered the degree to which each of 5 variables—primary diagnosis, age, sex, race, and select medical comorbidities—was predictive of in-hospital MI after TSA.
Statistical Analysis
Given the large sample used in this study, normal distribution of data was assumed. Using bivariate analysis, Pearson χ2 test for categorical data, and independent-samples t test for continuous data, we compared the nonacute MI and acute MI groups. Multivariable binary logistic regression analyses allowed us to isolate the extent that primary diagnosis, age, sex, race, and medical comorbidities were predictors of acute MI after shoulder arthroplasty. Statistical significance was set at P < .05. SPSS Version 22.0 (SPSS, Chicago, Illinois) was used for all statistical analyses and data modeling.
Results
Between January 1, 2002 and December 31, 2011, an estimated total of 422,371 patients underwent shoulder arthroplasty (59.3% TSA, 40.7% HSA). Of these patients, 1174 (0.28%) had a perioperative MI, and 421,197 (99.72%) did not (Table 1). Patients with a primary diagnosis of proximal humerus fracture (33.8% vs 16.6%; P < .001) or rotator cuff arthropathy (10.1% vs 9.9%; P < .001) were more likely than patients with other diagnoses to have an in-hospital MI.
Our review of the demographics found that patients who underwent shoulder arthroplasty and had a perioperative MI were likely older (75±8.9 years vs 69±11 years; P < .001), Caucasian (94.2% vs 91.9%; P = .002), male (43.2% vs 39.7%; P = .013), in the highest median household income bracket of $63,000 or more (30.8% vs 25.6%; P < .001), and using Medicare (80.9% vs 66.3%; P < .001). They were more likely to be treated in a medical center of medium size (25.6% vs 23.7%; P = .042) or larger (61.8% vs 61.2%; P = .042). MIs occurred more often in urban environments (91.4% vs 88.5%; P = .002) and in HSA patients (55% vs 40.6%; P < .001), resulting in longer hospital stays (9.4±7.9 days vs 2.7±2.5 days; P < .001) and higher probability of death (6.5% vs 0.1%; P < .001).
We then analyzed the 2 cohorts for medical comorbidities (Table 2). Patients in the MI cohort presented with a significantly higher incidence of congestive heart failure, previous MI, angina pectoris, chronic lung disease, hypertension, diabetes, renal failure, fluid and electrolyte disorders, pulmonary circulatory disease, coagulopathy, and deficiency anemia (P < .001) but not liver disease and obesity. Bivariate analysis of perioperative outcomes (Table 3) indicated that these patients also had a statistically higher rate of numerous other complications: pulmonary embolism (4.9% vs 0.2%; P < .001), pneumonia (15.1% vs 1.2%; P < .001), deep venous thrombosis (2.6% vs 0.2%; P < .001), cerebrovascular event (1.6% vs 0.1%; P < .001), acute renal failure (15.1% vs 1.2%; P < .001), gastrointestinal complication (1.2% vs 0.3%; P < .001), mechanical ventilation (1.2% vs 0.3%; P < .001), transfusion (33.4% vs 8.8%; P < .001), and nonroutine discharge (73.3% vs 36.0%; P < .001).
Multivariable logistic regression analysis was performed to determine independent predictors of perioperative MI after shoulder arthroplasty (Table 4). Patients with a primary diagnosis of proximal humerus fracture (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.15-1.65; P < .001) were more likely than patients with a primary diagnosis of osteoarthritis to have an MI. The odds of postoperative MI increased with age (OR, 1.04 per year; 95% CI, 1.03-1.05; P < .001) and were higher in males (OR, 1.72; 95% CI, 1.52-1.96; P < .001). Compared with Caucasians, African Americans (OR, 0.19; 95% CI, 0.09-0.40; P < .001) were less likely to have an in-hospital MI after shoulder arthroplasty. After shoulder arthroplasty, the odds of MI in the perioperative period increased with each subsequent day of care (OR, 1.10; 95% CI, 1.10-1.11; P < .001).
Regarding independent comorbidities, multivariable logistic regression analysis also determined that history of congestive heart failure (OR, 4.86; 95% CI, 4.20-5.61; P < .001), angina pectoris (OR, 2.90; 95% CI, 2.02-4.17; P < .001), complicated diabetes (OR, 1.96; 95% CI, 1.49-2.57; P < .001), renal failure (OR, 1.42; 95% CI, 1.17-1.72; P < .001), fluid and electrolyte disorders (OR, 1.42; 95% CI, 1.21-1.67; P < .001), and deficiency anemia (OR, 1.62; 95% CI, 1.40-1.88; P < .001) were significant predictors of perioperative MI after shoulder arthroplasty.
Discussion
Results of other studies have elucidated 30- and 90-day mortality rates and postoperative complications after shoulder arthroplasty, but, relative to hip and knee arthroplasty,17-19 little has been done to determine predictors of perioperative MI in a large sample of shoulder arthroplasty patients. Given the increasing rates of shoulder arthroplasty1-3 and the demographics of this population,4-6 it is likely that postoperative cardiovascular events will increase in frequency. We found that, in order of decreasing significance, the top 4 risk predictors for acute MI after shoulder arthroplasty were congestive heart failure, angina pectoralis, complicated diabetes mellitus, and male sex. Other pertinent risk factors included older age, Caucasian ethnicity, and a primary diagnosis of proximal humerus fracture. The rate of acute MI in patients who were older than 75 years when they underwent HSA for proximal humerus fracture was 0.80%.
Demographics
We found that patients who had an acute MI after shoulder arthroplasty were likely older, male, and Caucasian. Age and male sex are well-established risk factors for increased cardiac complications after arthroplasty.27-29 Previous studies have indicated that the rate of cardiac events increases in arthroplasty patients older than 65 years.19,28,29 In our study, more than 50% of the patients who had an acute perioperative MI were older than 85 years. Less explainable is the increased occurrence of acute MI in Caucasian patients and wealthy patients, given that minorities in the United States have higher rates of cardiovascular disease.30 Shoulder arthroplasty is an elective procedure, more likely to be undertaken by Caucasians. Therefore, at-risk minority groups and financially challenged groups may be less likely to have this procedure.
Primary Diagnosis
In this series, patients with a primary diagnosis of proximal humerus fracture were more likely to have an in-hospital MI. This finding is consistent with previous studies indicating a higher rate of complications for proximal humerus fracture patients than for shoulder arthroplasty patients.31,32 Given that more than 75% of patients who present with a proximal humerus fracture are older than 70 years, it would be prudent to examine operative indications after this diagnosis,33 particularly as benefit from surgery for fractures has not been definitively demonstrated.34-37
Comorbidities
Many of the patients in our MI cohort presented with congestive heart failure, angina pectoris, complicated diabetes, renal failure, fluid and electrolyte disorders, or deficiency anemia. This is in keeping with other studies indicating that preexisting cardiovascular morbidity increases the rate of MI after various forms of arthroplasty.7-11 Patients in our MI cohort were also susceptible to a variety of post-MI perioperative complications, including pulmonary embolism, pneumonia, deep venous thrombosis, cerebrovascular event, acute renal failure, gastrointestinal complication, mechanical ventilation, transfusion, and nonroutine discharge, and their incidence of death was higher. These findings are consistent with reports that postoperative cardiovascular complications increase the degree of morbidity and mortality in arthroplasty patients.14-16 It is also worth noting that the odds of MI in the perioperative period increase with each subsequent day of care. This is understandable given that patients presenting with numerous comorbidities are at increased risk for perioperative complications38 resulting in hospital readmission.39
The literature indicates that MI occurs as a complication in 0.7% of patients who undergo noncardiac surgery,7 though some series have shown it is more prevalent after arthroplasty procedures.28,40 MI significantly increases the rate of perioperative morbidity and mortality,8 and perioperative cardiac morbidity is a leading cause of death after anesthesia and surgery.12 Furthermore, the most common cause of death after lower extremity arthroplasty is cardiovascular-related.41,42 In patients who presented for elective hip arthroplasty, cardiorespiratory disease was one of the main risk factors (with older age and male sex) shown to increase perioperative mortality.43
Perioperative cardiovascular complications increase postoperative morbidity and mortality.12 The rate of cardiovascular complications after shoulder arthroplasty ranges from 0.8% to 2.6%, and the incidence of MI hovers between 0.3% and 0.9%.17,19,28,40,44 A recent study in 793 patients found that, over a 30-day period, cardiovascular complications accounted for more than one-fourth of all complications.17 Singh and colleagues19 analyzed cardiopulmonary complications after primary shoulder arthroplasty in a total of 3480 patients (4019 arthroplasties) and found this group had a 90-day cardiac morbidity (MI, congestive heart failure, arrhythmia) rate of 2.6%. In that study, a Deyo-Charlson index of 1 or more was a significant independent risk factor for cardiac complications following surgery. Scores on this weighted index of 17 comorbidities are used to assess the complexities of a patient population. Given the severity of cardiovascular perioperative complications, it is important to preoperatively identify high-risk population groups and sufficiently study and optimize patients before shoulder arthroplasty.
There is much debate about the effectiveness of perioperative β-blockers in reducing perioperative cardiac morbidity and mortality.45-48 Such a discussion is outside of the scope of this article, but it may be prudent to seek a cardiology consultation for patients presenting with risk factors for perioperative MI. β-Blockers may prove useful in reducing cardiac morbidity in high-risk patients after noncardiac surgery.45,49
Many limitations are inherent in studies that use a nationally represented database such as NIS, which we used in this study. It is highly likely that NIS does not capture all potential postoperative complications, as this database is very large and subject to errors in data entry and clinical coding. In addition, detailed clinical information (eg, severity of certain comorbid diseases before shoulder arthroplasty, details about the intraoperative course) was not readily available for analysis. Another limitation, which may have led to an underestimate of complication rates, was our not being able to obtain information about postdischarge complications.
Despite these limitations, NIS and other databases have helped researchers answer questions about low-incidence conditions and generalize findings to a national population. In the present study, we analyzed 2 cohorts, patients with and without acute MI after shoulder arthroplasty, to determine predictors for and complications of postarthroplasty MI. We identified numerous predictors for acute MI: congestive heart failure, angina pectoris, complicated diabetes, renal failure, fluid and electrolyte disorders, and deficiency anemia prior to arthroplasty. As perioperative MI is associated with significant morbidity,14-16 it would be wise to screen patients for such comorbid conditions, assess the severity of these conditions, and offer shoulder arthroplasty with prudence.
Conclusion
The top 4 predictors for acute MI after shoulder arthroplasty were congestive heart failure, angina pectoralis, complicated diabetes mellitus, and male sex. Other pertinent risk factors included older age, Caucasian ethnicity, and primary diagnosis of proximal humerus fracture. Surgeons and patients must be aware of predictors for adverse surgical outcomes such as perioperative MI and understand the extent to which these events increase perioperative morbidity and mortality.
The incidence of shoulder arthroplasty in the United States is increasing annually,1-3 and the majority of these operations occur in older patients.4-6 Elderly patients with cardiovascular, pulmonary, cerebral, renal, and hepatic disease are increasingly susceptible to numerous surgical complications.4 Myocardial infarction (MI) is a complication that occurs in 0.7% of noncardiac surgeries. This figure increases to 1.1% in patients with coronary artery disease.7-11 Perioperative MI increases morbidity and mortality,8 and perioperative cardiac morbidity is the leading cause of death after anesthesia and surgery.12 The financial effects of perioperative cardiac morbidity and mortality must also be considered. A 2009 claims analysis study estimated charges associated with a perioperative MI at $15,000 and the cost of cardiac death at $21,909.13
Cardiovascular complications are associated with a significant degree of morbidity and mortality in patients who undergo arthroplasty.14-16 Although studies have elucidated 30- and 90-day morbidity and mortality rates after shoulder arthroplasty, in hip and knee arthroplasty17-19 little has been done to determine predictors of perioperative MI in a representative database of patients. Given the increasing incidence of shoulder arthroplasty in the United States, the elective nature of this procedure, and the percentage of the US population with cardiovascular risk factors,20 it is important to establish predictors of perioperative MI to ensure patients and physicians have the necessary resources to make informed decisions.
We conducted a study to examine the risk factors for perioperative MI in a large cohort of patients admitted for shoulder arthroplasty to US hospitals. We wanted to evaluate the association between perioperative MI and shoulder arthroplasty with respect to demographics, primary diagnosis, medical comorbidities, and perioperative complications. Specifically, we tested the null hypothesis that, among patients undergoing shoulder arthroplasty, and accounting for confounding variables, there would be no difference in risk factors for patients who have a perioperative MI.
Materials and Methods
This study was exempt from approval by our institutional review board. All data used in this project were deidentified before use.
Nationwide Inpatient Sample (NIS)
The Nationwide Inpatient Sample (NIS), an annual survey of hospitals, is conducted by the Healthcare Cost and Utilization Project (HCUP) and sponsored by the Agency for Healthcare Research and Quality (AHRQ). This database is the largest publicly available all-payer inpatient discharge database in the United States.21 Sampling 8 million hospital stays each year, NIS includes information from a representative batch of 20% of US hospitals. In 2011, 46 states and 1045 hospitals contributed information to the database, representing 97% of the US population.22 This large sample allows researchers to analyze a robust set of medical conditions and uncommon treatments. The survey, conducted each year since 1988, includes demographic, clinical, and resource use data.23 Discharge weight files are provided by NIS to arrive at valid national estimates.
This database is particularly useful because it provides information on up to 25 medical diagnoses and 15 procedures, which are recorded with International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Researchers can use this database to analyze patient and hospital characteristics as well as inpatient outcomes.24,25 Numerous studies have used NIS to address pertinent queries across the medical landscape.22,26
Patient Selection and Analysis
We used NIS to isolate a population of 422,371 adults (≥18 years old) who underwent total shoulder arthroplasty (TSA) or hemi–shoulder arthroplasty (HSA) between January 1, 2002 and December 31, 2011. We then placed the patients in this population into 1 of 2 cohorts. The first cohort had an acute MI during the perioperative period after TSA, and the second, larger cohort did not have an acute MI after TSA. Acute MI was identified using ICD-9-CM code 410.xx. To identify a population of shoulder arthroplasty patients, we included discharges with an ICD-9-CM procedure code of 81.80 or 81.88 (both TSA) or 81.81 (HSA) in the sample. We then considered the degree to which each of 5 variables—primary diagnosis, age, sex, race, and select medical comorbidities—was predictive of in-hospital MI after TSA.
Statistical Analysis
Given the large sample used in this study, normal distribution of data was assumed. Using bivariate analysis, Pearson χ2 test for categorical data, and independent-samples t test for continuous data, we compared the nonacute MI and acute MI groups. Multivariable binary logistic regression analyses allowed us to isolate the extent that primary diagnosis, age, sex, race, and medical comorbidities were predictors of acute MI after shoulder arthroplasty. Statistical significance was set at P < .05. SPSS Version 22.0 (SPSS, Chicago, Illinois) was used for all statistical analyses and data modeling.
Results
Between January 1, 2002 and December 31, 2011, an estimated total of 422,371 patients underwent shoulder arthroplasty (59.3% TSA, 40.7% HSA). Of these patients, 1174 (0.28%) had a perioperative MI, and 421,197 (99.72%) did not (Table 1). Patients with a primary diagnosis of proximal humerus fracture (33.8% vs 16.6%; P < .001) or rotator cuff arthropathy (10.1% vs 9.9%; P < .001) were more likely than patients with other diagnoses to have an in-hospital MI.
Our review of the demographics found that patients who underwent shoulder arthroplasty and had a perioperative MI were likely older (75±8.9 years vs 69±11 years; P < .001), Caucasian (94.2% vs 91.9%; P = .002), male (43.2% vs 39.7%; P = .013), in the highest median household income bracket of $63,000 or more (30.8% vs 25.6%; P < .001), and using Medicare (80.9% vs 66.3%; P < .001). They were more likely to be treated in a medical center of medium size (25.6% vs 23.7%; P = .042) or larger (61.8% vs 61.2%; P = .042). MIs occurred more often in urban environments (91.4% vs 88.5%; P = .002) and in HSA patients (55% vs 40.6%; P < .001), resulting in longer hospital stays (9.4±7.9 days vs 2.7±2.5 days; P < .001) and higher probability of death (6.5% vs 0.1%; P < .001).
We then analyzed the 2 cohorts for medical comorbidities (Table 2). Patients in the MI cohort presented with a significantly higher incidence of congestive heart failure, previous MI, angina pectoris, chronic lung disease, hypertension, diabetes, renal failure, fluid and electrolyte disorders, pulmonary circulatory disease, coagulopathy, and deficiency anemia (P < .001) but not liver disease and obesity. Bivariate analysis of perioperative outcomes (Table 3) indicated that these patients also had a statistically higher rate of numerous other complications: pulmonary embolism (4.9% vs 0.2%; P < .001), pneumonia (15.1% vs 1.2%; P < .001), deep venous thrombosis (2.6% vs 0.2%; P < .001), cerebrovascular event (1.6% vs 0.1%; P < .001), acute renal failure (15.1% vs 1.2%; P < .001), gastrointestinal complication (1.2% vs 0.3%; P < .001), mechanical ventilation (1.2% vs 0.3%; P < .001), transfusion (33.4% vs 8.8%; P < .001), and nonroutine discharge (73.3% vs 36.0%; P < .001).
Multivariable logistic regression analysis was performed to determine independent predictors of perioperative MI after shoulder arthroplasty (Table 4). Patients with a primary diagnosis of proximal humerus fracture (odds ratio [OR], 1.38; 95% confidence interval [CI], 1.15-1.65; P < .001) were more likely than patients with a primary diagnosis of osteoarthritis to have an MI. The odds of postoperative MI increased with age (OR, 1.04 per year; 95% CI, 1.03-1.05; P < .001) and were higher in males (OR, 1.72; 95% CI, 1.52-1.96; P < .001). Compared with Caucasians, African Americans (OR, 0.19; 95% CI, 0.09-0.40; P < .001) were less likely to have an in-hospital MI after shoulder arthroplasty. After shoulder arthroplasty, the odds of MI in the perioperative period increased with each subsequent day of care (OR, 1.10; 95% CI, 1.10-1.11; P < .001).
Regarding independent comorbidities, multivariable logistic regression analysis also determined that history of congestive heart failure (OR, 4.86; 95% CI, 4.20-5.61; P < .001), angina pectoris (OR, 2.90; 95% CI, 2.02-4.17; P < .001), complicated diabetes (OR, 1.96; 95% CI, 1.49-2.57; P < .001), renal failure (OR, 1.42; 95% CI, 1.17-1.72; P < .001), fluid and electrolyte disorders (OR, 1.42; 95% CI, 1.21-1.67; P < .001), and deficiency anemia (OR, 1.62; 95% CI, 1.40-1.88; P < .001) were significant predictors of perioperative MI after shoulder arthroplasty.
Discussion
Results of other studies have elucidated 30- and 90-day mortality rates and postoperative complications after shoulder arthroplasty, but, relative to hip and knee arthroplasty,17-19 little has been done to determine predictors of perioperative MI in a large sample of shoulder arthroplasty patients. Given the increasing rates of shoulder arthroplasty1-3 and the demographics of this population,4-6 it is likely that postoperative cardiovascular events will increase in frequency. We found that, in order of decreasing significance, the top 4 risk predictors for acute MI after shoulder arthroplasty were congestive heart failure, angina pectoralis, complicated diabetes mellitus, and male sex. Other pertinent risk factors included older age, Caucasian ethnicity, and a primary diagnosis of proximal humerus fracture. The rate of acute MI in patients who were older than 75 years when they underwent HSA for proximal humerus fracture was 0.80%.
Demographics
We found that patients who had an acute MI after shoulder arthroplasty were likely older, male, and Caucasian. Age and male sex are well-established risk factors for increased cardiac complications after arthroplasty.27-29 Previous studies have indicated that the rate of cardiac events increases in arthroplasty patients older than 65 years.19,28,29 In our study, more than 50% of the patients who had an acute perioperative MI were older than 85 years. Less explainable is the increased occurrence of acute MI in Caucasian patients and wealthy patients, given that minorities in the United States have higher rates of cardiovascular disease.30 Shoulder arthroplasty is an elective procedure, more likely to be undertaken by Caucasians. Therefore, at-risk minority groups and financially challenged groups may be less likely to have this procedure.
Primary Diagnosis
In this series, patients with a primary diagnosis of proximal humerus fracture were more likely to have an in-hospital MI. This finding is consistent with previous studies indicating a higher rate of complications for proximal humerus fracture patients than for shoulder arthroplasty patients.31,32 Given that more than 75% of patients who present with a proximal humerus fracture are older than 70 years, it would be prudent to examine operative indications after this diagnosis,33 particularly as benefit from surgery for fractures has not been definitively demonstrated.34-37
Comorbidities
Many of the patients in our MI cohort presented with congestive heart failure, angina pectoris, complicated diabetes, renal failure, fluid and electrolyte disorders, or deficiency anemia. This is in keeping with other studies indicating that preexisting cardiovascular morbidity increases the rate of MI after various forms of arthroplasty.7-11 Patients in our MI cohort were also susceptible to a variety of post-MI perioperative complications, including pulmonary embolism, pneumonia, deep venous thrombosis, cerebrovascular event, acute renal failure, gastrointestinal complication, mechanical ventilation, transfusion, and nonroutine discharge, and their incidence of death was higher. These findings are consistent with reports that postoperative cardiovascular complications increase the degree of morbidity and mortality in arthroplasty patients.14-16 It is also worth noting that the odds of MI in the perioperative period increase with each subsequent day of care. This is understandable given that patients presenting with numerous comorbidities are at increased risk for perioperative complications38 resulting in hospital readmission.39
The literature indicates that MI occurs as a complication in 0.7% of patients who undergo noncardiac surgery,7 though some series have shown it is more prevalent after arthroplasty procedures.28,40 MI significantly increases the rate of perioperative morbidity and mortality,8 and perioperative cardiac morbidity is a leading cause of death after anesthesia and surgery.12 Furthermore, the most common cause of death after lower extremity arthroplasty is cardiovascular-related.41,42 In patients who presented for elective hip arthroplasty, cardiorespiratory disease was one of the main risk factors (with older age and male sex) shown to increase perioperative mortality.43
Perioperative cardiovascular complications increase postoperative morbidity and mortality.12 The rate of cardiovascular complications after shoulder arthroplasty ranges from 0.8% to 2.6%, and the incidence of MI hovers between 0.3% and 0.9%.17,19,28,40,44 A recent study in 793 patients found that, over a 30-day period, cardiovascular complications accounted for more than one-fourth of all complications.17 Singh and colleagues19 analyzed cardiopulmonary complications after primary shoulder arthroplasty in a total of 3480 patients (4019 arthroplasties) and found this group had a 90-day cardiac morbidity (MI, congestive heart failure, arrhythmia) rate of 2.6%. In that study, a Deyo-Charlson index of 1 or more was a significant independent risk factor for cardiac complications following surgery. Scores on this weighted index of 17 comorbidities are used to assess the complexities of a patient population. Given the severity of cardiovascular perioperative complications, it is important to preoperatively identify high-risk population groups and sufficiently study and optimize patients before shoulder arthroplasty.
There is much debate about the effectiveness of perioperative β-blockers in reducing perioperative cardiac morbidity and mortality.45-48 Such a discussion is outside of the scope of this article, but it may be prudent to seek a cardiology consultation for patients presenting with risk factors for perioperative MI. β-Blockers may prove useful in reducing cardiac morbidity in high-risk patients after noncardiac surgery.45,49
Many limitations are inherent in studies that use a nationally represented database such as NIS, which we used in this study. It is highly likely that NIS does not capture all potential postoperative complications, as this database is very large and subject to errors in data entry and clinical coding. In addition, detailed clinical information (eg, severity of certain comorbid diseases before shoulder arthroplasty, details about the intraoperative course) was not readily available for analysis. Another limitation, which may have led to an underestimate of complication rates, was our not being able to obtain information about postdischarge complications.
Despite these limitations, NIS and other databases have helped researchers answer questions about low-incidence conditions and generalize findings to a national population. In the present study, we analyzed 2 cohorts, patients with and without acute MI after shoulder arthroplasty, to determine predictors for and complications of postarthroplasty MI. We identified numerous predictors for acute MI: congestive heart failure, angina pectoris, complicated diabetes, renal failure, fluid and electrolyte disorders, and deficiency anemia prior to arthroplasty. As perioperative MI is associated with significant morbidity,14-16 it would be wise to screen patients for such comorbid conditions, assess the severity of these conditions, and offer shoulder arthroplasty with prudence.
Conclusion
The top 4 predictors for acute MI after shoulder arthroplasty were congestive heart failure, angina pectoralis, complicated diabetes mellitus, and male sex. Other pertinent risk factors included older age, Caucasian ethnicity, and primary diagnosis of proximal humerus fracture. Surgeons and patients must be aware of predictors for adverse surgical outcomes such as perioperative MI and understand the extent to which these events increase perioperative morbidity and mortality.
1. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM. Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg. 2010;19(8):1115-1120.
2. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011;93(24):2249-2254.
3. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop. 2009;467(10):2606-2612.
4. Boettcher WG. Total hip arthroplasties in the elderly. Morbidity, mortality, and cost effectiveness. Clin Orthop. 1992;(274):30-34.
5. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993;31(2):141-154.
6. Kreder HJ, Williams JI, Jaglal S, Hu R, Axcell T, Stephen D. Are complication rates for elective primary total hip arthroplasty in Ontario related to surgeon and hospital volumes? A preliminary investigation. Can J Surg. 1998;41(6):431-437.
7. Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564-578.
8. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 1990;323(26):1781-1788.
9. Tarhan S, Moffitt EA, Taylor WF, Giuliani ER. Myocardial infarction after general anesthesia. JAMA. 1972;220(11):1451-1454.
10. Landesberg G, Mosseri M, Zahger D, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol. 2001;37(7):1839-1845.
11. van Waes JA, Nathoe HM, de Graaff JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation. 2013;127(23):2264-2271.
12. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72(1):153-184.
13. Fleisher LA, Corbett W, Berry C, Poldermans D. Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients. J Cardiothorac Vasc Anesth. 2004;18(1):7-13.
14. Aynardi M, Pulido L, Parvizi J, Sharkey PF, Rothman RH. Early mortality after modern total hip arthroplasty. Clin Orthop. 2009;467(1):213-218.
15. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45(2):335-341.
16. Baser O, Supina D, Sengupta N, Wang L, Kwong L. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. Am J Health Syst Pharm. 2010;67(17):1438-1445.
17. Fehringer EV, Mikuls TR, Michaud KD, Henderson WG, O’Dell JR. Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans. Clin Orthop. 2010;468(3):717-722.
18. Farmer KW, Hammond JW, Queale WS, Keyurapan E, McFarland EG. Shoulder arthroplasty versus hip and knee arthroplasties: a comparison of outcomes. Clin Orthop. 2007;(455):183-189.
19. Singh JA, Sperling JW, Cofield RH. Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study. Semin Arthritis Rheum. 2012;41(5):689-697.
20. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
21. Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95(11):1028-1036.
22. Maynard C, Sales AE. Changes in the use of coronary artery revascularization procedures in the Department of Veterans Affairs, the National Hospital Discharge Survey, and the Nationwide Inpatient Sample, 1991–1999. BMC Health Serv Res. 2003;3(1):12.
23. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Obstructive sleep apnea as a risk factor after shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(12):e6-e9.
24. Hambright D, Henderson RA, Cook C, Worrell T, Moorman CT, Bolognesi MP. A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. J Shoulder Elbow Surg. 2011;20(1):77-85.
25. Odum SM, Troyer JL, Kelly MP, Dedini RD, Bozic KJ. A cost-utility analysis comparing the cost-effectiveness of simultaneous and staged bilateral total knee arthroplasty. J Bone Joint Surg Am. 2013;95(16):1441-1449.
26. Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(5):671-678.
27. Alfonso DT, Toussaint RJ, Alfonso BD, Strauss EJ, Steiger DT, Di Cesare PE. Nonsurgical complications after total hip and knee arthroplasty. Am J Orthop. 2006;35(11):503-510.
28. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96(5):1140-1146.
29. Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011;70(12):2082-2088.
30. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17(1):143-152.
31. Zhang AL, Schairer WW, Feeley BT. Hospital readmissions after surgical treatment of proximal humerus fractures: is arthroplasty safer than open reduction internal fixation? Clin Orthop. 2014;472(8):2317-2324.
32. Schairer WW, Zhang AL, Feeley BT. Hospital readmissions after primary shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(9):1349-1355.
33. de Kruijf M, Vroemen JP, de Leur K, van der Voort EA, Vos DI, Van der Laan L. Proximal fractures of the humerus in patients older than 75 years of age: should we consider operative treatment? J Orthop Traumatol. 2014;15(2):111-115.
34. Hauschild O, Konrad G, Audige L, et al. Operative versus non-operative treatment for two-part surgical neck fractures of the proximal humerus. Arch Orthop Trauma Surg. 2013;133(10):1385-1393.
35. Hanson B, Neidenbach P, de Boer P, Stengel D. Functional outcomes after nonoperative management of fractures of the proximal humerus. J Shoulder Elbow Surg. 2009;18(4):612-621.
36. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2012;12:CD000434.
37. Court-Brown CM, Cattermole H, McQueen MM. Impacted valgus fractures (B1.1) of the proximal humerus. The results of non-operative treatment. J Bone Joint Surg Br. 2002;84(4):504-508.
38. Chalmers PN, Gupta AK, Rahman Z, Bruce B, Romeo AA, Nicholson GP. Predictors of early complications of total shoulder arthroplasty. J Arthroplasty. 2014;29(4):856-860.
39. Mahoney A, Bosco JA 3rd, Zuckerman JD. Readmission after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(3):377-381.
40. Khan SK, Malviya A, Muller SD, et al. Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop. 2014;85(1):26-31.
41. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Causes of death after total hip arthroplasty: a nationwide cohort study with 24,638 patients. J Arthroplasty. 2002;17(3):274-281.
42. Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD Jr. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg. 1995;80(2):242-248.
43. Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG. Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am. 2001;83(10):1524-1528.
44. Morris MJ, Molli RG, Berend KR, Lombardi AV Jr. Mortality and perioperative complications after unicompartmental knee arthroplasty. Knee. 2013;20(3):218-220.
45. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361.
46. Wijeysundera DN, Beattie WS, Wijeysundera HC, Yun L, Austin PC, Ko DT. Duration of preoperative beta-blockade and outcomes after major elective noncardiac surgery. Can J Cardiol. 2014;30(2):217-223.
47. Andersson C, Merie C, Jorgensen M, et al. Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Int Med. 2014;174(3):336-344.
48. Bakker EJ, Ravensbergen NJ, Poldermans D. Perioperative cardiac evaluation, monitoring, and risk reduction strategies in noncardiac surgery patients. Curr Opin Crit Care. 2011;17(5):409-415.
49. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287(11):1435-1444.
1. Day JS, Lau E, Ong KL, Williams GR, Ramsey ML, Kurtz SM. Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg. 2010;19(8):1115-1120.
2. Kim SH, Wise BL, Zhang Y, Szabo RM. Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am. 2011;93(24):2249-2254.
3. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop. 2009;467(10):2606-2612.
4. Boettcher WG. Total hip arthroplasties in the elderly. Morbidity, mortality, and cost effectiveness. Clin Orthop. 1992;(274):30-34.
5. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care. 1993;31(2):141-154.
6. Kreder HJ, Williams JI, Jaglal S, Hu R, Axcell T, Stephen D. Are complication rates for elective primary total hip arthroplasty in Ontario related to surgeon and hospital volumes? A preliminary investigation. Can J Surg. 1998;41(6):431-437.
7. Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120(3):564-578.
8. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med. 1990;323(26):1781-1788.
9. Tarhan S, Moffitt EA, Taylor WF, Giuliani ER. Myocardial infarction after general anesthesia. JAMA. 1972;220(11):1451-1454.
10. Landesberg G, Mosseri M, Zahger D, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol. 2001;37(7):1839-1845.
11. van Waes JA, Nathoe HM, de Graaff JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation. 2013;127(23):2264-2271.
12. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. 1990;72(1):153-184.
13. Fleisher LA, Corbett W, Berry C, Poldermans D. Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients. J Cardiothorac Vasc Anesth. 2004;18(1):7-13.
14. Aynardi M, Pulido L, Parvizi J, Sharkey PF, Rothman RH. Early mortality after modern total hip arthroplasty. Clin Orthop. 2009;467(1):213-218.
15. Gangireddy C, Rectenwald JR, Upchurch GR, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg. 2007;45(2):335-341.
16. Baser O, Supina D, Sengupta N, Wang L, Kwong L. Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. Am J Health Syst Pharm. 2010;67(17):1438-1445.
17. Fehringer EV, Mikuls TR, Michaud KD, Henderson WG, O’Dell JR. Shoulder arthroplasties have fewer complications than hip or knee arthroplasties in US veterans. Clin Orthop. 2010;468(3):717-722.
18. Farmer KW, Hammond JW, Queale WS, Keyurapan E, McFarland EG. Shoulder arthroplasty versus hip and knee arthroplasties: a comparison of outcomes. Clin Orthop. 2007;(455):183-189.
19. Singh JA, Sperling JW, Cofield RH. Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study. Semin Arthritis Rheum. 2012;41(5):689-697.
20. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-e292.
21. Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95(11):1028-1036.
22. Maynard C, Sales AE. Changes in the use of coronary artery revascularization procedures in the Department of Veterans Affairs, the National Hospital Discharge Survey, and the Nationwide Inpatient Sample, 1991–1999. BMC Health Serv Res. 2003;3(1):12.
23. Griffin JW, Novicoff WM, Browne JA, Brockmeier SF. Obstructive sleep apnea as a risk factor after shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22(12):e6-e9.
24. Hambright D, Henderson RA, Cook C, Worrell T, Moorman CT, Bolognesi MP. A comparison of perioperative outcomes in patients with and without rheumatoid arthritis after receiving a total shoulder replacement arthroplasty. J Shoulder Elbow Surg. 2011;20(1):77-85.
25. Odum SM, Troyer JL, Kelly MP, Dedini RD, Bozic KJ. A cost-utility analysis comparing the cost-effectiveness of simultaneous and staged bilateral total knee arthroplasty. J Bone Joint Surg Am. 2013;95(16):1441-1449.
26. Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(5):671-678.
27. Alfonso DT, Toussaint RJ, Alfonso BD, Strauss EJ, Steiger DT, Di Cesare PE. Nonsurgical complications after total hip and knee arthroplasty. Am J Orthop. 2006;35(11):503-510.
28. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96(5):1140-1146.
29. Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG. Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty. Ann Rheum Dis. 2011;70(12):2082-2088.
30. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular disease risk factors: a systematic review. Ethn Dis. 2007;17(1):143-152.
31. Zhang AL, Schairer WW, Feeley BT. Hospital readmissions after surgical treatment of proximal humerus fractures: is arthroplasty safer than open reduction internal fixation? Clin Orthop. 2014;472(8):2317-2324.
32. Schairer WW, Zhang AL, Feeley BT. Hospital readmissions after primary shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(9):1349-1355.
33. de Kruijf M, Vroemen JP, de Leur K, van der Voort EA, Vos DI, Van der Laan L. Proximal fractures of the humerus in patients older than 75 years of age: should we consider operative treatment? J Orthop Traumatol. 2014;15(2):111-115.
34. Hauschild O, Konrad G, Audige L, et al. Operative versus non-operative treatment for two-part surgical neck fractures of the proximal humerus. Arch Orthop Trauma Surg. 2013;133(10):1385-1393.
35. Hanson B, Neidenbach P, de Boer P, Stengel D. Functional outcomes after nonoperative management of fractures of the proximal humerus. J Shoulder Elbow Surg. 2009;18(4):612-621.
36. Handoll HH, Ollivere BJ, Rollins KE. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2012;12:CD000434.
37. Court-Brown CM, Cattermole H, McQueen MM. Impacted valgus fractures (B1.1) of the proximal humerus. The results of non-operative treatment. J Bone Joint Surg Br. 2002;84(4):504-508.
38. Chalmers PN, Gupta AK, Rahman Z, Bruce B, Romeo AA, Nicholson GP. Predictors of early complications of total shoulder arthroplasty. J Arthroplasty. 2014;29(4):856-860.
39. Mahoney A, Bosco JA 3rd, Zuckerman JD. Readmission after shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(3):377-381.
40. Khan SK, Malviya A, Muller SD, et al. Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop. 2014;85(1):26-31.
41. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Causes of death after total hip arthroplasty: a nationwide cohort study with 24,638 patients. J Arthroplasty. 2002;17(3):274-281.
42. Sharrock NE, Cazan MG, Hargett MJ, Williams-Russo P, Wilson PD Jr. Changes in mortality after total hip and knee arthroplasty over a ten-year period. Anesth Analg. 1995;80(2):242-248.
43. Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG. Thirty-day mortality after elective total hip arthroplasty. J Bone Joint Surg Am. 2001;83(10):1524-1528.
44. Morris MJ, Molli RG, Berend KR, Lombardi AV Jr. Mortality and perioperative complications after unicompartmental knee arthroplasty. Knee. 2013;20(3):218-220.
45. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361.
46. Wijeysundera DN, Beattie WS, Wijeysundera HC, Yun L, Austin PC, Ko DT. Duration of preoperative beta-blockade and outcomes after major elective noncardiac surgery. Can J Cardiol. 2014;30(2):217-223.
47. Andersson C, Merie C, Jorgensen M, et al. Association of beta-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. JAMA Int Med. 2014;174(3):336-344.
48. Bakker EJ, Ravensbergen NJ, Poldermans D. Perioperative cardiac evaluation, monitoring, and risk reduction strategies in noncardiac surgery patients. Curr Opin Crit Care. 2011;17(5):409-415.
49. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA. 2002;287(11):1435-1444.